<!DOCTYPE html>

<html lang="en">


<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
      
      
      
        <link rel="prev" href="../Immunology/">
      
      
      
      <link rel="icon" href="../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.5.3, mkdocs-material-9.5.12">
    
    
<title>Literature Survey (VPE)</title>

    
      <link rel="stylesheet" href="../assets/stylesheets/main.7e359304.min.css">
      
        
        <link rel="stylesheet" href="../assets/stylesheets/palette.06af60db.min.css">
      
      


    
    
  <!-- Add scripts that need to run before here -->
  <!-- Add jquery script -->
  <script src="https://code.jquery.com/jquery-3.7.1.js"></script>
  <!-- Add data table libraries -->
  <script src="https://cdn.datatables.net/2.0.1/js/dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/2.0.1/css/dataTables.dataTables.css">
  <!-- Load plotly.js into the DOM -->
	<script src='https://cdn.plot.ly/plotly-2.29.1.min.js'></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/buttons/3.0.1/css/buttons.dataTables.css">
  <!-- fixedColumns -->
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/dataTables.fixedColumns.js"></script>
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/fixedColumns.dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/fixedcolumns/5.0.0/css/fixedColumns.dataTables.css">
  <!-- Already specified in mkdocs.yml -->
  <!-- <link rel="stylesheet" href="../docs/custom.css"> -->
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/dataTables.buttons.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.dataTables.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/jszip/3.10.1/jszip.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/pdfmake.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/vfs_fonts.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.html5.min.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.print.min.js"></script>
  <!-- Google fonts -->
  <link rel="stylesheet" href="https://fonts.googleapis.com/icon?family=Material+Icons">
  <!-- Intro.js -->
  <script src="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/intro.min.js"></script>
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/minified/introjs.min.css">


  <!-- 
      
     -->
  <!-- Add scripts that need to run afterwards here -->

    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../assets/_mkdocstrings.css">
    
      <link rel="stylesheet" href="../custom.css">
    
    <script>__md_scope=new URL("..",location),__md_hash=e=>[...e].reduce((e,_)=>(e<<5)-e+_.charCodeAt(0),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

<header class="md-header" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href=".." title="Literature Survey for Swathi" class="md-header__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3V6m0 5h18v2H3v-2m0 5h18v2H3v-2Z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Literature Survey for Swathi
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Oncology
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 6H7c-3.31 0-6 2.69-6 6s2.69 6 6 6h10c3.31 0 6-2.69 6-6s-2.69-6-6-6zm0 10H7c-2.21 0-4-1.79-4-4s1.79-4 4-4h10c2.21 0 4 1.79 4 4s-1.79 4-4 4zM7 9c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="slate" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 7H7a5 5 0 0 0-5 5 5 5 0 0 0 5 5h10a5 5 0 0 0 5-5 5 5 0 0 0-5-5m0 8a3 3 0 0 1-3-3 3 3 0 0 1 3-3 3 3 0 0 1 3 3 3 3 0 0 1-3 3Z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var media,input,key,value,palette=__md_get("__palette");if(palette&&palette.color){"(prefers-color-scheme)"===palette.color.media&&(media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']"),palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent"));for([key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      <label class="md-header__button md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
      </label>
      <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41Z"/></svg>
        </button>
      </nav>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
      <div class="md-header__source">
        <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
            
<nav class="md-tabs" aria-label="Tabs" data-md-component="tabs">
  <div class="md-grid">
    <ul class="md-tabs__list">
      
        
  
  
  
    <li class="md-tabs__item">
      <a href=".." class="md-tabs__link">
        
  
    
  
  Home

      </a>
    </li>
  

      
        
  
  
  
    <li class="md-tabs__item">
      <a href="../Immunology/" class="md-tabs__link">
        
  
    
  
  Immunology

      </a>
    </li>
  

      
        
  
  
    
  
  
    <li class="md-tabs__item md-tabs__item--active">
      <a href="./" class="md-tabs__link">
        
  
    
  
  Oncology

      </a>
    </li>
  

      
    </ul>
  </div>
</nav>
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
                
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" hidden>
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    


  


<nav class="md-nav md-nav--primary md-nav--lifted" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href=".." title="Literature Survey for Swathi" class="md-nav__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    Literature Survey for Swathi
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href=".." class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Home
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../Immunology/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Immunology
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
    
  
  
  
    <li class="md-nav__item md-nav__item--active">
      
      <input class="md-nav__toggle md-toggle" type="checkbox" id="__toc">
      
      
      
      <a href="./" class="md-nav__link md-nav__link--active">
        
  
  <span class="md-ellipsis">
    Oncology
  </span>
  

      </a>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
                
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              <article class="md-content__inner md-typeset">
                
                  

  
  


  <h1>Oncology</h1>

<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
</head>

<body>
  <p>
  <i class="footer">This page was last updated on 2025-12-22 09:21:40 UTC</i>
  </p>

  <div class="note info" onclick="startIntro()">
    <p>
      <button type="button" class="buttons">
        <div style="display: flex; align-items: center;">
        Click here for a quick intro of the page! <i class="material-icons">help</i>
        </div>
      </button>
    </p>
  </div>

  <!--
  <div data-intro='Table of contents'>
    <p>
    <h3>Table of Contents</h3>
      <a href="#plot1">1. Citations over time on Oncology</a><br>
      <a href="#manually_curated_articles">2. Manually curated articles on Oncology</a><br>
      <a href="#recommended_articles">3. Recommended articles on Oncology</a><br>
    <p>
  </div>

  <div data-intro='Plot displaying number of citations over time 
                  on the given topic based on recommended articles'>
    <p>
    <h3 id="plot1">1. Citations over time on Oncology</h3>
      <div id='myDiv1'>
      </div>
    </p>
  </div>
  -->

  <div data-intro='Manually curated articles on the given topic'>
    <p>
    <h3 id="manually_curated_articles">Manually curated articles on <i>Oncology</i></h3>
    <table id="table1" class="display" style="width:100%">
    <thead>
      <tr>
          <th data-intro='Click to view the abstract (if available)'>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th data-intro='Highest h-index among the authors'>Highest h-index</th>
          <th data-intro='Recommended articles extracted by considering
                          only the given article'>
              View recommendations
              </th>
      </tr>
    </thead>
    <tbody>

        <tr id="Sustained smouldering, or low-grade activation, of myeloid cells is a common hallmark of several chronic neurological diseases, including multiple sclerosis1. Distinct metabolic and mitochondrial features guide the activation and the diverse functional states of myeloid cells2. However, how these metabolic features act to perpetuate inflammation of the central nervous system is unclear. Here, using a multiomics approach, we identify a molecular signature that sustains the activation of microglia through mitochondrial complex I activity driving reverse electron transport and the production of reactive oxygen species. Mechanistically, blocking complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in an animal disease model in vivo. Complex I activity in microglia is a potential therapeutic target to foster neuroprotection in chronic inflammatory disorders of the central nervous system3. Blocking mitochondrial complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in vivo in an animal disease model.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf" target='_blank'>
                Mitochondrial complex I activity in microglia sustains neuroinflammation
                </a>
              </td>
          <td>
            L. Peruzzotti-Jametti, C. Willis, G. Krzak, R. Hamel, L. Pirvan, Rosana-Bristena Ionescu, J. Reisz, H. Prag, M. E. Garcia-Segura, V. Wu, Y. Xiang, B. Barlas, A. Casey, A. van den Bosch, A. Nicaise, L. Roth, G. R. Bates, H. Huang, P. Prasad, A. E. Vincent, C. Frezza, C. Viscomi, G. Balmus, Z. Takáts, J. Marioni, A. D'alessandro, M. P. Murphy, I. Mohorianu, S. Pluchino
          </td>
          <td>2024-03-13</td>
          <td>Nature</td>
          <td>133</td>
          <td>31</td>

            <td><a href='../recommendations/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

        <tr id="The COVID-19 pandemic is an ongoing global health threat, yet our understanding of the dynamics of early cellular responses to this disease remains limited1. Here in our SARS-CoV-2 human challenge study, we used single-cell multi-omics profiling of nasopharyngeal swabs and blood to temporally resolve abortive, transient and sustained infections in seronegative individuals challenged with pre-Alpha SARS-CoV-2. Our analyses revealed rapid changes in cell-type proportions and dozens of highly dynamic cellular response states in epithelial and immune cells associated with specific time points and infection status. We observed that the interferon response in blood preceded the nasopharyngeal response. Moreover, nasopharyngeal immune infiltration occurred early in samples from individuals with only transient infection and later in samples from individuals with sustained infection. High expression of HLA-DQA2 before inoculation was associated with preventing sustained infection. Ciliated cells showed multiple immune responses and were most permissive for viral replication, whereas nasopharyngeal T cells and macrophages were infected non-productively. We resolved 54 T cell states, including acutely activated T cells that clonally expanded while carrying convergent SARS-CoV-2 motifs. Our new computational pipeline Cell2TCR identifies activated antigen-responding T cells based on a gene expression signature and clusters these into clonotype groups and motifs. Overall, our detailed time series data can serve as a Rosetta stone for epithelial and immune cell responses and reveals early dynamic responses associated with protection against infection. A human SARS-CoV-2 challenge study in individuals without previous exposure to the virus or vaccines provides detailed profiles of local and systemic epithelial and immune cell response dynamics over time and infection status.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/380489b0c6f9106219184f0c5fe6612e0b4e165a" target='_blank'>
                Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
                </a>
              </td>
          <td>
            Rik G. H. Lindeboom, Kaylee B. Worlock, L. Dratva, M. Yoshida, David Scobie, Helen R. Wagstaffe, Laura Richardson, A. Wilbrey-Clark, Josephine L. Barnes, Lorenz Kretschmer, K. Polański, J. Allen-Hyttinen, Puja Mehta, D. Sumanaweera, J. M. Boccacino, W. Sungnak, R. Elmentaite, Ni Huang, L. Mamanova, R. Kapuge, L. Bolt, E. Prigmore, B. Killingley, M. Kalinova, Maria Mayer, A. Boyers, Alex J. Mann, Leo Swadling, M. Woodall, Samuel Ellis, Claire M. Smith, V. Teixeira, Sam M. Janes, R. Chambers, M. Haniffa, A. Catchpole, R. Heyderman, M. Noursadeghi, Benjamin M. Chain, Andreas Mayer, Kerstin B. Meyer, Christopher Chiu, Marko Z. Nikolić, Sarah A. Teichmann
          </td>
          <td>2024-06-19</td>
          <td>Nature</td>
          <td>74</td>
          <td>75</td>

            <td><a href='../recommendations/380489b0c6f9106219184f0c5fe6612e0b4e165a' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
          <th>View recommendations</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

  <div data-intro='Recommended articles extracted by contrasting
                  articles that are relevant against not relevant for Oncology'>
    <p>
    <h3 id="recommended_articles">Recommended articles on <i>Oncology</i></h3>
    <table id="table2" class="display" style="width:100%">
    <thead>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </thead>
    <tbody>

        <tr id="Severe pneumonia is associated with an increased risk of cognitive decline and dementia, particularly in the elderly. Changes in microglia, the most abundant immune cell population in the brain, are also associated with cognitive decline and dementia, including the emergence of a transcriptional cell state referred to as disease-associated microglia (DAM). We sought to test the hypothesis that non-neuroinvasive influenza A virus (IAV) pneumonia results in transcriptional responses in brain microglia that drive premature expansion of DAM. Using bulk and single-cell RNA-sequencing, metabolomics, and spatial transcriptomics, we profiled neuroimmune populations in young, middle-aged, and old male mice during IAV infection and recovery. We observed an increased abundance of DAM, interferon-responsive microglia (IRM), CD4+ T cells, and CD8+ T cells in white matter regions beginning in middle age and persisting in old animals, irrespective of IAV infection. DAM exhibited a metabolic shift toward aerobic glycolysis with disrupted TCA cycling, citrulline depletion, and an elevated itaconate/α-ketoglutarate ratio. Spatial transcriptomic profiling of the human middle frontal gyrus (MFG) in normal agers, SuperAgers, and patients with dementia revealed an analogous accumulation of DAM and CD8+ T cells in white matter. IAV pneumonia induced a transient immunosenescent-like response in microglia, marked by glucocorticoid-responsive gene expression and Ccnd3 upregulation. In response to IAV pneumonia, DAM expanded in middle-aged mice, whereas old mice were elevated at baseline and were largely unaffected by IAV infection. The age-related expansion of DAM was unaffected by pharmacological depletion and repopulation of microglia with a CSF1R antagonist or genetic gain or loss of function of the phagocytic receptor MERTK, suggesting the DAM phenotype is driven by the CNS microenvironment, rather than cell-intrinsic mechanisms. Our findings suggest that IAV pneumonia induces an acute immunosenescence response in microglia and accelerates the age-dependent expansion of DAM in white matter.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0fda447848e1da3e24e80cd9f6f09a302a4923b4" target='_blank'>
              Influenza A infection accelerates disease-associated microglia formation during physiological aging
              </a>
            </td>
          <td>
            R. Grant, C. Runyan, Grace Minogue, J. Stoolman, Satoshi Watanabe, Fei Chen, Karolina J. Senkow, L. Cusick, M. Schleck, R. Nafikova, Ziyan Lu, E. Bunyan, H. Abdala-Valencia, Jacob I. Sznajder, Robert J. Vassar, Rudy J Castellani, Changiz Geula, T. Gefen, Navdeep S. Chandel, A. Misharin, G. S. Budinger
          </td>
          <td>2025-12-14</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="COVID-19 vaccines provide robust protection against severe disease, hospitalization, and death. Neutralizing antibodies are a strong correlate of protection and can prevent SARS-CoV-2 infection of the lungs. We used a conventional laboratory mouse model combined with high- or low-dose vaccination to understand the early immunological response following SARS-CoV-2 infection in the lungs of vaccinated mice. The lungs of high-dose vaccinated mice were completely protected against SARS-CoV-2 infection whereas low-dose vaccinated mice were partially protected. We observed a greater influx of total monocytes, macrophages, dendritic cells, neutrophils, and eosinophils in the lungs of low-dose vaccinated mice compared to naïve infected mice. The different proportions of innate immune cells in the lungs indicated that infection in low-dose vaccinated mice induces a unique inflammatory environment compared to naïve infected or uninfected mice. A prominent feature of infection of low-dose vaccinated mice was infiltration of eosinophils in the lungs, which we observed across different COVID-19 vaccines and SARS-CoV-2 variants. Single cell transcriptional profiling of lung parenchymal immune cells showed that viral RNA was predominantly associated with eosinophils. Eosinophils from low-dose vaccinated mice were transcriptionally distinct from naïve mice after challenge and showed an IFN-γ biased signature. Further, monocytes from low-dose vaccinated mice expressed eotaxin-2, suggesting a monocyte-eosinophil signaling axis. Antibody mediated depletion of eosinophils in low-dose vaccinated mice resulted in increased virus replication and dissemination in the lungs. These findings demonstrate the protective nature of eosinophils during SARS-CoV-2 infection in the context of vaccination and highlight quantitative and qualitative differences in the immune response in a model for vaccine breakthrough infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/206331da0365bbfba8d623c1563fc323742af9bb" target='_blank'>
              Monocyte-eosinophil signaling axis promotes vaccine-mediated protection against SARS-CoV-2
              </a>
            </td>
          <td>
            Kathryn M. Moore, Stephanie L. Foster, Meenakshi Kar, K. Floyd, Elizabeth J. Elrod, M. E. Williams, Jacob Vander Velden, M. Ellis, Ansa Malik, B. Wali, Stacey A. Lapp, Amanda Metz, S. Bosinger, Vineet D. Menachery, Robert A. Seder, R. Amara, Jacob E. Kohlmeier, Arash Grakoui, M. Suthar
          </td>
          <td>2025-12-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>69</td>
        </tr>

        <tr id="Aging and cerebrovascular pathology drive neuroinflammation in vascular dementia (VaD) but immune mechanisms underlying this interplay remain unresolved. Leveraging multi-modal high-dimensional imaging, flow cytometry, and split pool ligation transcriptomic sequencing in a mouse model of VaD, we constructed a brain immune cell atlas spanning young and aged mice in health and disease. We profiled microglia, T cells, macrophages, neutrophils, and B cells and integrated transcriptomics, cell-cell communication, multiplex imaging, and comparative analysis with human microglia. We found striking depletion of Ccr7+ naïve T cells and expansion of Gzmk+ cytotoxic Cd8+ effector memory T cells in the aging brain. At the same time, microglia shifted toward a pro-inflammatory state with enhanced activity of major histocompatibility class complex I (MHC-I) to T cell receptor and co-stimulation from CD86 to CD28. These shifts suggest enhanced neuroinflammatory polarization within the aged brain and in VaD. These signals were strongest from activated microglia to Gzmk+ Cd8+ TEM cells, indicating that age-related microglial polarization may sustain cytotoxic T cell activation in the aged brain. Our findings suggest pro-inflammatory microglia and Gzmk+ CD8+ TEM cells are central drivers of immune brain aging and highlights a therapeutic potential to disrupt age-related neuroinflammatory cascades in VaD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/42ac3a3908e79bc0f916a88d264039358a6730c2" target='_blank'>
              High-Dimensional Single-Cell Analysis Reveals Coordinated Age-Dependent Neuroinflammatory Microglia-T cell Circuits in the Brain
              </a>
            </td>
          <td>
            Md Akkas Ali, Md. Hasanul Banna Siam, Donald Vardaman, Chase Bolding, J. N. Brazell, Ashleigh D. Whatley, Christopher A. Risley, Harrison Tidwell, Syed Nakib Hossain, Juhi Samal, Ashley S. Harms, Mallikarjun Patil, Daniel J. Tyrrell
          </td>
          <td>2025-12-13</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Cytomegalovirus is the leading viral cause of congenital infection with neurological sequelae. Effective medical treatments are limited due to an inadequate understanding of the underlying pathogenesis. Here, we applied single-cell transcriptomics to analyze neonatal mouse brains with congenital cytomegalovirus infection (cCMV). We profiled cCMV in 22 cell types and identified neural progenitor cells (NPCs) and monocyte-derived macrophages (MDMs) as the most commonly infected cells. Infected NPCs exhibited dysregulated neurodevelopment-associated signaling pathways, correlating with viral transcript levels that indicate viral replication levels. Genes associated with phagocytosis and antigen presentation were downregulated exclusively in infected MDMs but remained largely unaffected in microglia and barrier-associated macrophages regardless of infection status. Analysis of intrinsic and induced interferon-stimulated gene expression revealed great heterogeneity across cell types but no direct correlation with cCMV susceptibility. Furthermore, our findings indicate that interferon type II is crucial for the control of cCMV and consequent cortical damage and calcification in the neonatal brain. This study advances our understanding of cCMV tropism and the molecular details of cCMV-induced neurodevelopmental impairment, cerebral immune response, and brain pathology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/37e868bb50c4bf02ba4bc61b84aaec7d5968b07e" target='_blank'>
              Molecular features of congenital cytomegalovirus infection in neonatal mouse brain at single-cell resolution
              </a>
            </td>
          <td>
            Meng-Jie Mei, Yue-Peng Zhou, Yu-Ting Pan, Jin-yan Sun, Wen-Bo Zeng, Tong Wu, M. McVoy, William J. Britt, Wen Zhou, Bo Yang, Xuan Jiang, Simon Rayner, Han Cheng, Min-Hua Luo
          </td>
          <td>2025-11-17</td>
          <td>Acta Neuropathologica Communications</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="Aberrant and sustained activation of microglia is implicated in the progression and severity of multiple sclerosis (MS). However, whether intrinsic alterations in microglial function impact the pathogenesis of this disease remains unclear. We conducted transcriptomic and functional analyses of microglia-like cells (iMGLs) differentiated from induced pluripotent stem cells (iPSCs) from patients with MS (pwMS) to answer this question. We generated iPSCs from six pwMS showing increased microglial activity via translocator protein (TSPO)-PET imaging. We demonstrated that the differentiated iMGL transcriptional profile resembled the microglial signature found in MS lesions. Importantly, compared with healthy controls, MS iMGLs presented cell-autonomous differences in their regulation of inflammation, both in the basal state and following inflammatory lipopolysaccharide challenge. Through transcriptomic profiling, we showed that MS iMGLs display increased expression of genes known to be upregulated in MS microglia. Furthermore, upregulated genes in MS iMGLs were associated with immune receptor activation, antigen presentation, and the complement system, with known MS implications. Finally, functional analyses indicated that the transcriptional changes in MS iMGLs corresponded with alterations in the secretion of inflammatory cytokines and chemokines and increased phagocytosis. Together, our results provide evidence of putative cell-autonomous microglial activation in pwMS and identify transcriptomic and functional changes that recapitulate the phenotypes observed in vivo in microglia from pwMS. These findings indicate that MS disease-specific iPSCs are valuable tools for studying disease-specific microglial activation in vitro and highlight microglia as potential therapeutic targets in MS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ce483627b1620ca8e2ea90bf499e8cad452ba523" target='_blank'>
              Microglia from patients with multiple sclerosis display a cell-autonomous immune activation state
              </a>
            </td>
          <td>
            Tanja Hyvärinen, J. Lotila, Luca Giudice, Iisa Tujula, M. Nylund, S. Ohtonen, Flavia Scoyni, Henna Jäntti, Sara Pihlava, H. Skottman, Susanna Narkilahti, L. Airas, T. Malm, S. Hagman
          </td>
          <td>2024-12-11</td>
          <td>Journal of Neuroinflammation</td>
          <td>2</td>
          <td>47</td>
        </tr>

        <tr id="Severe SARS-CoV-2 infection is characterized by lung hyperinflammation, impaired interferon responses, and defective T-cell activation, yet the molecular drivers of these immune dysregulations remain incompletely understood. Caspase-11 (CASP11), a key mediator of the non-canonical inflammasome, has been shown to mediate an innate hyperinflammatory response and cytokine release in a non-severe, non-lethal SARS-CoV-2 infection model. However, the role played by CASP11 in severe SARS-CoV-2 disease and how it impacts adaptive immunity is not identified. Here, we newly discover that CASP11 exacerbates severe SARS-CoV-2 pathogenesis by amplifying early innate immune responses while concurrently impairing antiviral CD8 T-cell immunity. Using global knockouts, reciprocal bone marrow chimeras, and phagocyte-monocyte system (PMS) cell-specific CASP11 deletion models, we show that CASP11 deletion in monocyte-derived cells reduces lung inflammation, enhances type I and II interferon signaling, and promotes robust virus-specific effector CD8⁺ T-cell response. This was associated with enhanced viral clearance and improved survival, even under lethal infection conditions. Importantly, CASP11 KO mice also exhibited faster resolution of post-viral inflammation, suggesting a role in long-term immune remodeling. These findings position CASP11 as a promising immunomodulatory target for acute and delayed manifestations of severe SARS-CoV-2.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fa0d09c722147bd759ef9cedc307b8c6a5fb7718" target='_blank'>
              Caspase-11 Mediated Hyperinflammation Impairs CD8+ T Cell Immunity and Viral Clearance in Severe SARS-CoV-2 Infection
              </a>
            </td>
          <td>
            Mostafa Eltobgy, Mohamed M. Shamseldin, Owen Whitham, Heba M Amer, Jeffery Atkinson, Asmaa Badr, Jesse Hall, Jihad Omran, Gauruv A. Gupta, Yara Hassan, Rabab Abdelaleem, Richard Perez, Sarah Faber, Maciej Pietrzak, Amy Webb, Xiaoli Zhang, A. Kenney, Destiny Bissel, Shady Z K Estfanous, Kylene P. Daily, Andrew Mcnamara, Mahesh Kc, M. Peeples, Emily A. Hemann, Shahid M. Nimjee, E. Cormet-Boyaka, Jianrong Li, P. Boyaka, Jacob S. Yount, Benjamin M. Segal, Purnima Dubey, Amal O Amer
          </td>
          <td>2025-11-03</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>43</td>
        </tr>

        <tr id="Abstract After severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, a minority of patients experience persistent or emerging symptoms, termed ‘long coronavirus disease (COVID)’ or post-acute sequelae of COVID-19. The molecular causes of long COVID remain unclear, but disrupted immune functions, such as inflammation and immune deficit, have been posited as factors. In this retrospective cohort study, we measured markers of immune function in a group of patients with long COVID up to 40 months post infection. As proxies for immune function, we measured serum antibody levels, antibody neutralizing capability and production of IFN gamma (IFN-γ) and IL-2 against SARS-CoV-2 and other viral peptides. As expected, serum antibody levels increased over time with vaccinations and reinfections with later variants of SARS-CoV-2. Patients also showed corresponding increasing SARS-CoV-2-specific IL-2 responses and stable IFN-γ responses. We observed no significant differences in immune responses among patients with ongoing long COVID, those who had recovered from it or individuals who recovered from acute COVID-19. Overall, we found no indication of a reduction in these aspects of immune function after SARS-CoV-2 infection. This study provides a valuable foundation for further research aimed at understanding the causes of long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dd9f2a9af816e4527bff007fe6bd487c949ce190" target='_blank'>
              Robust antibody and T cell responses tracked longitudinally in patients with long COVID
              </a>
            </td>
          <td>
            M. Metaxaki, Ranjana Ram, Marianne Perera, Mark Wills, Ben Krishna, N. Sithole
          </td>
          <td>2025-12-01</td>
          <td>The Journal of General Virology</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c559472c33293babdbbd5dda4f528462a56a71a7" target='_blank'>
              Meningeal γδ T cells facilitate bacterial entry into the brain in neonatal meningitis and trigger long-term behavioural sequelae
              </a>
            </td>
          <td>
            Inês Lorga, Joana Soares, Joana Bravo, Pedro Mesquita, Nuno Ribeiro, João Rodrigues, Ahmed Hassan, Morgana Mesquita, Bruno Cavadas, Hristo Georgiev, Ana Magalhães, T. Summavielle, Manuel Vilanova, J. Ribot, Elva Bonifácio Andrade
          </td>
          <td>2025-11-09</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="Circadian disruptions perturb the brain and immune system and increase the risk of developing Alzheimer’s Disease (AD), yet whether this involves dysregulation of brain immunity remains less clear. Here, we perform single-cell RNA sequencing of the brain immune compartment around the day-night cycle and identify brain border-associated macrophages (BAMs) as highly rhythmic cells. During the rest phase, we find that BAMs exhibit coordinated upregulation of endocytic genes and enhanced uptake of extracellular fluid-borne material including amyloid-beta (Aβ). Rhythmicity in BAM scavenging is regulated by the clock gene Bmal1, mediated by the endocytic receptor CD206, and perturbed with age. In a mouse model of AD, we show that deletion of Bmal1 in BAMs worsens perivascular and leptomeningeal Aβ plaque burden. Our results identify endocytosis as a specialized and rhythmic BAM function and identify perturbed timing of brain border immune functions as a potential mechanism by which circadian disruptions precipitate amyloidosis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a0c471e03c2aa28dba89ca368e4c1fb780adb456" target='_blank'>
              The circadian clock regulates scavenging of fluid-borne substrates by brain border-associated macrophages
              </a>
            </td>
          <td>
            Helena J. Barr, Sydney K. Caldwell, Justin M. Reimertz, Constanze Depp, Alec J. Walker, Samuel E. Marsh, Anushree S. Gupte, Maximilian Hingerl, Jasmin Patel, Sang-O Park, Sarah Ferraro, Jonathan Lipton, Beth Stevens
          </td>
          <td>2025-12-11</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Our understanding of the immune response in tuberculosis (TB) remains incomplete. This applies in particular to extrapulmonary TB (EPTB), a highly heterogeneous disease affecting up to 30% of patients in certain regions. Based on data-driven clustering of blood transcriptomes in an EPTB patient cohort, we define three highly distinct immunotypes. Combining bulk with single-cell RNA-sequencing delineates immunological trajectories characterized by dynamic IFN- and IL-1-mediated signalling in monocytes, alongside hyperactivation of T and NK cells, ultimately resulting in extensive immune dysregulation. Integrative analysis of multi-omics data provides deep insights into different layers of the anti-tuberculous immune response and the identification of immunotypes enabling stratification strategies for personalized host-directed treatments. In addition, our comprehensive approach helps to develop an accurate diagnostic gene expression signature for both EPTB and pulmonary TB highlighting the translational potential of our data. This work uses gene expression and single cell analyses to group extrapulmonary tuberculosis patients into three immune types, revealing immune pathways driving pathogenesis and markers that could improve diagnosis and guide tailored treatments.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/03cb07105c64f52d8dc00fc9152c22bdcb4ddb77" target='_blank'>
              Deep immune profiling delineates hallmarks of disease heterogeneity in extrapulmonary tuberculosis
              </a>
            </td>
          <td>
            Sebastian J. Theobald, Kilian Dahm, Dinah Lange, Jannis B. Spintge, S. Winter, Angela Klingmüller, L. Holsten, Alexander Simonis, Elena De Domenico, H. Walczak, Martina van Uelft, J. Schultze, M. Beyer, Thomas Ulas, Isabelle Suárez, J. Rybniker
          </td>
          <td>2025-11-10</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>33</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/72d62689c5dd46733c3aa071e7330253553893df" target='_blank'>
              IRF4 is a master regulator of multinucleated giant cell formation
              </a>
            </td>
          <td>
            M. Hofmann, G. Heller, M. Kieler, L. Musiejovsky, Lukas Kremp, Martina Kerndl, P. Ettel, Birgit Niederreiter, Lucia Quemada Garrido, Anahita Sedighi, Thomas Krausgruber, Leonhard X. Heinz, Axel Dietschmann, David Voehringer, Bart Everts, Thomas Weichhart, Omar Sharif, Stephan Blüml, Gernot Schabbauer
          </td>
          <td>2025-11-04</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused a global health crisis, marked by high transmissibility and virulence. Despite widespread vaccination efforts, effective treatments for COVID-19, particularly for severe cases leading to Acute Respiratory Distress Syndrome (ARDS), remain limited. This study investigates the efficacy of KVX-053, a protein tyrosine phosphatase type IVA (PTP4A3) small molecule inhibitor, in modulating SARS-CoV-2-induced inflammation and lung injury using in vitro cell models and in vivo K18-hACE2 transgenic mice. KVX-053 reduced in vitro pro-inflammatory cytokine expression, including TNFα, CXCL10, and CXCL11, without impacting viral replication or cell viability. K18-hACE2 mice treated with KVX-053 demonstrated marked improvement in clinical scores and reduced histological evidence of lung injury compared to untreated SARS-CoV-2-infected controls. KVX-053 mitigated the activation of key inflammatory mediators in the lung, including NLRP3 inflammasomes, IL-6, and phosphorylated STAT3, effectively curbing the “cytokine storm” associated with severe COVID-19. Importantly, treatment preserved lung parenchymal integrity, reduced edema, and minimized macrophage infiltration. Our findings highlight PTP4A3 as a potential critical regulator of the inflammatory response during SARS-CoV-2 infection. KVX-053, a potent and selective PTP4A3 inhibitor, emerges as a promising host-directed therapeutic strategy for mitigating ARDS and inflammation-driven lung injury in SARS-CoV-2 and potentially other respiratory viral infections. Future studies are required to optimize dosing strategies, elucidate precise molecular mechanisms, and validate these findings in clinical settings.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/20ae8d61209d49d0e74feaa9c96947aababae586" target='_blank'>
              The PTP4A3 inhibitor KVX-053 reduces Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virulence, inflammation, and development of acute lung injury in K18-hACE2 mice
              </a>
            </td>
          <td>
            Ruben M. L. Colunga-Biancatelli, P. Solopov, Caitlin M Woodson, I. Allen, I. Akhrymuk, Maryna Akhrymuk, Brittany N. Heath, Hannah M. Ivester, T. Day, Dan E. Austin, K. Kehn-Hall, John S. Lazo, E. Sharlow, J. Catravas
          </td>
          <td>2025-10-28</td>
          <td>Respiratory Research</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/48dac9de2c81b45da57ef12b64fdabc04b31fc63" target='_blank'>
              Prolonged Loss of Oxidative Phosphorylation and Mitochondrial Mass Characterize CD66b+ Leukocytes from Patients with Sepsis
              </a>
            </td>
          <td>
            Christine Rodhouse, Evan L. Barrios, Leilani Zeumer-Spataro, Leandro Balzano-Nogueira, Ruoxuan Wu, Xuanxuan Yu, Guimei Tian, Jason O. Brant, Marie-Pierre L. Gauthier, Jing Chen, Miguel Hernandez-Rios, Valerie E. Polcz, Whitman Wiggins, Angel M. Charles, M. Dirain, Ricardo F. Ungaro, J. Rincon, Tyler Loftus, Feifei Xiao, Guoshuai Cai, L. Moldawer, Robert Maile, Michael P. Kladde, Philip A. Efron, Clayton E. Mathews
          </td>
          <td>2025-12-18</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections worldwide, particularly affecting infants, older adults, and immunocompromised individuals. Understanding the cellular immune response to RSV infection is essential for developing effective treatments for infection and its complications. In this study, we investigated the susceptibility of blood-derived primary monocytes and monocytic THP-1 cells to infection with a contemporary RSV A-ON1 strain and characterized the subsequent cytokine and chemokine secretion, as well as the expression of surface markers involved in antigen presentation. Our findings demonstrate that primary monocytes and related THP-1 cells are permissive to abortive infection by RSV, leading to increased expression of proinflammatory cytokines and chemokines, including IP-10, IL-6, and CCL2. Furthermore, primary monocytes expressed CD80, CD86, and HLA-DR upon direct infection or through potential paracrine stimulation. Collectively, these findings demonstrate the activation of monocytes by RSV infection, suggesting their contributory role in orchestrating early immune responses during infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e0a13235925d18993e167d01b4f6d405002e8701" target='_blank'>
              A contemporary strain of RSV activates primary human monocytes after abortive infection
              </a>
            </td>
          <td>
            Ayse Agac, M. Ludlow, Marie-Christin Knittler, C. K. Prajeeth, G. Saletti, A. Osterhaus, Robert Meineke, G. Rimmelzwaan
          </td>
          <td>2025-11-07</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>96</td>
        </tr>

        <tr id="Chronic activation of innate immune responses in the brain is increasingly recognized as a contributor to neurodegenerative diseases, including Alzheimer's disease (AD). AD remains a major global health challenge due to the inefficacy of current therapies to modify disease progression. In AD, hyperactivated microglia, the brain’s resident macrophages, play a central role by responding to amyloid-beta peptides (Aβ) through activation of the NLRP3 inflammasome, a key innate immune sensor and a promising therapeutic target. Leishmania infantum, a protozoan parasite causing visceral leishmaniasis, is known to employ sophisticated mechanisms to subvert inflammatory responses in macrophages, including modulation of the NLRP3 inflammasome, thus representing a potential natural model for counteracting microglia-related inflammation. However, microglia-Leishmania interactions remain unexplored, particularly the parasite’s ability to modulate microglial NLRP3 activation. Here, we demonstrate that L. infantum invades and persists in microglia without inducing cell activation, indicating an immunologically silent entry. Aβ-stimulated NLRP3 activation was suppressed by Leishmania infection, as evidenced by a significant reduction in key pro-inflammatory mediators, including IL-1β, IL-18, TNF-α, and neurotoxic nitric oxide. Mechanistically, L. infantum disrupted NLRP3 priming by interfering with NF-κB signaling and upregulating the negative regulator A20. Additionally, L. infantum limited ASC speck formation, caspase-1 activation and ROS production while preserving lysosomal integrity. These findings reveal, for the first time, an unrecognized inhibitory effect of L. infantum on the microglial NLRP3/NF-κB axis and provide mechanistic insights into the parasite’s immune subversion in Aβ-activated microglia. Deciphering the molecular pathways exploited by L. infantum and the specific parasitic effectors involved could offer novel therapeutic targets and bioinspired strategies to mitigate microglial inflammatory responses in the context of AD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5d4274589a2e9af8d7c8bc822e827f06747927ea" target='_blank'>
              Immune subversion by Leishmania infantum parasites suppresses NLRP3-driven inflammatory responses in amyloid-β-activated microglia
              </a>
            </td>
          <td>
            Estefanía Calvo Alvarez, Chiara Sfogliarini, F. La Rosa, M. Saresella, M. Dolci, Elisabetta Vegeto, D. Taramelli, N. Basilico, Mario Clerici
          </td>
          <td>2025-10-29</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>46</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/69df5fd6672a630864c6251428da30e869ad36a2" target='_blank'>
              Neuronal activity promotes repair by microglial reprogramming following demyelination
              </a>
            </td>
          <td>
            C. Perrot, R. Ronzano, Z. Li, M.S. Aigrot, V. Pantazou, P. Stheneur, FX Lejeune, B. Zalc, F. Quintana, B. Stankoff, C. Lubetzki, A. Desmazières
          </td>
          <td>2025-12-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="


 Caspase 11 is a critical component of the noncanonical inflammasome with multifaceted roles in the innate immune response, contributing to host defense against pathogens. We demonstrated that Casp11 deletion improved disease outcomes in SARS-CoV-2 infection by modulating the innate inflammatory response. However, its role in shaping adaptive immune responses after SARS-CoV-2 infection remains unclear. We found that Casp11-/- MA10 infected mice exhibited higher numbers of activated lung resident memory T cells at Day 7 post-infection compared to wild-type (WT) controls, independent of lung viral load. Ex vivo stimulation of lung-resident T cells with SARS-CoV-2 peptides and tetramer staining revealed that T cells from Casp11-/- mice retained their activation status, antigen specificity, and phenotype. This suggests that Casp11 deletion promotes the expansion and activation of lung resident T cells without impairing their functionality. Using Casp11-/- bone marrow chimera and Casp11-/- Cre-flox mouse models, we identified that the enhanced adaptive immune response was mediated by Casp11 in peripheral immune cells, particularly myeloid cells. These findings indicate that Casp11 deletion leads to a more robust lung-resident adaptive immune response by modulating the early innate immune response. This enhanced adaptive immunity contributed to more effective viral clearance, improved infection control, and reduced progression to severe disease in a P30 severe infection model.



 NIH 1P01AI175399-01A1 NIH 5R01HL168501-02



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f4123fdbf56086c0c4d68d79c27fddbd6c198d90" target='_blank'>
              Caspase11 modulates the adaptive immune response in SARS-CoV-2 infection through innate immune regulation 4503
              </a>
            </td>
          <td>
            Mostafa Eltobgy, Benjamin Segal, Eugene M. Oltz, Jacob Yount, Shahid M. Nimjee, Purnima Dubey, Amal O Amer
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Human microglia are central regulators and actors in brain infections and neuro-inflammatory pathologies. However, access to such cells is limited, and studies systematically mapping the spectrum of their inflammatory states are scarce. Here, we generated microglia-like cells (MGLCs) from human induced pluripotent stem cells and characterized them as a robust, accessible model system for studying inflammatory activation. We validated lineage identity through transcriptome profiling, revealing selective upregulation of microglial signature genes and enrichment of microglia/macrophage-related gene sets. MGLCs displayed distinct morphologies and produced stimulus- and time-dependent cytokine secretion profiles upon exposure to diverse inflammatory stimuli, including pro-inflammatory cytokines (TNFα, interferon-γ) and agonists of the Toll-like receptors TLR2 (FSL-1), TLR3 (Poly(I:C)), TLR4 (lipopolysaccharide, LPS), and TLR7 (imiquimod). Transcriptome profiling and bioinformatics analysis revealed distinct activation signatures. Functional assays demonstrated stimulus-specific engagement of NFκB and JAK-STAT signaling pathways. The shared NFκB nuclear translocation response of TLR ligands and TNFα was reflected in overlapping transcriptome profiles: they shared modules (e.g., oxidative stress response and TNFα-related signaling) identified by weighted gene co-expression network analysis. Finally, the potential consequences of microglia activation for neighboring cells were studied on the example of microglia-astrocyte crosstalk. The capacity of MGLC supernatants to stimulate astrocytes was measured by quantifying astrocytic NFκB translocation. MGLCs stimulated with FSL-1, LPS, or Poly(I:C) indirectly activated astrocytes via a strictly TNFα-dependent mechanism, highlighting the role of soluble mediators in the signal propagation. Altogether, this platform enables a dissection of microglia activation states and multi-parametric characterization of subsequent neuroinflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c6c2e585f64e6cf445d9d321d469983b932dac9d" target='_blank'>
              Differential Responses of Human iPSC-Derived Microglia to Stimulation with Diverse Inflammogens
              </a>
            </td>
          <td>
            Chiara Wolfbeisz, J. Suess, N. Dreser, H. Leisner, Markus Brüll, M. Fandrich, Nicole Schneiderhan-Marra, O. Poetz, Thomas Hartung, Marcel Leist
          </td>
          <td>2025-10-28</td>
          <td>Cells</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Tuberculosis (TB) remains a global public health challenge, with the current BCG vaccine providing limited efficacy in adults, and available treatments being lengthy and debilitating. To overcome these challenges, we have previously developed a recombinant BCG strain expressing the detoxified E. coli Heat-Labile Toxin (LTAK63), providing increased protection in mouse models and reduced lung pathology. Here, using systems biology and RNA sequencing of lung tissues in a murine model, we uncover the molecular mechanisms underlying rBCG-LTAK63’s increased protection. Immunization triggered early activation of cAMP-related pathways, leading to hypoxia, autophagy, and circadian rhythm gene regulation. These processes were associated with an enhanced innate immunity and promoted long-lasting Th1/Th17 adaptive responses. Upon challenge, mice immunized with rBCG-LTAK63 exhibited an earlier onset of interferon-gamma response, reduced bacterial burden, and improved lung histopathology. Notably, circadian rhythm regulation was directly linked to a controlled inflammatory response and reduced migration of infection-susceptible cells, resulting in decreased immunopathology. Our findings demonstrate that rBCG-LTAK63 orchestrates protection through the integration of metabolic and temporal immune pathways. This work provides mechanistic insights into how rational vaccine design can reprogram host immunity to enhance protection and reduce pathology, supporting rBCG-LTAK63 as a promising next-generation TB vaccine candidate.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a2a1c920c02189ea2ce616d05d66a9ab9edfc010" target='_blank'>
              rBCG-LTAK63 enhances protection against tuberculosis by inducing autophagy and circadian gene regulation
              </a>
            </td>
          <td>
            Lázaro M Marques-Neto, M. Trentini, Ana Carolina R. Moreno, S. F. Eto, Ana Carolina O. Carvalho, Almiro Pires da Silva Neto, M. S. Amaral, André G. C. Martins, André N. A. Gonçalves, A. Chudzinski-Tavassi, A. I. Kanno, A. Tagliabue, Diana Boraschi, Sergio Verjovski-Almeida, Helder Nakaya, L. P. Farias, P. I. P. Ramos, Luciana C C Leite
          </td>
          <td>2025-10-24</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="Influenza A virus (IAV) infection is a significant cause of morbidity and mortality for patients worldwide. Alveolar type 2 (AT2) cells are the preferential target of IAV as part of the pathogenesis of viral pneumonia and acute respiratory distress syndrome (ARDS). Early IAV infection of alveolar cells has been challenging to model both in vitro and in vivo. To address this challenge, we used a combination of murine and human primary alveolar organoids to define methods for robust IAV infection and evaluated cell-autonomous consequences of IAV using a temporal series of multiome paired single nuclei RNA/ATAC sequencing. Infected AT2 cells undergo conserved changes defined by early loss of surfactant secretion, decreased lipid biogenesis, a rapid burst of antiviral response, and late viral-mediated suppression. Surprisingly, uninfected AT2 cells undergo substantial transcriptional and epigenomic changes in IAV-treated cultures, leading to transition to damage-associated cell states within hours via a process driven by the inflammatory milieu of murine organoids. Together, these data provide new methods for high-fidelity modeling of IAV infection in alveolar cells and define a conserved AT2 cell response signature to IAV with implications for ARDS pathogenesis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b1d0d64915e039a05df492a9420be5b6930184b1" target='_blank'>
              Early cell autonomous and niche-mediated alveolar epithelial response to influenza infection in primary lung organoids
              </a>
            </td>
          <td>
            Amber Elitz, Sharlene Fernandes, K. Cook, H. Warheit-Niemi, Barbara Zhao, Andrea Toth, Amanda L. Zacharias, William J. Zacharias
          </td>
          <td>2025-10-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/687800177db6f90a1dee9be6bba3ed7087d04c6e" target='_blank'>
              Oncolytic Reovirus mediates innate-driven SARS-CoV-2 elimination in the absence of cell toxicity
              </a>
            </td>
          <td>
            Samantha Garcia-Cardenas, Gemma Swinscoe, Amy Moran, Liam Barningham, Graham P. Cook, A. Samson, Sam Wilson, Michael Malim, Russell Hughes, Stephen Griffin
          </td>
          <td>2025-12-18</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="


 The reasons for varied SARS-CoV-2 transmission risk among infected individuals remain unclear. In this study, we identify cellular immune signatures associated with the speed of viral clearance in individuals with acute SARS-CoV-2 infection. We utilized mass cytometry (CyTOF) on peripheral blood mononuclear cells (PBMCs) from 34 vaccinated and unvaccinated individuals sampled during acute SARS-CoV-2 infection (4-6 days post-symptom onset), with uninfected controls for comparison (n = 5). Amongst unvaccinated participants, greater activation of non-naïve CD8+ T cells, plasmablasts, Th1 CD4+ T cells, and γδ T cells correlated significantly with faster viral clearance (Spearman’s p_adj < 0.05). In addition, coordinated activation between 297 pairs of innate and/or adaptive immune cell features was observed uniquely in infected and not in uninfected individuals (Spearman’s p_adj < 0.05, r > |0.65|). Finally, vaccinated individuals had a cellular immune signature during acute SARS-CoV-2 infection that was similar to uninfected participants, and showed significantly less immune activation across broad cell types (T/B/NK cells and monocytes) compared to unvaccinated individuals with similar duration of viral shedding (p_adj < 0.05, Kruskal-Wallis test). Our findings provide crucial insight into early immune signatures associated with the speed of clearance of infectious SARS-CoV-2 and could inform future vaccine strategies and therapeutic approaches to reduce transmission.



 Supported by the Centers for Disease Control and Prevention Broad Agency Announcement (contract 75D30120C08009)



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/90fd04a5d1a5966484b843aab431d168630f313d" target='_blank'>
              Cellular immune signatures associated with fast versus slow clearance of infectious SARS-CoV-2 4227
              </a>
            </td>
          <td>
            L. Zemelko, Rafael Tibúrcio, Yen Y. Wang, Christian M. Constantz, G. Borgo, M. Spitzer, K. Anglin, Jeffrey N. Martin, M. Peluso, J. Kelly, A. Deitchman, R. Rutishauser
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="Sterile alpha motif and HD domain-containing protein 1 (SAMHD1) restricts a board spectrum of viruses through multifaceted mechanisms. It also limits spontaneous- and virus-induced innate immune responses by suppressing proinflammatory cytokine and type-I interferon (IFN-I) production. Some viruses escape SAMHD1 restriction by utilizing SAMHD1-mediated innate immune suppression to establish effective infection through viral antagonism. Our previous studies showed that SAMHD1 is a proviral factor facilitating replication of severe acute respiratory syndrome coronavirus (SARS-CoV-2) in human macrophages, monocytic THP-1 and epithelial-like HEK293T cell lines by suppressing IFN responses. However, it is unclear about the function of SAMHD1 in lung epithelial cells during SARS-CoV-2 infection. Here, we report that SAMHD1 facilitates SARS-CoV-2 replication in lung epithelial Calu-3 cells by enhancing endogenous expression of the viral receptor angiotensin-converting enzyme 2 (ACE2) via hepatocyte nuclear factor 1-alpha (HNF1α) and HNF1β. Using pseudotyped SARS-CoV-2 and lentiviral vectors, we found that SARS-CoV-2 spike protein-mediated viral entry was suppressed in Calu-3 cells with SAMHD1 knockout (KO). SAMHD1 KO repressed ACE2 expression in Calu-3 cells at mRNA and protein levels. Functional analyses revealed that HNF1α and HNF1β were crucial for the endogenous ACE2 expression in Calu-3 cells. Additionally, SAMHD1 KO led to a reduction in the expression levels and ACE2-promoting function of HNF1α and HNF1β. Inhibition of IFN antiviral response by baricitinib, a Janus kinase 1 and 2 (JAK 1/2) inhibitor, did not revert the suppression of SARS-CoV-2 in SAMHD1 KO Calu-3 cells. Our findings demonstrate that SAMHD1 facilitates HNF1-mediated ACE2 expression and SARS-CoV-2 replication in Calu-3 cells via a novel mechanism beyond its IFN-suppressive function. Author Summary During viral infection, SAMHD1 acts as a viral restriction factor and a suppressor of the innate immune system, controlling viral replication while also ensuring immune homeostasis. The innate immune suppressive function of SAMHD1 can be proviral for some viruses. SAMHD1 has been shown to facilitate SARS-CoV-2 infection in human macrophages, THP-1 and HEK293T cell lines by promoting IFN antagonism, but its role in lung epithelial cells is unclear. Here, we demonstrated that SAMHD1 promotes SARS-CoV-2 replication in human lung epithelial Calu-3 cells by enhancing expression of the major viral receptor ACE2. We found that SAMHD1 facilitated HNF1-medaited ACE2 expression that was required for spike protein-mediated SARS-CoV-2 entry. However, inhibiting IFN signaling in SAMHD1 KO Calu-3 cells was not sufficient to revert SARS-CoV-2 replication. Our findings shed light on the differential proviral function of SAMHD1 in ACE2 expressing cells and suggest that SAMHD1 can facilitate SARS-CoV-2 infection beyond enhancing IFN antagonism.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1adb144859e1add4bf4fcfba4fbb11e22fcf1d31" target='_blank'>
              SAMHD1 promotes SARS-CoV-2 infection by enhancing HNF1-dependent ACE2 expression in lung epithelial cells
              </a>
            </td>
          <td>
            Pak-Hin Hinson Cheung, Pearl Chan, Hua Yang, Shravya Honne, Baek Kim, Stanley Perlman, Li Wu
          </td>
          <td>2025-10-26</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="SARS-CoV-2 infection is associated with long-lasting neuropsychiatric and cognitive symptoms, collectively referred to as neuro-PASC. Emerging studies indicates that accelerate brain aging and cellular senescence in COVID brain could lead to altered neuroimmune responses and neurodegenerative outcomes. However, little is known about how cellular senescence is development in neuro-PASC. Here, we examined the role of spike protein subunit S1, a persistent viral antigen, in driving the development of cellular senescence in primary human astrocytes. We have demonstrated that S1 enters endolysosomes and induces endolysosome dysfunction and cellular senescence. Moreover, the multibasic motif is critical for such S1-induced damaging effects. Importantly, we identified Toll-like receptor 7 (TLR7), an endolysosome-resident pattern recognition receptor, as a critical mediator of S1-induced damaging effects. Mechanistically, S1 interacts with TLR7 at the site of the endolysosome lumen and activates p38 MAPK signaling of downstream of TLR7, which drive the development of cellular senescence. Together, these findings suggest that TLR7 mediates S1-induced endolysosome dysfunction and cellular senescence, and that TLR7 represents a therapeutic target for mitigating neuro-PASC.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8ee07e08edc89cce8e4214928941b26b2316b896" target='_blank'>
              SARS-CoV-2 spike triggers TLR7-dependent endolysosome dysfunction and senescence in human astrocytes
              </a>
            </td>
          <td>
            Wendie A. Hasler, Emily McKay, Gaurav Datta, Samantha Johnson, Neda Rezagholizadeh, Xuesong Chen
          </td>
          <td>2025-10-31</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="Significance SARS-CoV-2 infection of the respiratory tract continues to be a health risk even among immunized individuals suggesting that localized factors could maintain viral infection and transmission. Here, we show that although the locally produced innate immune-surveillance molecule collectin-11 (CL-11) is bound by SARS-CoV-2 to trigger complement activation, the virus is resistant to complement lysis offering a means of immune escape. Moreover, we reveal CL-11 binding enhances SARS-CoV-2 infectivity of respiratory epithelial cells (RECs) by a complement-independent mechanism affording highly transmissible variants of SARS-CoV-2 a survival advantage. Additionally, SARS-CoV-2-infected RECs are vulnerable to membrane injury by self-generated CL-11 and complement. These insights provide a strong rationale for CL-11 blockade to reduce SARS-CoV-2 infection and injury of the respiratory tract.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/770c499cd02634b3a9ade6f8f24779629ad4fcd0" target='_blank'>
              Glycan recognition by collectin-11 drives SARS-CoV-2 infectivity and membrane injury of respiratory epithelial cells
              </a>
            </td>
          <td>
            Anastasia Polycarpou, Tara Wagner-Gamble, Roseanna Greenlaw, Lauren O'Neill, Varsha Kanabar, Alanoud Alrehaili, Yusun Jeon, Jonathan Baker, Mona Bafadhel, H. Khan, M. Malim, Marco Romano, C. Farrar, Dorota Smolarek, R. Martinez-Nunez, K. Doores, Russell Wallis, Linda S. Klavinskis, Steven H Sacks
          </td>
          <td>2025-10-24</td>
          <td>Proceedings of the National Academy of Sciences of the United States of America</td>
          <td>0</td>
          <td>91</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0a82efc5b2c9cc4922bf6d2b205d9310648f4f84" target='_blank'>
              Single-cell multiomics reveals epigenetic rewiring of splenic memory B cells in murine malaria reinfection
              </a>
            </td>
          <td>
            Montserrat Coronado, Á. Vincelle-Nieto, Isabel G. Azcárate, S. Pérez-Benavente, A. Puyet, Amalia Díez, José M. Bautista, A. Reyes-Palomares
          </td>
          <td>2025-12-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Pediatric acute-onset neuropsychiatric syndrome (PANS) is characterized by the sudden onset of obsessive-compulsive symptoms alongside a constellation of neuropsychiatric and somatic features. Disease progression typically includes flare and recovery states, with some patients exhibiting a persistent disease course (> 12 months of flare). We characterized circulating monocyte subsets during flare and recovery in pediatric patients with PANS, uncovering disease-state–dependent shifts in polarization and trafficking phenotypes. Inflammatory M1-like monocytes and monocyte-derived dendritic cells were elevated during flare, while anti-inflammatory M2-like monocytes were enriched in recovery. We also identified a circulating subset with a surface phenotype consistent with central nervous system (CNS) homing, which was reduced during flare and restored in recovery. These cells were detectable in the cerebrospinal fluid (CSF) of new-onset patients but not in persistent cases, suggesting differential compartmentalization during disease progression. Notably, monocyte phenotypes, including M2 polarization (monocytosis) and circulating CNS-homing profiles, exhibited striking sex-associated differences, particularly during recovery, with several subsets enriched in males but not females. Plasma from flare-phase patients modestly induced CNS-homing markers in monocytes from healthy donors, indicating the presence of circulating modulators. Together, these findings support a model in which distinct myeloid phenotypes—including sex-biased patterns—may contribute to both the pathogenesis and resolution of neuroinflammation in PANS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ab805830c315ccc3f7c69d468623a69aa039f03c" target='_blank'>
              Sex-associated and disease state-dependent monocyte polarization and CNS-trafficking phenotypes in pediatric acute-onset neuropsychiatric syndrome (PANS)
              </a>
            </td>
          <td>
            Shamma S. Rahman, Noor Hussein, Silvia Giulia Galfrè, Fabian Gaertner, C. Macaubas, Avis L. Chan, Laurie Columbo, Jaynelle Gao, Samira Galehdari, Batuhan Bayram, Meiqian Ma, C. Manko, Kate Miles, B. Farhadian, M. Silverman, M. Thienemann, Noga Or-Geva, Keith Van Haren, Kari C. Nadeau, Lu Tian, Jennifer Frankovich, Elizabeth D. Mellins
          </td>
          <td>2025-11-18</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="Neurocognitive symptoms have emerged as notable sequelae of SARS-CoV-2 infection (COVID-19). Although primarily a respiratory virus, SARS-CoV-2 has been associated with central nervous system (CNS) changes observed in both clinical and experimental settings. To better understand these effects and their pathological mechanisms, we conducted a systematic literature search of published studies and employed a qualitative, analytical approach to identify and synthesize key findings from peer-reviewed studies, including large-scale retrospective clinical cohorts, human autopsy reports, animal models (murine, non-human primate), and in vitro brain organoid systems. While viral components were detected in post mortem central nervous system tissues, COVID-19 neuropathology appears to stem primarily from immune-mediated inflammation and vascular injury rather than direct CNS infection. Persistent glial activation and BBB disruption may underlie the long-term neurological symptoms reported in long COVID-19. Although animal models offer mechanistic insight, species-specific differences necessitate cautious extrapolation to human pathology. Further investigation into the chronic effects of SARS-CoV-2 on the brain is essential to guide long-term clinical management and therapeutic development.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/80dbd9c5ebe55dfb43d42e081dfaadab6e430c79" target='_blank'>
              Neurological Manifestations of SARS-CoV-2
              </a>
            </td>
          <td>
            Jasmine Miftahof, Blake Bernauer, Chen Sabrina Tan
          </td>
          <td>2025-10-28</td>
          <td>Viruses</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Intracerebral hemorrhage (ICH) causes hematoma formation, leading to PHE, which is associated with leukocyte mobilization and increased inflammation at the site of brain injury. However, the fate of accumulated leukocytes within the hematoma and their impact on PHE expansion remain unknown. We performed single-cell immune profiling of hematoma cells from patients with acute ICH and reported a distinct phenotypic transformation of CD8+ T cells within the hematoma during the first 24 h after onset. In addition to enhanced IFN-γ production and migration capacity, these CD8+ T cells displayed remarkable glycolytic signatures. The metabolic fitness and functional reprogramming of hematomal CD8+ T cells are associated with the transcription factor FOXO1. Single-cell profiling of brain-infiltrating CD8+ T cells within the perihematomal tissues of ICH patients and cell culture assays revealed their capacity to activate microglia via the production of IFN-γ. Furthermore, the removal of hematomal CD8+ T cells reduced neuroinflammation, PHE expansion and neurological deficits in ICH mice. Thus, CD8+ T cells undergo metabolic and functional reprogramming within the hematoma during the acute phase of ICH, which contributes to PHE formation and neurological deterioration. FOXO1-driven metabolic reprogramming of hematomal CD8+ T cells drives the expansion of perihematomal edema following intracerebral hemorrhage—mechanisms and clinical implications CD8+ T cells within the hematoma are transformed during the first 24 h after ICH onset. These hematomal CD8+ T cells can possess remarkable glycolytic signatures and enhanced IFN-γ production and migration capacity, which are associated with the transcription factor FOXO1. The infiltration of CD8+ T cells in the brain augments perihematomal edema and neurological deterioration. (Figure created with BioRender). FOXO1-driven metabolic reprogramming of hematomal CD8+ T cells drives the expansion of perihematomal edema following intracerebral hemorrhage—mechanisms and clinical implications CD8+ T cells within the hematoma are transformed during the first 24 h after ICH onset. These hematomal CD8+ T cells can possess remarkable glycolytic signatures and enhanced IFN-γ production and migration capacity, which are associated with the transcription factor FOXO1. The infiltration of CD8+ T cells in the brain augments perihematomal edema and neurological deterioration. (Figure created with BioRender).">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/276070da491f835ea64518208e42721a08ff69fe" target='_blank'>
              FOXO1-driven metabolic reprogramming of hematomal CD8+ T cells drives the expansion of perihematomal edema following intracerebral hemorrhage
              </a>
            </td>
          <td>
            Jie Lin, Honglei Ren, Youliang Wang, Hanzhi Yu, Zhili Chen, Xintong Yu, Zhuyu Gao, Yan Zheng, Quanhong Wu, Yizhe Zhang, Qijian Lin, Rui Li, Decai Tian, Zhigang Cai, Qiang Liu, Ying Fu
          </td>
          <td>2025-11-14</td>
          <td>Cellular and Molecular Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/49a5db351ada41d17475ee46b247329414cc1f0f" target='_blank'>
              Dynamics of interactions between three major respiratory pathogens in reconstituted human epithelium
              </a>
            </td>
          <td>
            Aurélien Gibeaud, Charles Terra, Émilie Portier, Pascal Lukas, Audrey Le Gouellec, Jérémie Guedj, Frederik Graw, A. Pizzorno, O. Terrier
          </td>
          <td>2025-11-17</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>32</td>
        </tr>

        <tr id="The COVID-19 pandemic has left a lasting imprint on immune function, particularly in the elderly—a population already vulnerable to immunosenescence. While acute and long-COVID immune responses have been widely studied, the long-term apoptotic behavior of peripheral blood mononuclear cells (PBMCs) remains underexplored. This study aims to investigate the legacy of SARS-CoV-2 on PBMC apoptosis in elderly individuals during the post-COVID era, shedding light on potential persistent immune dysregulation. In this cross-sectional study, PBMCs were isolated from peripheral blood samples of elderly individuals (> 65 years old) with a documented history of COVID-19 infection at least six months prior. Using multiparametric flow cytometry, we quantified early and late apoptosis markers (Annexin V/PI), mitochondrial membrane potential disruption (ΔΨm), and expression of pro-apoptotic (Bax, Caspase-3) and anti-apoptotic (Bcl-2) proteins. Statistical analyses were performed to assess intergroup differences and correlations with clinical history. This study was conducted in 2025. Elderly post-COVID individuals exhibited a significantly elevated proportion of apoptotic PBMCs compared to controls (p < 0.01), particularly within the CD4 + and CD8 + T-cell subsets. Mitochondrial depolarization and increased Bax/Bcl-2 ratios indicated a shift toward intrinsic apoptotic pathways. Caspase-3 activation was also heightened in the post-COVID group. Notably, apoptotic burden correlated with time since infection and severity of initial illness. Our findings suggest a prolonged apoptotic signature in the immune cells of elderly individuals following recovery from COVID-19. These alterations may reflect a sustained immune exhaustion or maladaptive remodeling of lymphocyte populations, potentially contributing to impaired immunosurveillance and increased vulnerability to secondary infections or chronic inflammatory conditions. COVID-19 may cast a long immunological shadow in the elderly, with persistent PBMC apoptosis representing a novel facet of post-viral immune dysregulation. Flow cytometry reveals a unique apoptotic phenotype that could serve as a biomarker for long-term immune health and guide post-pandemic clinical management strategies for aging populations.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/096a986d262753a585b2bfff92537948a29f8c5b" target='_blank'>
              Investigating apoptosis in peripheral blood mononuclear cells among the elderly in the post-COVID-19 era
              </a>
            </td>
          <td>
            Elaheh Abiri, Najmeh Hemmatian
          </td>
          <td>2025-10-31</td>
          <td>BMC Immunology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Post-COVID syndrome (PCS) affects approximately 3-17% of individuals following acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and poses a potential global health burden. While improved assessment strategies are emerging, mechanistic insights and treatment options remain limited. This study investigates molecular mechanisms underlying PCS using single-cell RNA (scRNA) transcriptomics combined with in vitro validation. scRNA analysis is performed on nasal biopsies from 25 patients with moderate or severe PCS to investigate differential cell types, signalling pathways, and cell-cell communication. Air-liquid interface cultures are used to validate findings, focusing on the TNFα-TGFβ axis. Severe PCS shows reduced numbers of ciliated cells, increased immune cell infiltration, and heightened inflammatory signaling that drives TGFβ and TNFα upregulation, in the absence of a detectable viral load. These changes trigger epithelial-mesenchymal transition, basal cell expansion and a mis-stratified nasal epithelium. In vitro experiments confirm TGFβ and TNFα as causal cytokines promoting ciliated cell loss and increased basal cell abundance. These findings indicate a sustained severe PCS is not driven by ongoing viral load but by immune cell activity and chronic cytokine production. Targeting the TNFα-TGFβ axis may mitigate immune-mediated nasal tissue damage and support epithelium restoration, offering a potential therapeutic strategy for PCS. In this work, authors apply single-cell transcriptomics to nasal biopsies from post-COVID syndrome patients, revealing chronic inflammation driven by TNFα and TGFβ, alongside persistent airway epithelial remodelling in the absence of viral load.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f11cef8e6987c6f7f18c86a6ad021d44e359f249" target='_blank'>
              scRNA-seq reveals persistent aberrant differentiation of nasal epithelium driven by TNFα and TGFβ in post-COVID syndrome
              </a>
            </td>
          <td>
            K. Reddy, Y. Maluje, F. Ott, R. Saurabh, A. Schaaf, A. Bohnhorst, S. Biedermann, J. Pierstorf, S. Winkelmann, B. Voss, M. Laudien, T. Bahmer, J. Heyckendorf, F. Brinkmann, S. Schreiber, W. Lieb, C. Jakwerth, C. Schmidt‐Weber, G. Hansen, E. von Mutius, K. F. Rabe, A. Dittrich, N. Maison, B. Schaub, M. Kopp, H. Busch, M. Weckmann, A. Fähnrich
          </td>
          <td>2025-10-28</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="Background Ischemic stroke remains a leading cause of mortality and disability worldwide. Microglia, the resident immune cells of the central nervous system, perform critical roles in immune surveillance, debris clearance, and tissue repair. Analyzing the heterogeneity, activation trajectories, and metabolic states of microglia in ischemic stroke is essential for discovering therapeutic targets. Methods We performed single-cell RNA sequencing (scRNA-seq) on brains from ischemic and control rats and identified transcriptionally distinct microglial subpopulations. We conducted differential expression, pathway enrichment, pseudotime analysis, regulatory network inference, and cell-cell communication mapping to characterize functional states, key transcription factors, and intercellular crosstalk underlying microglial responses following cerebral ischemia-reperfusion injury. We used Real-Time Quantitative PCR (RT-qPCR), Western blot, and immunohistochemistry to measure relative RNA and protein expression levels. Results We identified seven microglial subclusters with distinct transcriptional signatures. Ischemia-associated clusters exhibited strong activation of inflammatory pathways, increased glycolysis and lipid metabolism, and suppressed TCA cycle and oxidative phosphorylation (OXPHOS), reflecting a shift toward proinflammatory, energy-demanding phenotypes. Pseudotime analysis revealed transitions from homeostatic to pathological states, highlighting potential therapeutic windows. Regulatory network analysis identified activating transcription factor 3 (ATF3) as a central regulator controlling the expression of cholesterol 25-hydroxylase (CH25H) and secreted phosphoprotein 1 (SPP1). Notably, ATF3 overexpression enhanced CH25H expression and selectively increased proinflammatory cytokine production, linking metabolic reprogramming to neuroinflammatory responses. Cell-cell communication analysis further revealed extensive remodeling of interactions with astrocytes, endothelial cells, and fibroblasts, potentially amplifying postischemic neuroinflammation. Conclusion Our study demonstrates that cerebral ischemia induces transcriptionally and functionally distinct microglial subpopulations, characterized by metabolic reprogramming and proinflammatory activation. ATF3 serves as a central regulator linking CH25H-mediated metabolic changes to cytokine-driven neuroinflammation, highlighting potential therapeutic targets for modulating microglial responses and mitigating ischemia-induced brain injury.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/21c20effa3ad945d21b01c8ec4f5a72133113a12" target='_blank'>
              Single-Cell RNA Sequencing Reveals Microglial Heterogeneity and Functional States After Cerebral Ischemia-Reperfusion Injury
              </a>
            </td>
          <td>
            Yu-jing Tang, Qi Zhang, Yewei Qu, Lian Yi, Fangqin Li, Changda Qu, Shanshan Shi, Byron Fei Pan, Shirong Wen, Ruohan Sun, Yujun Pan
          </td>
          <td>2025-12-01</td>
          <td>Journal of Inflammation Research</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Background Sepsis is a life-threatening syndrome characterized by dysregulated host immune responses, yet the metabolic drivers of immune dysfunction remain poorly understood. Methods Here we systematically profiled metabolism-related genes (MRGs) in sepsis using bulk transcriptomic data and stratified patients into two subgroups with distinct immune infiltration profiles by MRGs, as assessed by CIBERSORT and single-cell RNA-seq integration. Machine learning identified five hub metabolic genes for constructing a metabolic risk score, whose prognostic relevance was robustly validated in an external cohort. Single cell analyses, cell–cell communication, and cell-type-specific differential expression analyses were performed to dissect the immunological context. Finally, in vivo validation was conducted using an LPS-induced sepsis mouse model. Results Patients in the high metabolic risk group exhibited a neutrophil-dominant and lymphocyte-suppressed immune landscape, consistent across bulk and single-cell analyses. Among the five hub genes (ALPL, CYP1B1, GYG1, OLAH, VNN1), GYG1 demonstrated the strongest predictive performance and was highly expressed in monocytes, neutrophils, and proliferating myeloid cells. High-risk patients displayed intensified monocyte–dendritic cell interactions and transcriptional programs enriched in neutrophil degranulation pathways. In vivo, Gyg1 was markedly upregulated in septic mice, and LNP-mediated siRNA knockdown of Gyg1 significantly improved survival in the LPS model. Mechanistically, Gyg1 knockdown significantly reduced glycogen content in myeloid cells, attenuated IL-6 and TNF-α production, alleviated LPS-induced neutrophil, and modestly decreased CD40 expression in monocytes and dendritic cells. These results collectively suggest that Gyg1 regulates metabolic fueling of inflammatory activation and intercellular communication during sepsis. Conclusions This integrative multi-omics study established a robust immune–metabolic risk score system to predict sepsis patient outcomes and identified GYG1 as a metabolic driver of innate immune hyperactivation. Targeting GYG1 via LNP–siRNA delivery reduces glycogen availability and inflammatory output in myeloid cells, mitigating immune overactivation and improving disease outcomes in vivo, thereby highlighting its potential as a novel therapeutic target for sepsis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/37a2f6c35edb793df86e8e6ac1048684df29f596" target='_blank'>
              Comprehensive analysis of metabolism-related genes in sepsis reveals metabolic–immune heterogeneity and highlights GYG1 as a potential therapeutic target
              </a>
            </td>
          <td>
            Jie Zheng, Kangjie Qin, Xiaoqin Wang, Banghai Feng, Yuting Zhang, Yiyu Wang, Han Qin, Qiuyu Dai, Xinxin Liu, Kun Yu, Song Qin
          </td>
          <td>2025-11-17</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Gastrointestinal (GI) dysfunction, characterized by severe diarrhea and dehydration, is a central contributor to morbidity and mortality in filovirus disease in patients, yet the role of the epithelium in this clinical outcome remains poorly defined. Here, we employ induced pluripotent stem cell (iPSC)-derived human intestinal (HIOs) and colonic organoids (HCOs) to model Ebola virus (EBOV) and Marburg virus (MARV) infection. These organoids are permissive to filovirus infection and support viral replication. Bulk RNA sequencing revealed distinct intestinal and colonic epithelial responses, including apical and junctional disruption and a delayed virus-specific induction of interferon-stimulated genes. Moreover, infection impaired adenylate cyclase signaling and CFTR-mediated ion transport, providing mechanistic insight into virus-induced secretory diarrhea. This platform recapitulates key features of human GI pathology in filoviral disease and serves as a powerful system to dissect host-pathogen interactions and identify therapeutic targets.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c68db2f80b5b3b83a6105b9d72af121706a4d306" target='_blank'>
              Filovirus infection disrupts epithelial barrier function and ion transport in human iPSC-derived gut organoids
              </a>
            </td>
          <td>
            Elizabeth Y. Flores, A. Hume, J. Olejnik, A. Mithal, Andrew D’Amico, Mengwei Yang, P. Bawa, Feiya Wang, A. O’Connell, Anna E. Tseng, Nicholas A. Crossland, Gustavo Mostoslavsky, Elke Mühlberger
          </td>
          <td>2025-11-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="ABSTRACT Severe COVID‐19 is an immunological disorder characterized by excessive immune activation following infection with SARS‐CoV‐2, which typically occurs around the time of seroconversion. Anti‐spike IgG of critically ill COVID‐19 patients induces excessive inflammation by activation of Fc gamma receptors (FcγRs) on human alveolar macrophages, leading to tissue damage, pulmonary edema, and coagulopathy. While metabolic reprogramming of immune cells is critical for the induction of inflammatory responses, still little is known about the metabolic pathways that are involved in COVID‐19‐specific hyperinflammation. In this study, we identified that anti‐spike IgG immune complexes (ICs) induce rapid metabolic reprogramming of alveolar macrophages, which is essential for the induction of inflammation. Through functional inhibition, we identified that glycolysis, fatty acid synthesis, and pentose phosphate pathway (PPP) activation are critical for anti‐spike IgG‐induced hyperinflammation. Remarkably, while excessive proinflammatory cytokine production by macrophages is critically dependent on simultaneous stimulation with viral stimuli and anti‐spike IgG complexes, we show that the required metabolic reprogramming is specifically driven by anti‐spike IgG complexes. These findings provide new insights into the metabolic pathways driving hyperinflammation by macrophages in the context of severe COVID‐19. Targeting of these pathways may reveal new possibilities to counteract pathological inflammatory responses in severe COVID‐19 and related diseases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7d09f7fb7e4fd28a04356b3213eb05a7c8386673" target='_blank'>
              Hyperinflammation by Human Macrophages Induced by SARS‐CoV‐2 Anti‐Spike IgG Is Dependent on Glucose and Fatty Acid Metabolism
              </a>
            </td>
          <td>
            Chiara E. Geyer, Luís Almeida, Lynn Mes, F. Otto, W. A. Mak, Graham A Heieis, Jennifer Veth, Steven W. de Taeye, Tom G. Caniels, Tom P. L. Bijl, Marit J. van Gils, Menno de Winther, Amsterdam Umc, COVID-19 Biobank, J. Bossche, Hung-Jen Chen, R. Houtkooper, Bart Everts, J. D. Dunnen
          </td>
          <td>2025-12-01</td>
          <td>European Journal of Immunology</td>
          <td>0</td>
          <td>63</td>
        </tr>

        <tr id="There is a subgroup of people infected with the SARS-CoV-2 virus who manifest lingering sequelae (LongC), with neurological symptoms (nLongC). We recruited 86 COVID-19 volunteers, 35 of whom were fully recovered (Cov) and 51 who had neurological symptoms (nLongC) 4–53 months after infection and compared them to 51 healthy pre-pandemic controls (HC). Thirty-five percent of nLongC individuals carried the apolipoprotein E4 (APOE4) gene, compared to 11% of Cov. Four plasma proteins, interleukin 1 beta (IL-1β), interleukin 8 (IL-8), glial fibrillary acidic protein (GFAP), and hemopexin, continued to be elevated in both Cov and nLongC compared to HC. Soluble CD14 was elevated in nLongC but not Cov. As a group, IL-1β decreased over time in Cov but not nLongC. Two of the elevated proteins, IL-8 and GFAP, correlated with age, with both Cov and nLongC showing higher levels than HC. Using a combination of four plasma proteins, along with age, body mass index, and APOE4 presence, we were able to achieve an area under the curve (AUC) of 0.81. These results suggest that SARS-CoV-2 infection causes a low-grade inflammatory process that, even months or years after infection, does not return to pre-COVID-19 levels, which may contribute to neurologic sequelae and accelerated aging.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d6dc097b9097119d707ae7261b40c50b96e52a07" target='_blank'>
              Chronic Inflammation and Altered Immune Responses in LongCOVID Associate with Neurological Manifestations and Accelerated Aging
              </a>
            </td>
          <td>
            Norina Tang, Judith M. Ford, Kaitlyn Dal Bon, Lynn Pulliam
          </td>
          <td>2025-11-26</td>
          <td>Cells</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="The COVID-19 pandemic, which began in 2019 due to SARS-CoV-2, remains a global health crisis, especially as new variants emerge that could trigger widespread outbreaks again. While various aspects of SARS-CoV-2 infection warrant attention, the antiviral innate immune response is a crucial area of focus. Understanding how viruses evade host defenses is vital for developing effective vaccines and therapies. SARS-CoV-2 targets key components of the innate immune system for its survival, and this interference with the host immune system is central to the virus's ability to cause disease. However, the specific mechanisms by which the innate immune response counteracts SARS-CoV-2 infection have not been fully clarified. This review examines key elements of the antiviral innate immune response to SARS-CoV-2 infection, concentrating on viral evasion strategies and potential therapeutic targets.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2283fdb7927a9966d77a4f3f180d82163d69d72b" target='_blank'>
              Host’s innate immune response to SARS-CoV-2 infection—Current understanding and trends
              </a>
            </td>
          <td>
            Nitin Saksena
          </td>
          <td>2025-11-08</td>
          <td>Journal of Cellular and Molecular Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="The mechanisms by which Enterovirus D68 (EV-D68) infection leads to acute flaccid myelitis (AFM), a severe neurological condition characterized by sudden muscle weakness and paralysis, remain poorly understood. To investigate the cellular tropism and infection dynamics of EV-D68, we profiled naive and EV-D68-infected human spinal cord organoids (hSCOs) derived from induced pluripotent stem cells (iPSCs) using single-cell RNA sequencing (scRNA-seq). Examining the cellular composition of healthy hSCOs, we found that hSCOs include diverse cell types, including neurons, astrocytes, oligodendrocyte progenitor cells (OPCs), and multipotent glial progenitor cells (mGPCs). Upon infection with 2 EV-D68 strains, US/IL/14-18952 (a B2 strain) and US/MA/18-23089 (a B3 strain), we observed distinct viral tropism and host transcriptional responses. Notably, US/IL/14-18952 showed a significant preference for neurons, while US/MA/18-23089 exhibited higher rates of infection in cycling astrocytes and OPCs. These findings provide novel insights into the host cell tropism of EV-D68 in the spinal cord, offering insight into the potential mechanisms underlying AFM pathogenesis. Understanding the dynamics of infection at single-cell resolution will inform future therapeutic strategies aimed at mitigating the neurological impact of enterovirus infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fb54cf51aa995a2705a7d71cb812e43393ceb04a" target='_blank'>
              Strain-specific tropism and transcriptional responses of enterovirus D68 infection in human spinal cord organoids
              </a>
            </td>
          <td>
            Nathânia Dábilla, Sarah Maya, Colton McNinch, Taylor Eddens, Patrick T. Dolan, M. Freeman
          </td>
          <td>2025-11-19</td>
          <td>Frontiers in Microbiology</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system (CNS) characterized by multifocal inflammation and axonal degeneration, driven by innate and adaptive immune cells. The Janus Kinase (JAK)/Signal Transducers and Activators of Transcription (STAT)/Suppressors Of Cytokine Signaling (SOCS) pathway regulates immune cell activity, with SOCS proteins functioning as negative regulators. Using the Experimental Autoimmune Encephalomyelitis (EAE) model of MS, our prior work demonstrated that mice lacking Socs3 in myeloid cells (Socs3ΔLysM) developed severe, brain-targeted EAE (btEAE), with increased cerebellar infiltration of activated neutrophils. To define neutrophil-specific roles, we generated mice with Socs3 deletion restricted to neutrophils (Socs3ΔLy6G). Following MOG-induced EAE, these mice exhibited clinical features identical to Socs3ΔLysM mice, including severe cerebellar demyelination, increased cerebellar infiltration of activated neutrophils and CD4+ T-cells, and clinical symptoms of both btEAE and classical EAE (cEAE), the latter involving the spinal cord (SC). Cerebellar neutrophils from Socs3ΔLy6G mice exhibited a primed, inflammatory phenotype with elevated reactive oxygen species, neutrophil extracellular traps (NETs) and heightened production of pro-inflammatory cytokines/chemokines. Neutrophil depletion alleviated btEAE, confirming their pathogenic role. Single-cell RNA Sequencing (scRNA-Seq) of cerebellum (CB) and SC neutrophils revealed five clusters in naïve and EAE mice, with expansion of two clusters (Neu2 and Neu4) in Socs3ΔLy6G mice with EAE. Neu2, Neu3 and Neu4 clusters showed high expression of Saa3, Il1b and Cxcl2, with Neu4 enriched in cytokine signaling pathways and inflammatory responses. Strikingly, Saa3 mRNA and protein expression were markedly increased in the CB and SC of Socs3ΔLy6G mice with EAE compared to controls. Translationally, the human orthologue SAA1 was significantly elevated in plasma from MS patients relative to healthy controls. Collectively, these findings demonstrate that Socs3 deficiency unleashes pathogenic neutrophil activity in Socs3ΔLy6G mice with EAE. They further reveal neutrophil heterogeneity within the inflamed CNS, define inflammatory transcriptional states and identify Saa3/SAA1 as potential biomarkers and therapeutic targets to attenuate autoimmune neuroinflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fe5a2480e246a352587ff976b7ff5324d95b8c9e" target='_blank'>
              Single-Cell RNA Sequencing Uncovers Neutrophil Clusters Associated with Autoimmune Neuroinflammation
              </a>
            </td>
          <td>
            Yong Wang, William Turbitt, Lianna Zhou, Zhaoqi Yan, Sweta B Patel, Wei Yang, Zhang Li, Jessica A. Buckley, R. Welner, William R. Meador, Chander Raman, H. Qin, Etty N. Benveniste
          </td>
          <td>2025-11-19</td>
          <td>Research Square</td>
          <td>0</td>
          <td>44</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/083cd9665e2adce6c636caf445e71437ffb29674" target='_blank'>
              Astrocytes control the Neuroinflammation and ILC2 response through IL-33/ST2 signaling, during protection against Cerebral Malaria in Toxoplasma-P. berghei coinfected Mice
              </a>
            </td>
          <td>
            Inès Leleu, Tarun Keswani, Fabien Herbert, Capucine Picavet, Manon Arnaud, Marion Sabrina, Corine Glineur, Pied Sylviane
          </td>
          <td>2025-10-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="ABSTRACT Avian coronavirus infectious bronchitis virus (IBV) induces severe renal inflammation and urate deposition in chickens, but the underlying mechanisms remain incompletely understood. Here, we used both in vivo chicken infection models and in vitro primary renal epithelial cell cultures and found that IBV activates the NLRP3 (NOD-like receptor family, pyrin domain containing 3) inflammasome, leading to the maturation and secretion of IL-1β (interleukin-1 beta). Pharmacological inhibition of NLRP3 in an in vivo chicken model alleviates renal pathology without affecting viral replication, implicating host inflammatory responses in disease progression. These findings indicate that host inflammasome activation, rather than direct viral replication or cytotoxicity, plays a central role in IBV-associated renal pathology. Notably, we observed that NLRP3 is predominantly expressed in the renal collecting duct, primarily within AQP2 (Aquaporin-2)-positive epithelial cells—an anatomic localization of inflammasome activity not previously reported. Single-cell transcriptomic profiling further revealed that IBV infection reprograms collecting duct cells from an electrolyte-regulating phenotype into a pro-inflammatory state, accompanied by disrupted urate metabolism and impaired ion transport. These findings identify collecting duct-targeted NLRP3 activation as a central mechanism of IBV-induced nephropathy and provide a theoretical foundation for developing targeted anti-inflammatory therapies. IMPORTANCE In vivo studies in chickens demonstrate that the activation of the NLRP3 inflammasome is a key driver of renal injury during infectious bronchitis virus (IBV) infection. Pharmacological inhibition of NLRP3 significantly alleviates renal inflammation and tissue damage without affecting viral replication, highlighting the central role of host inflammatory responses in disease progression. Importantly, we report for the first time that NLRP3 activation is predominantly localized to AQP2-positive collecting ducts, a nephron segment essential for uric acid excretion and electrolyte balance. IBV infection reprograms these epithelial cells into a pro-inflammatory, metabolically dysregulated state, promoting urate crystal formation and amplifying tissue injury. These findings reveal a spatially confined epithelial-immune axis of coronavirus-induced renal pathology and suggest new avenues for targeted intervention. In vivo studies in chickens demonstrate that the activation of the NLRP3 inflammasome is a key driver of renal injury during infectious bronchitis virus (IBV) infection. Pharmacological inhibition of NLRP3 significantly alleviates renal inflammation and tissue damage without affecting viral replication, highlighting the central role of host inflammatory responses in disease progression. Importantly, we report for the first time that NLRP3 activation is predominantly localized to AQP2-positive collecting ducts, a nephron segment essential for uric acid excretion and electrolyte balance. IBV infection reprograms these epithelial cells into a pro-inflammatory, metabolically dysregulated state, promoting urate crystal formation and amplifying tissue injury. These findings reveal a spatially confined epithelial-immune axis of coronavirus-induced renal pathology and suggest new avenues for targeted intervention.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/baa28b1eb0fbf6fb53108019955f2aeab6f74090" target='_blank'>
              Avian coronavirus IBV-induced activation of the NLRP3–Caspase-1–IL-1β axis in renal collecting ducts contributes to nephropathogenesis
              </a>
            </td>
          <td>
            Min Huang, Chengyin Liukang, Rong Liang, Yingfei Li, Ruihua Yang, Mingwei Zhang, Ye Zhao, Jing Zhao, Guozhen Zhang
          </td>
          <td>2025-12-03</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="The clinical outcome of Mycobacterium tuberculosis (Mtb) infection ranges from latent/nonprogressive disease to active/progressive tuberculosis (TB), but the cellular events contributing to these variable outcomes remain unknown. Here, we report that progressive Mtb infection is associated with upregulation of guanylate‐binding protein‐1 (GBP1), hypoxia‐inducible factor‐1 alpha (HIF‐1α), and elevated NLR family pyrin domain‐containing (NLRP3) inflammasome activation pathways. Using rabbit lungs and primary rabbit and human macrophages, as well as human monocytic THP‐1‐derived macrophages for infection with Mtb strains (H37Rv, HN878, or CDC1551) that differ in virulence, we show that NLRP3 inflammasome activation by HIF‐1α and GBP1 leads to elevated mitochondrial stress, apoptosis, and necrosis during progressive infection by HN878. These biological functions and pathways are dampened during nonprogressive TB in rabbit lungs, and in primary rabbit and human macrophages infected by CDC1551. These findings are consistent with and confirmed by Mtb infection studies of macrophages knocked down for HIF‐1α or GBP1 expression. Our study indicates that differences in HIF‐1α‐ and GBP1‐mediated NLRP3 inflammasome activation influence the outcome of Mtb infection in the host.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/03a725a42954422089b5cdb821dd4c57f65d3e21" target='_blank'>
              Inflammasome Activation Differences Underpin Different Mycobacterium tuberculosis Infection Outcomes
              </a>
            </td>
          <td>
            Ranjeet Kumar, Afsal Kolloli, G. Bhargavi, Seema Husain, Theresa L. Chang, Saleena Ghanny, Patricia Soteropoulos, S. Subbian
          </td>
          <td>2025-11-23</td>
          <td>MedComm</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/679a7b822ce567d8ac2ac1c2ea01dd417c348cfe" target='_blank'>
              The SARS-CoV-2 nucleocapsid protein induces microglia senescence-mediated cognitive impairment via Glycolysis.
              </a>
            </td>
          <td>
            Nan-Shi-Yu Yang, Han-Xi Sha, Chen-Yu Zhang, Hui Chen, Yu-Biao Liu, Jian-Bing Xiong, J. Duan, Jun Zhang, Cha-Xiang Guan, Yong Zhou, Feng Su, W. Zhong
          </td>
          <td>2025-12-12</td>
          <td>Molecular medicine</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8a1eeb94ba00b3791cf49e1ba52939a4a9de01a3" target='_blank'>
              Sickness engrams modulate anticipatory immune responses
              </a>
            </td>
          <td>
            A. Douglas, Andrea Muñoz Zamora, Paul B. Conway, Esteban Urrieta, Lydia Lynch, T. Ryan
          </td>
          <td>2025-11-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="COVID-19, caused by the SARS-CoV-2 virus, manifests with varying degrees of severity, affecting individuals worldwide. The spectrum of symptoms ranges from mild to severe, with respiratory failure being a leading cause of death. Immunological factors, particularly excessive cytokine production such as IL-18 and IL-1β, significantly contribute to disease severity. In this context, the NLRP3 inflammasome, a key component of the innate immune system, has influenced COVID-19 outcomes. This study investigated the association between single-nucleotide variants (SNVs) in the NLRP3 inflammasome and COVID-19 severity. A case-control study was conducted involving 800 adult participants infected with SARS-CoV-2, stratified into mild/moderate and severe/critical cases. Genetic associations were assessed through qPCR-based genotyping. While no association was found between SNVs in IL1B and CASP1 with COVID-19 severity, the multivariate analysis revealed that the gain-of-function SNV in the NLRP3 gene (rs35829419) was associated with a protective effect against COVID-19-related mortality. These findings suggest that genetic variations in the NLRP3 inflammasome may modulate the host response to SARS-CoV-2, highlighting potential biomarkers for disease prognosis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c3bc942541c2b74961a12f103de05cc6065fe633" target='_blank'>
              An NLRP3 Variant Protects Against Severe COVID-19: An Unexpected Contribution of Inflammasome Genetics in SARS-CoV-2 Infection.
              </a>
            </td>
          <td>
            L. M. Paulino, V. N. C. Leal, W. M. D. S. Santiago, Débora de Fátima Almeida Donanzam, Célio Roberto Siqueira Ledesma, Maria Fernanda Silva Bertelli, W. S. Fava, A. Latini, Alessandra Pontillo, James Venturini
          </td>
          <td>2025-10-27</td>
          <td>International journal of immunogenetics</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/79fbb4abcb1eeb6127549b886296b47a4c3b2fa0" target='_blank'>
              Temporal single-cell analysis reveals age-associated delay in immune resolution after respiratory viral infection
              </a>
            </td>
          <td>
            Yue Wu, Chaofan Li, Jinyi Tang, Xiaochen Gao, I. Cheon, Bibo Zhu, Ruixuan Zhang, C. Fain, Shengen Shawn Hu, H. Narasimhan, Gislane de Almeida Santos, K. Ayasoufi, , Hui Zong, Chongzhi Zang, Haidong Dong, Jie Sun
          </td>
          <td>2025-12-17</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="Abstract Background Human T-lymphotropic virus type 1 (HTLV-1) infects up to ten million people worldwide, and causes severe diseases, including adult T-cell leukemia/lymphoma and HTLV-1–associated myelopathy/tropical spastic paraparesis (HAM/TSP). Individuals with HAM/TSP are prone to pulmonary complications (e.g., bronchiectasis). Their bronchoalveolar lavage fluid typically shows increased levels of inflammatory cytokines, chemokines and cell adhesion molecules contributing to chronic inflammation. Results This study assessed the impact of HTLV-1 infection on lung inflammation by analyzing the alveolar transcriptome of A549 epithelial cells following exposure to HTLV-1. Co-culture with HTLV-1-infected MT-2 cells caused transcriptomic changes related to viral response, NF-κB activation, and inflammation. RT-qPCR confirmed elevated expression of the chemokine monocyte chemotactic protein-1 (MCP-1/CCL2) and colony stimulating factor 1 (CSF-1) in A549 MT-2 co-cultures. Increased CSF-1 expression was mechanistically linked to NF-κB signaling, using CRISPR/Cas9 RELA knockout. Supernatant from A549 MT-2 co-cultures triggered chemotaxis and macrophage differentiation of THP-1 and primary monocytes. Systems biology analysis revealed enrichment in pathways associated with monocyte infiltration and bronchiectasis. Finally, we validate the in vivo relevance of our in vitro model through multi-cohort multi-omics analysis combining bulk and single-cell transcriptomics, viral interactomics and multi-ancestry GWAS. Conclusions We describe an in vitro co-culture model that recapitulates HTLV-1-triggered lung inflammation, through RELA/NF-kB-dependent release of pro-inflammatory cytokines and chemokines resulting in monocyte chemotaxis, activation and differentiation. Integrated multi-omics analysis confirmed the in vivo relevance of our in vitro model.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f2fcc915bbd12bb88b05e375c5c2d91f60fb7f15" target='_blank'>
              Deciphering HTLV-1-associated Lung Pathology through Integrated in vitro and Multi-cohort Multi-omics Analysis: Inflammation, Monocyte Recruitment and Differentiation Triggered by HTLV-1-exposed Alveolar Epithelial Cells
              </a>
            </td>
          <td>
            Clément J F Heymann, M. Gouwy, Robin Hermans, J. Twizere, Tatiana Assone, J. Casseb, Isaac Racine, Isabelle Cleynen, Edward L. Murphy, Roberta Bruhn, Dominique Schols, E. Vanderlinden, J. V. Weyenbergh
          </td>
          <td>2025-11-24</td>
          <td>Research Square</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="Respiratory virus infections have been presenting significant global public health challenges. The virulence of SARS-CoV-2 and seasonal influenza largely relies on triggering abnormal host immune responses, particularly the production of a cytokine storm, which is notably increased in elderly patients. However, as the mechanisms underlying this age-associated exacerbation remain unclear, we investigated the role of the aging tissue microenvironment in promoting inflammation associated with viral infection. Our research, based on clinical samples, cellular experiments, and mouse models, provides evidence that the aging lung microenvironment induces severe inflammatory responses and leads to tissue damage, with senescent cells playing a crucial role in this process. Further mechanistic insights reveal that elevated levels of downstream inflammatory factors result from a significant and robust activation of the NF-κB pathway. This increase is attributed to the accumulation of reactive oxygen species in senescent cells and subsequent reduced expression of PDLIM2, an E3 ubiquitin ligase regulating P65 degradation. Finally, restoring PDLIM2 significantly inhibits viral infection-mediated inflammatory responses and organ damage in the aging body. Therefore, this study offers a novel perspective by elucidating the molecular mechanism and exploring the therapeutic potential behind viral infection-related inflammatory responses, particularly the mechanism accelerating inflammatory storms in elderly patients post-infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e07f24dbbacd6b1011804f10fdf4109e7d35e755" target='_blank'>
              Senescent cells promote viral infection-associated inflammation and tissue damage through a robust NF-κB pathway
              </a>
            </td>
          <td>
            Mingfu Tian, June Ma, Zhiqiang Li, Chenglin Ye, Xianghua Cui, Guolei Wang, Siyu Liu, Muhammad Suhaib Qudus, Uzair Afaq, Hong Fan, Jiali Xiong, Guangli Li, Chuanjin Luo, Zhen Wang, Zhengjiang Jin, Ming Guo, Xin Wang, Zhixiang Huang, Fang Zheng, Kailang Wu, Chengliang Zhu
          </td>
          <td>2025-10-28</td>
          <td>Cell Communication and Signaling : CCS</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="Cytotoxic T cell (CTL) dysfunction is a hallmark of immune paralysis after major surgery, increasing susceptibility to severe nosocomial infections and contributing to mortality in critically ill patients. The mechanisms remain poorly understood. We demonstrate that reactive oxygen species (ROS) released by myeloid-derived suppressor cells (MDSC) transiently emerging after surgery, drive perioperative CTL immunoparalysis. These ROS damage CTL mitochondria, triggering secondary mitochondrial ROS amplification and overwhelming antioxidant defenses. The resulting oxidative cascade impairs oxidative phosphorylation and suppresses CTL effector function. Concurrently, stress-induced mitochondrial hyperfusion disrupts fission-dependent translocation to the immunological synapse, exacerbating bioenergetic failure. MitoTEMPO, a mitochondria-targeted antioxidant, partially mitigates these effects, highlighting mitochondrial stabilization as a potential strategy to prevent perioperative immune dysfunction. Major surgery is associated with transient suppression of T-cell immunity, increasing susceptibility to severe infections. This study identifies a previously unrecognized mechanism that drives cytotoxic T lymphocyte (CTL) suppression in the postoperative period. Postoperative oxidative stress is primarily generated by Myeloid-Derived Suppressor Cells (MDSC) and exceeds the antioxidant capacity of CTL, resulting in mitochondrial damage. This dysfunction leads to excessive ROS production, stress-induced mitochondrial hyperfusion, impaired ATP generation, and reduced CTL effector function. CTL mitochondrial function and immune competence are restored by mitochondria-targeted antioxidant therapy. Postoperative oxidative stress is primarily generated by Myeloid-Derived Suppressor Cells (MDSC) and exceeds the antioxidant capacity of CTL, resulting in mitochondrial damage. This dysfunction leads to excessive ROS production, stress-induced mitochondrial hyperfusion, impaired ATP generation, and reduced CTL effector function. CTL mitochondrial function and immune competence are restored by mitochondria-targeted antioxidant therapy. Major surgery is associated with transient suppression of T-cell immunity, increasing susceptibility to severe infections. This study identifies a previously unrecognized mechanism that drives cytotoxic T lymphocyte (CTL) suppression in the postoperative period.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4ecfd94a6acc8bae59497180259a7eb1030fe58a" target='_blank'>
              Mitochondrial damage drives T-cell immunometabolic paralysis after major surgery
              </a>
            </td>
          <td>
            S. Hirschberger, Martin B Müller, Hannah Mascolo, Melissa Seitz, Stefan Nibler, David Effinger, Kun Lu, Joscha Büch, Martin Bender, Tobias Kammerer, Sven Peterß, K. Kleigrewe, Miriam Abele, Teresa Barth, Olga Kushnir, A. Imhof, Steffen Dietzel, Bernd Wegener, Ralf Sowa, Frank Vogel, Peter Lamm, Roland Tomasi, Kristian Unger, M. Sperandio, Erich Kilger, Simone Kreth, Max Hübner
          </td>
          <td>2025-11-03</td>
          <td>EMBO Molecular Medicine</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e1cac498108b5305e7d2a1dde250a33c8a3e03b2" target='_blank'>
              Acute SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Amy C. Sherman, Glenda E Gray, Bin Cao, K. To, Nadine G Rouphael, A. Henao-Restrepo, Anthony C Gordon, Lindsey Baden
          </td>
          <td>2025-10-24</td>
          <td>Nature Reviews Disease Primers</td>
          <td>0</td>
          <td>73</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/68a61536fdb213f77defcf43b41942dda2c2a3d0" target='_blank'>
              SARS-CoV-2 Variant-Dependent Alterations in Nasopharyngeal Microbiota and Host Inflammatory Response
              </a>
            </td>
          <td>
            Mario Maulen, Ignacio Pezoa-Soto, Daniel León, Ela M. Dominguez, Alberto J. M. Martin, W. Díaz-Vásquez
          </td>
          <td>2025-10-30</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="Enterovirus D68 (EV-D68) is a significant global pathogen associated with severe respiratory infections and acute flaccid myelitis in children. Currently, there are no vaccines or antiviral drugs available for EV-D68, and a robust model to elucidate the pathogenesis of EV-D68 and evaluate treatment methods is lacking. We developed a mouse-adapted EV-D68 strain that caused progressive limb paralysis after intramuscular inoculation in 7-day-old mice. Viral load analysis showed that the skeletal muscle and spinal cord had the highest titers and most severe injuries. RNA sequencing of the infected muscle, brain, spinal cord, and lung tissues revealed differentially expressed genes (DEGs) associated with viral infection and pathogenesis. DEGs were significantly enriched in various pathways associated with antiviral immunity, interferon responses, and cytokine signaling. In the spinal cord, DEGs highlighted mitochondrial dysfunction and oxidative stress as crucial contributors to neural damage. Flow cytometry analysis of spinal cord cells showed that EV-D68 activates the immune system, leading to systemic inflammation and significant increases in CD8+ and CD4+ T cells, but limited neutrophil and monocyte infiltration. This mouse model provides a valuable tool for studying EV-D68 pathogenesis and evaluating antiviral and vaccine efficacy, thereby advancing the understanding of its neuropathological mechanisms. Importance: We developed a novel mouse model of EV-D68 that provides a valuable tool for studying its pathogenesis and evaluating antiviral and vaccine efficacy, deepening the understanding of its neuropathological basis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ec65cdb91c340614db24a50d4f78be18da8803ac" target='_blank'>
              Spinal Cord Injury in Enterovirus D68 Infection: Mechanisms and Pathophysiology in a Mouse Model
              </a>
            </td>
          <td>
            Wei Duan, Jichen Li, Ying Liu, Rui Wang, Qian Yang, Huijie Li, Yucai Liang, Qi Shi, Jiao Wang, Jinbo Xiao, Jianfang Zhou, Qiang Sun, Yong Zhang
          </td>
          <td>2025-11-01</td>
          <td>Viruses</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="


 Multiple sclerosis (MS) is a chronic disease of the central nervous system (CNS). Comparison of COVID-19 and MS brain autopsies showed similar neuropathology and preliminary work in our lab revealed the presence of immune cell aggregates in the meningeal layers surrounding the brain of Syrian Hamsters infected with SARS-CoV2. As such, it is critical to learn whether SARS-CoV2-induced brain pathology augments MS disease severity or accelerates progression. More specifically, we wish to determine whether SARS-CoV2 infection augments the neuropathogenic potential of myelin-primed Th17 cells in animal models of MS. I have established a working model in humanized ACE2 knock-in (hACE2-KI) mice that combines experimental autoimmune encephalomyelitis (EAE) with SARS-CoV-2 infection. Following resolution of infection with a non-lethal dose of the delta strain of SARS-CoV2, I induce passive EAE and assess: (1) clinical presentation of disease and (2) CNS pathology. Thus far, we have seen that mice with prior SARS-CoV2 infection exhibited reduced incidence of EAE by approximately 50% and less severe EAE clinical symptoms during the chronic phase of EAE. Immunophenotyping of the spinal cord revealed a reduction in CD4+ T cell numbers in these mice. These findings suggest that SARS-CoV2 infection prior to EAE reduces the impact of encephalogenic T cells and/or delays their progression to the CNS. We wish to further investigate the mechanism behind this observed phenotype.



 Supported by the Coronavirus Variants Rapid Response Network (CoVaRR-Net), the MS Society of Canada, and the Emerging and Pandemic Infections Consortium



 Neuroimmunology (NEUR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b0b463f6e24123fcf44514b3edccf3d2b816b173" target='_blank'>
              Impact of SARS-CoV2 infection on the neuropathogenic potential of myelin-primed Th17 cells in an animal model of MS 2436
              </a>
            </td>
          <td>
            B. Isho, Catherine Chi, Salma Sheikh-Mohamed, J. Gommerman
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>49</td>
        </tr>

        <tr id="Introduction Neuroinflammation triggered by viral infections is increasingly recognized as a driving force in neurodegenerative disease, promoting chronic neuronal injury and cognitive decline. A central mechanism in this process is impaired glutamate clearance due to downregulation of the astrocytic glutamate transporter GLT-1 (EAAT2/SLC1A2), which exacerbates excitotoxicity and neuronal death. Methods In this study, we assessed the neuroprotective effects of the β-lactam antibiotic ceftriaxone—a known upregulator of GLT-1—in an in vitro tri-culture model of neurons, microglia, and astrocytes challenged with the viral mimic polyinosinic:polycytidylic acid (Poly I:C). Results and discussion Poly I:C exposure elicited robust microglial and astrocytic activation and increased levels of TNF-α, IL-6, and IL-10. Concomitantly, we observed significant downregulation of GLT-1, synapse loss, impaired synaptic plasticity, and disrupted amino acid metabolism. A complementary Mendelian randomization analysis of GWAS data revealed that genetically determined alterations in plasma amino acid levels are significantly associated with the risk of five major neurodegenerative disorders, underscoring the role of metabolic dysregulation in disease pathogenesis. Treatment with ceftriaxone effectively reversed the Poly I:C–induced phenotypes: GLT-1 expression, dendritic spine density, and measures of synaptic plasticity were all restored, and abnormalities in amino acid and tricarboxylic acid cycle metabolites normalized. These findings highlight ceftriaxone’s multifaceted neuroprotective profile—modulating glutamate homeostasis, preserving synaptic integrity, and rebalancing metabolic pathways—and support its potential as a therapeutic agent to prevent neuronal degeneration in the context of virus-driven neuroinflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/40b63bf1f6fcbfab7da258e50a2adaf9994182d6" target='_blank'>
              Ceftriaxone attenuates Poly I:C–induced neuroinflammation in vitro by modulating glutamate transport, synaptic integrity, and immunometabolic reprogramming
              </a>
            </td>
          <td>
            Xizi Shi, Yesheng Sun, Shirin Hosseini, Fangfang Chen, Thekla Cordes, Kristin Michaelsen-Preusse, Martin Korte
          </td>
          <td>2025-10-28</td>
          <td>Frontiers in Cellular Neuroscience</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="Early immune perturbations increase the risk of neurodegenerative and neurodevelopmental disorders, yet the mechanisms underlying the maturation of microglia, the resident immune cells of the brain parenchyma, remain poorly defined. Specifically, how proliferation, morphological differentiation, and phagocytosis are coordinated among microglia progenitors as they colonize the embryonic brain remains unclear. Here, we combined mathematical modeling with spatiotemporal analyses of the murine hippocampus and cerebellum from postnatal day 2 (P2) to P60 to reconstruct the trajectory of microglial development. We identified a proliferative-to-quiescent (P/Q) switch around P3/P4 that preceded the acquisition of morphological complexity and efficient phagocytosis and was accompanied by coordinated shifts in cell-cycle dynamics and metabolic state. Strikingly, this P/Q switch was recapitulated in repopulation contexts in mice and in the human fetal brain, where later stages displayed enhanced phagocytic function coupled to reduced proliferation. Perturbing the proliferative phase through pharmacological or genetic disruption of CSF1R signaling impaired subsequent microglial complexity and phagocytosis efficiency, revealing an unexpected reliance of phagocytosis on proliferation-driven colonization. Finally, we show that microglia stepwise maturation during development is associated with chromatin remodeling and driven by the epigenetic regulator Ikaros. Together, these findings uncover the sequential milestones of microglial development, revealing a potential period of early vulnerability and establishing an unexpected linkage between proliferation and phagocytosis essential to understanding how these processes are coordinated in neurodegenerative disorders.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bb674fe85695033b3a066007d0322414981ac69f" target='_blank'>
              Epigenetic control of microglial developmental milestones from proliferative progenitors to efficient phagocytes
              </a>
            </td>
          <td>
            Marta Pereira-Iglesias, Duncan Martinson, Carles Falcó, Joel Maldonado-Teixidó, Marco González-Domínguez, Rodrigo Senovilla-Ganzo, S. Beccari, Jorge Valero, Bella Mora-Romero, I. Ballasch, Sarah Viguier, Philipp Hane, Molly Boettiger, J. Reisz, Alba Elías-Tersa, Yasmina Manso, L. Parkkinen, A. M. Aransay, Federico N. Soria, A. D'alessandro, Eduardo Soriano, M. S. Thion, S. Garel, M. Greter, A. Giralt, Alberto Pascual, Fernando García-Moreno, D. Menassa, José A. Carrillo, Amanda Sierra
          </td>
          <td>2025-11-04</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>49</td>
        </tr>

        <tr id="Severe Acute Respiratory Syndrome Coronavirus-2 infection has been associated to neurological symptoms characteristic of long-lasting post-acute coronavirus disease. However, the complex mechanisms involved in these clinical manifestations are still unclear. Glial cells are key to inflammation and neurodegeneration in response to central nervous system infection. To investigate this pathway, induced pluripotent stem cells human astrocytes and human microglial HMC3 cells were infected with SARS-CoV-2. Astrocytes showed to be prone to infection, while HMC3 supported only marginal virus replication. A significant IFN-β response was induced in astrocytes, while both cell types showed some level of chemoattractant production. Interestingly, both glial cells showed signs of senescence and activation of the pro-inflammatory cGAS-STING pathway. To investigate if glial cells infection could impair the function of neuronal networks, primary rat cortical cultures seeded on multi-electrode arrays were used to monitor the electrical activity after exposure to SARS-CoV-2. Effective SARS-CoV-2 infection of the glia led to a major loss of synaptic connections, an increase expression and production of pro-inflammatory cytokines and chemokines, and an increase of DNA damage foci. Intriguingly, the pro-inflammatory response was cGAS-STING dependent. Finally, an antagonist of the cGAS-STING pathway was able to ameliorate the decrease in electrical activity early post-infection. These data point to SARS-CoV-2 infection of the glia as a culprit for neurological complications during COVID-19. Supplementary Information The online version contains supplementary material available at 10.1007/s13365-025-01283-6.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2fef0ecf5b990a10a1f0fae7554cfa28ceb163d2" target='_blank'>
              SARS-CoV-2-induced damage to rat cortical neuronal networks ex vivo is mediated by the pro-inflammatory activation of the cGAS-STING pathway
              </a>
            </td>
          <td>
            Pamela Martinez-Orellana, Matteo Manzati, Diletta Pozzi, Yingying Xiao, Alessio Di Clemente, Marika Mearelli, Chiara Kalebić, Valentina Perrera, Denise Ferrarini, Tea Carletti, Carmen Falcone, Michele Giugliano, Alessandro Marcello
          </td>
          <td>2025-10-25</td>
          <td>Journal of Neurovirology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f3f466a8b6bbef99c55e8bb31d40feefddd8931f" target='_blank'>
              Tuberculous meningitis alters the proteomic landscape of brain-derived extracellular vesicles
              </a>
            </td>
          <td>
            Blanca V. Rodriguez, Nerketa N. L. Damiba, Nicole Beaubien, Daisy Puca, D. B. Foster, Samarjit Das, Elizabeth W. Tucker
          </td>
          <td>2025-12-08</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="As primary immune sentinels of the central nervous system (CNS), microglia respond rapidly to acute brain injury and engage in dynamic crosstalk with infiltrating peripheral immune cells. This interplay critically shapes the neuroinflammatory microenvironment—a key determinant of secondary brain injury (SBI) following intracerebral hemorrhage (ICH). Fatty acid-binding protein 4 (FABP4), an adipokine associated with metabolic disorders, is recognized as a pivotal modulator of inflammatory responses; however, its role in ICH-induced SBI remains undefined. To investigate the pathogenic functions of FABP4 in microglia after ICH, elucidate its molecular mechanisms, and develop targeted therapeutic strategies. Blood and brain tissue samples from ICH patients were analyzed to evaluate the relationships between FABP4 expression and prognosis. Behavioral tests, Nissl staining, and Golgi-Cox staining were used to quantify neuronal damage. Immunofluorescence and flow cytometry were used to assess microglial activation and immune cell infiltration. Transcriptomic, proteomic, co-immunoprecipitation, western blotting, and ChIP‒qPCR analyses were used to examine the FABP4 regulatory network. Brain-targeted nanoparticles were engineered to deliver FABP4-specific siRNA. Clinical analyses revealed microglia-specific FABP4 upregulation in ICH patients, correlating with poor neurological outcomes. Microglial Fabp4 knockout in mice attenuated neuronal loss, ameliorated cerebral edema, and enhanced functional recovery after ICH. Mechanistically, FABP4 promoted lipid droplet accumulation and inhibited the ubiquitin–proteasome-mediated degradation of S100A9 in microglia, synergistically amplifying neuroinflammation. Moreover, the activity of FABP4 in microglia facilitated neutrophil transendothelial migration into the brain parenchyma, exacerbating injury via the release of neutrophil extracellular traps (NETs). Finally, pharmacological FABP4 inhibition using brain-targeted nanoparticles conferred significant neuroprotective effects in ICH models. This study establishes that FABP4 acts as a novel orchestrator of post-ICH neuroinflammation through dual enzymatic and nonenzymatic pathways. We also demonstrate a targeted nanotherapeutic strategy to suppress FABP4 and improve neurological outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cbd6afea19f2780d62b43438f150276eb07542a8" target='_blank'>
              Fatty acid-binding protein 4 drives microglia-mediated neuroinflammation through promoting S100A9 expression and lipid droplet accumulation after intracerebral hemorrhage
              </a>
            </td>
          <td>
            Jiaqing He, Zijuan Qin, Haixiao Liu, Yaning Cai, Hao Wu, Tinghao Wang, Qing Hu, Yanni Xu, Pan Yang, Xun Wu, Yan Qu, Wei Guo
          </td>
          <td>2025-11-07</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Abstract Background Postacute sequelae of SARS-CoV-2 infection, also known as long COVID (LC), is a complex and heterogenous condition affecting millions worldwide with a poorly understood underlying pathology. Although metabolic dysregulations have been described in LC, it remains unclear whether circulating immune cells exhibit immunometabolic alterations. Methods We conducted a detailed clinical, immunologic, and mitochondrial analysis on 27 patients with LC and 27 who recovered from COVID-19 and were healthy. Symptom burden and severity were assessed and quantified via a digital platform with the modified COVID-19 Yorkshire Rehabilitation Scale. Mitochondrial function of circulating immune cell populations (lymphocytes and monocytes) was analyzed by measuring mitochondrial mass and mitochondrial membrane potential. Production of 11 cytokines after whole blood stimulation with bacterial and viral agonists was measured by multiplex immunoassay. Relationships between mitochondrial and immune parameters with LC symptoms were investigated. Results Patients with LC exhibited significant symptom burden, with worsening across all symptom domains as compared with their health state before SARS-CoV-2 infection. They also had a decreased mitochondrial membrane potential of CD56bright natural killer cells, particularly in patients experiencing dizziness, whereas reduced mitochondrial membrane potential in CD4+ lymphocytes was found in patients with worsening breathlessness. Upon LPS stimulation, patients with LC demonstrated significantly lower IFN-γ production. In response to viral ligand R848, impaired IFN-β and IL-10 responses were associated with worsening cough and executive functions. Conclusions Symptom severity in LC is associated with immune cell mitochondrial dysfunction and altered cytokine responses, highlighting potential disease biomarkers and targets for future therapeutic strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0904ca34a4e483fad93aba4e12dab5090971f617" target='_blank'>
              Digitally Assessed Long COVID Symptomatology Is Associated With Lymphocyte Mitochondrial Dysfunction and Altered Immune Potential
              </a>
            </td>
          <td>
            Vasile Mihai Sularea, L. Townsend, Cian Reid, Andreea V Atanasescu, A. Dyer, F. Giangrazi, R. Lawrence, Manoj Sivan, Barry Moran, Derek G Doherty, Niall P Conlon, A. Long, Cliona O’Farrelly
          </td>
          <td>2025-11-01</td>
          <td>Open Forum Infectious Diseases</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="Introduction Despite extensive research, the pathogenesis and predispositions underlying long COVID (long-term coronavirus disease 2019) remain poorly understood. Methods To address this, we analyzed the immunological landscapes of 44 patients with long COVID and 44 matched convalescents using single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) and validated the findings with plasma cytokine measurements via Luminex technology. Results While the immune cell compositions showed minimal quantitative differences only among natural killer (NK) cells, the transcriptome analyses identified distinct gene expression patterns, particularly in classical monocytes: patients with long COVID exhibited downregulation of the inflammation-associated genes, including IL1B and CXCL2. Imputation of the transcription factor activity hinted at a reduced inflammasome activity (via SNAI1) and an impaired monocyte differentiation (via ATF2) in long COVID. The RNA velocity data supported the presence of immature classical monocytes in these patients. Discussion These findings show that monocytes might be dysregulated and/or exhausted in patients with long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3892a0439deb222191d646b042b2e39ae2bf0fef" target='_blank'>
              Transcriptome analysis of classical blood cells reveals downregulation of pro-inflammatory genes in the classical monocytes of long COVID patients
              </a>
            </td>
          <td>
            Florian Fricke, Franz Mai, Christine Wossidlo, Felix Steinbeck, Wendy Bergmann-Ewert, Marcel Kordt, Karin Kraft, Britta Müller, Emil C. Reisinger, Brigitte Müller-Hilke
          </td>
          <td>2025-11-07</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) preferentially infects airway epithelial cells. This infection is mediated by the binding of SARS-CoV-2 spike (S) protein to ACE2 expressed on target cells. Patients with allergic (type-2) asthma have been reported to be less susceptible to coronavirus disease 2019 (COVID-19), but these effects are controversial and mechanistically unclear. We previously showed lower expression of ACE2 mRNA in airway epithelial cells from type-2 asthmatics compared to healthy donors. Moreover, we and others demonstrated that the type-2 cytokine interleukin 13 (IL-13) suppresses ACE2 expression and SARS-CoV-2 infection in human epithelial cells. To better understand the relationship between type-2 inflammation, ACE2 expression, and SARS-CoV-2 infection, we investigated the effects of IL-13 on critical steps of epithelial cell infection by SARS-CoV-2: S protein-mediated binding to ACE2 on epithelial cells, and ACE2-mediated SARS-CoV-2 entry into these cells. Recombinant IL-13 significantly inhibited both these processes. This inhibition appeared to be mediated by IL-13-induced suppression of ACE2 transcription because IL-13 failed to affect S protein-mediated viral entry into cells that express ACE2 under the control of an IL-13 unresponsive heterologous promoter. We propose that IL-13 protects epithelial cells from SARS-CoV-2 infection largely by inhibiting ACE2 expression and ACE2-mediated downstream events that allow the virus to access its cellular targets.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/df8083f73ae8478fb1031798b020e6d2348e4b62" target='_blank'>
              IL-13 protects epithelial cells from SARS-CoV-2 infection by inhibiting ACE2-mediated virus binding and cell entry
              </a>
            </td>
          <td>
            Vadim Pivniouk, Oksana Pivniouk, J. Uhrlaub, Seongmin Hahn, Allyson Molzahn, Hiroki Kimura, Mari Numata, H. Chu, J. Ledford, Monica Kraft, J. Nikolich, Donata Vercelli
          </td>
          <td>2025-11-24</td>
          <td>ImmunoHorizons</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="Precise control of cell–cell communication networks within brain neurovascular units (NVUs) promotes normal tissue physiology. Dysregulation of these networks can lead to pathologies including uncontrolled angiogenesis, endothelial barrier disruption, and intracerebral hemorrhage (ICH). The cellular and molecular mechanisms underlying ICH pathogenesis and subsequent tissue repair processes remain poorly understood. Here we employed fixed single cell RNA profiling coupled with spatial in situ gene expression profiling to characterize NVU signaling pathways associated with ICH in Itgb8/β8 integrin mutant mice. In this model, early neonatal stages of ICH were characterized by downregulation of extracellular matrix (ECM)-associated signaling factors (Adamtsl2, Htra3, and Lama4) linked to canonical TGFβ activation and signaling in endothelial cells. Conversely, the progressive resolution of ICH involved upregulation of neuroinflammatory signaling networks (Gas6 and Axl) alongside activation of iron metabolism pathway components (Hmox1, Cp, and Slc40a1) in microglia/macrophages. Integrated computational modeling identifies additional ligand-receptor signaling networks between perivascular glial cells and angiogenic endothelial cells. Collectively, these findings illuminate the molecular signaling networks that promote NVU maturation and provide novel mechanistic insights into the pathways controlling ICH pathogenesis and repair in Itgb8 mutant mice.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/196d46e68f6d694e757a27b2ec5e73dcd59d1a6b" target='_blank'>
              Integrative single cell RNA and spatial profiling identify mechanisms of neonatal brain hemorrhage pathophysiology and repair
              </a>
            </td>
          <td>
            Santiago A Forero, Zhihua Chen, Ali Pirani, Arpan De, Zachary Wise, Xiaofeng Zheng, John E. Morales, Joseph H. McCarty
          </td>
          <td>2025-12-07</td>
          <td>Angiogenesis</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Abstract Although most SARS-CoV-2 infections result in mild or moderate symptoms not requiring hospitalization, many patients experience persistent symptoms after their initial recovery, a condition termed Post-Acute Sequelae of SARS-CoV-2 infection (PASC). The underlying pathogenesis behind infection associated chronic illnesses, such as PASC, are poorly understood, thus critically limiting the development of therapeutics to prevent or alleviate symptoms. The current study examined the neurocognitive impact of SARS-CoV-2 induced inflammation in a nonhuman primate model. Ten adult rhesus macaques (5 female, 5 male) were monitored before, during, and after recovery from a mild COVID-19 illness (SARS-CoV-2 strain 2019-noCoV/USA-WA1/2020). Macaques exhibited persistent alterations in taste and smell, as well as decreased cognitive flexibility up to 3 months post-infection. Female macaques experienced sleep disturbances, greater stress and poorer autonomic function months after SARS-CoV-2 infection. Importantly, the development of these neurocognitive changes were associated with acute cytokine response to infection and increased microglia activation in brain tissue at 4 months post-infection. These findings suggest a causative link between the inflammatory response to mild COVID-19 symptoms and persistent neurocognitive changes associated with PASC and provide rationale for therapeutic strategies aimed at reducing acute inflammatory responses to the virus.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e39b66a62b804a305ef8c1e9f417b8c7fa8e3e19" target='_blank'>
              Inflammation from mild COVID-19 results in persistent neurological and behavioral changes in rhesus macaques
              </a>
            </td>
          <td>
            Tomas R Wiche Salinas, Sienna Freeman, Rebecca Richardson, Winni Weng, Muskan Ali, Alex van Schoor, Elise G. Viox, Kevin Nguyen, James Auger, Richard Ketan, Matthew Gagne, Breanna Picou, Nadia A Golden, Monica Vaccari, Sherri Jean, Jennifer S Wood, Joyce Cohen, R. P. Johnson, Daniel C Douek, Benoit A Niclou, Rebecca D. Levit, Ian N Moore, Mirko Paiardini, Jessica Raper
          </td>
          <td>2025-12-02</td>
          <td>Research Square</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Immunosuppressive therapies used in clinics to reduce the risk of rejection in transplanted patients unfortunately also decrease the response of the immune system to the pathogens. Previous data has shown that the most diffuse SARS-CoV-2 variants of concern between 2020 and 2021 showed a different modulation of the host immune response in healthy subjects, with the Delta B.1.617.2 variant leading to a failure in the activation of the adaptive immune response. In this study, the transcriptomic profiles of monocyte-derived macrophages (MDM), isolated from four immunosuppressed kidney transplant patients and exposed to SARS-CoV-2 VOCs, were analyzed and compared with previously published data gathered from immune-competent subjects. Human monocytes were isolated from peripheral blood mononuclear cells (PBMCs) of four kidney transplant patients admitted to the IRCCS Policlinico San Matteo of Pavia (Italy), differentiated into macrophages, and exposed to the active and the UV-inactivated particles of the different SARS-CoV-2 VOCs (D614G, Alpha B.1.1.7, Gamma P.1, Delta B.1.617.2 and Omicron BA.1). Bulk RNA-Seq was performed and significant transcripts were assessed based on Student’s t-test (p-value < 0.05) and Fold change > 2. RNA-Seq data analyses of immunosuppressed MDMs showed that SARS-CoV-2 VOCs, although transcriptionally active, did not induce strong alterations in the transcriptomic profiles of these cells, while a strong down-regulation of key genes involved in the innate immunity pathways was observed when comparing these data to the ones obtained from immunocompetent participants. Overall, this study suggests that patients under immunosuppressive therapies do have an altered macrophage response to SARS-CoV-2 viral infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/04f26f9af852ab5923f6e34e833030407d8ac128" target='_blank'>
              Attenuated Molecular Response to SARS-CoV-2 in MDMs Isolated from Immunosuppressed Transplanted Patients
              </a>
            </td>
          <td>
            R. Vazzana, J. Sammartino, N. Cuscino, R. Giambruno, C. Carcione, V. Miceli, Matteo Bulati, Valentina Agnese, D. Lilleri, P. Conaldi, Fausto Baldanti, I. Cassaniti, A. Gallo
          </td>
          <td>2025-10-28</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="


 SARS-CoV2 infection is uniquely characterized by the sudden onset of anosmia and dysgeusia in many individuals. While most recover, a subset continues to experience persistent symptoms known as long-COVID, with 30% reporting dysgeusia. In our long-COVID cohort, objective testing revealed significant distortion in the perception of bitter and sweet tastes. Although polymorphisms in TAS2R38 and gustin genes are linked to bitter taste perception, haplotype analysis in our long-COVID cohort was inconclusive. We hypothesized that a disrupted homeostasis between taste cell loss and replenishment due to chronic inflammation leads to dysgeusia. Single cell transcriptomic analysis revealed cellular heterogeneity including epithelial cells (such as KRT14, KRT15, SPRR3), cells exhibiting neuronal markers (such as SNAP25, SNAP47, KCNQ2) suggestive of taste receptor cells and immune cells in saliva. However, differences in marker expressions between the long-COVID and healthy cohort were not significant except for inflammatory chemokine and interleukin genes. Immunofluorescence and flow cytometry confirmed the presence of epithelial cells, taste receptor like cells and immune cells in saliva. Elevated proinflammatory cytokine expression in saliva indicated persistent localized inflammatory immune response. Collectively these findings suggest that persistent epithelial-neuro-immune response locally in the tongue following SARS-CoV2 infection contributes to the dysgeusia in long-COVID.



 DENTAL RESEARCH FOUNDATION #44-76-254



 Innate Immune Responses and Host Defense: Molecular Mechanisms (INM)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/605d94a3b6b43a60bc2e61018169ec477647406c" target='_blank'>
              Epithelial-neuro-immune dynamics in dysgeusia triggered by chronic viral infection 3795
              </a>
            </td>
          <td>
            Shveta Jaishankar, David Schaeper, S. Janga, Mythily Srinivasan
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>39</td>
        </tr>

        <tr id="Mpox re-emerged globally in 2022 with atypical clinical features and efficient human-to-human transmission, which underscores the need to better understand host immune responses. We conducted an integrative transcriptomic analysis of mpox virus (MPXV) infection in nonhuman primates by leveraging RNA-Seq datasets from whole-blood and skin. We applied the Generalized Linear Model with Quasi-Likelihood F-test and Magnitude-Altitude Score (GLMQL-MAS), a method that combines rigorous statistical testing with a ranking metric to identify and prioritize differentially expressed genes (DEGs), and the Cross-Magnitude-Altitude Score (Cross-MAS) gene selection strategy, which integrates results across multiple time points to identify reproducible signatures, to define compact and robust markers of infection. Longitudinal analysis of whole-blood revealed a staged immune trajectory: early induction of interferon-stimulated genes (IFI27, ISG15) was followed by proliferative and hematopoietic programs and later enrichment of adaptive immune signatures, including B cell activation and TNF signaling. A minimal six-gene panel (IFI27, ISG15, MYO7B, HEY1, VASH1, CNTD2) distinguished infected from control animals with 100% accuracy in both training and independent held-out test sets. In contrast, skin transcriptomes showed upregulation of keratinocyte-related genes (KRT10, KRT1, SOSTDC1) and downregulation of immune mediators (IL1B, CXCL8, S100A8, ISG15), which suggests epithelial remodeling with limited local immune activation. Cross-tissue comparisons revealed that under stringent criteria (BH-adjusted p-value < 0.05 and |log₂FC|> 1), only 10 genes were commonly significant between whole-blood and skin, and all (100%) exhibited opposite regulation. When thresholds were relaxed for exploratory purposes (unadjusted p-value < 0.05 and |log₂FC|> 1), 58 common significant immune-related genes were identified from the curated nCounter® Host Response Panel, of which 74.1% were oppositely regulated. Shared immune genes such as ISG15, MX1, IFIT2, and OAS2 were upregulated in blood but suppressed in skin, and Reactome enrichment of discordant genes highlighted interferon and cytokine signaling pathways. These contrasts suggest that MPXV may trigger systemic interferon activation while suppressing local antiviral responses in lesions; however, because they are derived from independent secondary datasets in different species, they should be regarded as hypothesis-generating signals that require confirmation in matched, longitudinal studies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f42e167ab73e8ee0f1b9da83613dfa3150236874" target='_blank'>
              Opposite regulation of immune genes in blood and skin highlights tissue-specific dynamics of mpox virus
              </a>
            </td>
          <td>
            Mostafa Rezapour, Sean V. Murphy, D. Ornelles, Patrick M. McNutt, Anthony Atala
          </td>
          <td>2025-11-07</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="Clinical observations suggest that obstructive sleep apnea (OSA) and Alzheimer’s disease (AD) pathology may be linked; however, causal mechanisms and relationships are unclear. To investigate the potential interaction between amyloidosis and intermittent hypoxia (IH), a hallmark of OSA, starting at 4 months of age 5XFAD mice were exposed to chronic IH (CIH) consisting of 20 episodes per hour of hypoxia for 12 h/day, daily for 4 months (males) or 6 months (females). CIH did not induce significant changes in amyloid burden or the number of astrocytes in males or females, but there was a slight decrease in the number of microglia observed in the cortex of 5XFAD mice of both sexes. To further explore this effect, we performed bulk RNA sequencing on isolated microglia. In WT mice, the most robust gene changes induced by CIH were identified in male microglia, many of which were pro-inflammatory. In microglia from 5XFAD mice, compared to normoxia (NX), CIH exposure induced comparatively more DEGs in males. Further, in genes that were upregulated by CIH in WT vs 5XFAD mice of both sexes, there was an enrichment of pathways associated with oxidative phosphorylation, aerobic and cellular respiration, and ATP synthesis. These changes indicate that CIH has a more robust effect on the microglial transcriptome in 5XFAD mice than in WT mice, suggesting that the synergy between AD and OSA pathologies may be driven by metabolic changes in the microglial transcriptome. These observations are particularly interesting given the known sex differences in OSA and AD pathology in human disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8727e54e7992921c8779ef401d96df0e163a6576" target='_blank'>
              Chronic Intermittent Hypoxia Exposure Induces a Unique Microglial Transcriptome in 5XFAD Mice
              </a>
            </td>
          <td>
            Kaitlyn M. Marino, Andrea C. Ewald, Jaidynne N. Lash, Erin C. McCann, Shibani Ram, Phinea Z. Romero, Tao Wang, Abby Watters, A. Radcliff, Daniel C. Shippy, Tracy L. Baker, Tyler K. Ulland, Jyoti J. Watters
          </td>
          <td>2025-11-19</td>
          <td>Molecular Neurobiology</td>
          <td>1</td>
          <td>16</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5d5581192995f28d24b781c1e7c2e69bf2aa53d8" target='_blank'>
              Systems Immunology of Long Covid: Insights from the STOP-PASC Clinical Trial
              </a>
            </td>
          <td>
            E. Maestri, W. J. Kwon, H. Zheng, T. Prestwood, H. Hedlin, J. W. Liang, H. McCann, B. Shaw, L. Tian, B. Jones, R. Lu, G. Wiley, E. Haraguchi, O. Wirz, J. Afaghani, B. Lam, D. F. D. Mahmood, N. A. Phillips, M. M. S. Sim, J. P. Wood, J. R. Heath, S. D. Boyd, J. Guthridge, U. Singh, H. Bonilla, P. Jagannathan, P. Utz, L. Geng, P. Khatri
          </td>
          <td>2025-12-05</td>
          <td>None</td>
          <td>0</td>
          <td>61</td>
        </tr>

        <tr id="Despite effective viral suppression with antiretroviral therapy (ART), people living with HIV (PLWH) experience persistent inflammation, immune dysfunction, and premature onset of cardiovascular and aging-related comorbidities. To define the underlying mechanisms, we performed longitudinal transcriptomic profiling in peripheral blood mononuclear cells (PBMCs) from a cohort of simian immunodeficiency virus (SIV)-infected rhesus macaques spanning four key stages: pre-infection, acute infection, short-term ART, and long-term ART. Bulk RNA sequencing revealed dynamic immune remodeling across infection and treatment. Acute SIV infection induced robust antiviral and inflammatory programs, with upregulation of interferon-stimulated genes (ISGs), IL-27, JAK/STAT, and NF-κB signaling, coupled with suppression of T- and B-cell activation pathways. Short-term ART effectively reversed these transcriptional perturbations, restoring adaptive immune gene expression and reducing innate antiviral responses to near-baseline levels. In contrast, chronic SIV infection on long-term ART maintained viral suppression but was characterized by reactivation of innate immune pathways, including TLR2/TLR4/MYD88, NF-κB, and inflammasome (NLRP3/or NLRP12, caspase-1) signaling, along with sustained macrophage activation, platelet/coagulation signaling, and senescence-associated secretory phenotype. Protein analyses confirmed persistent CASPASE-1 and NF-κB activation in spleen tissue. Pathologic evaluation of a carotid artery from an SIV-infected, long-term ART– treated macaque revealed macrophage-rich plaques with p21⁺ senescent cells with intraluminal thrombus formation, recapitulating key features of HIV-associated atherogenesis. Together, these findings demonstrate that while ART normalizes acute infection–induced immune dysregulation, chronic SIV infection sustains a chronic, macrophage- and TLR-driven inflammatory state linked to vascular injury and aging process regardless of long-term suppression of viremia. Targeting inflammasome, NF-κB, and senescence pathways may mitigate non-AIDS comorbidities in PLWH.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c7a8f96a2324d1327914a92bba9009e04dbf070e" target='_blank'>
              Persistent Activation of Monocytes/Macrophages and Cell Senescence in SIV-Infected Macaques on ART
              </a>
            </td>
          <td>
            Yilin Chen, Xiaofeng Ding, Sonalika Ray, Siva Thirugnanam, Robert V. Blair, Ahmad Saied, S. Sukhanov, J. Kolls, Woong-ki Kim, P. Delafontaine, Jay Rappaport, Xuebin Qin, Namita Rout
          </td>
          <td>2025-11-06</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>46</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c67902287b707e2a864fa94a99930bc5171cdb8e" target='_blank'>
              Susceptibility of Human Neural Stem Cells to SARS-CoV-2: Entry Mechanisms and Glycocalyx Influence
              </a>
            </td>
          <td>
            Ann Song, Cori Zuvia, P. Talbot
          </td>
          <td>2025-11-10</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>43</td>
        </tr>

        <tr id="In the context of neurodegeneration, activated microglia facilitate inflammation via secretion of TNF-α, IL-1α, and C1q. Astrocytes exposed to this signaling array polarize to a reactive inflammatory phenotype, termed A1 or A1-like. Astrocytes are essential for neuronal survival, synaptic support, and blood–brain barrier (BBB) function, but A1-like astrocytes upregulate inflammatory gene expression, downregulate neurotrophic factors, and secrete neurotoxic signals. The consequences of A1-like polarization on BBB function are unknown but may have etiological implications for some diseases. Frequently identified by upregulation of complement component 3 (C3), A1-like astrocytes have been characterized in neurodegenerative disorders like Alzheimer’s disease, with polarization correlated with disease progression and severity. However, the role of A1-like astrocytes in neurodegeneration associated with chronic viral infections, like HIV-1-associated neurocognitive disorder (HAND), remains unclear. An in vitro system using primary human astrocytes, as well as a BBB model featuring primary human brain microvascular endothelial cells (BMECs) co-cultured with astrocytes, was used to elucidate cellular and molecular consequences of chronic astrocyte activation. As measured by whole transcriptome analysis and protein expression assays, repeated treatment with TNF-α, IL-1α, and C1q induced A1-like polarization of astrocytes both in monoculture and in a BBB model, resulting in increased secretion of pro-inflammatory signals. No substantial change to BBB permeability was observed. In contrast, exposure to HIV-1 viral protein Tat did not independently induce A1-like polarization. Ongoing investigations into the effect of astrocyte polarization on BBB integrity and treatment with pathogenic proteins may provide insights into the role of neurotoxic astrocytes in neurovirologic pathologies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/33a034aeaf82d86cd18ab74f1a0b8c466df7ff53" target='_blank'>
              Inflammatory microglia signals drive A1-like polarization of astrocytes even in the presence of HIV-1 Tat
              </a>
            </td>
          <td>
            Jill M. Lawrence, W. Dampier, J. Mell, Diehl R. De Souza, Kayla Schardien, Kyle Yeakle, R. J. Barnett, Bhaswati Sen, Azad Ahmed, Michael Bouchard, Brian Wigdahl, Micheal Nonnemacher
          </td>
          <td>2025-12-04</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Purpose Monocytes and macrophages are recognized as predominant immune populations in human glioblastoma, where they play vital roles in tumor progression. Despite their established significance, the heterogeneity of these cells—particularly within the monocyte compartment—remains incompletely characterized. Methods We comprehensively used scRNA-seq, spatial transcriptome sequencing combined with immunofluorescence and T cell co-culture assays to illuminate the heterogeneity and function of monocyte in glioblastoma. Results In this study, from the perspective of ligand-receptor networks, we have identified and characterized three distinct glioblastoma subtypes. Single-cell RNA-seq analysis further revealed that the C3 subtype with bad prognosis exhibited a higher proportion of S100A9high monocytes. Spatial transcriptomics combined with immunofluorescence assays demonstrated that these S100A9high monocytes were spatially adjacent to M2 macrophages, exhausted CD8+ T cells, and endothelial cells. In vitro T cell co-culture assays revealed S100A9high monocyte produced elevated levels of the immunosuppressive cytokine IL-10, reactive oxygen species (ROS) and inducible nitric oxide synthase (iNOS), all of which might impair T cell function and immune response. Notably, elevated abundance of S100A9high monocyte correlated with poor patient prognosis. Conclusion In summary, our results deciphered the heterogeneity of monocytes in glioblastoma and identified a novel poor prognosis-associated monocyte subset, S100A9high monocytes, which foster an immunosuppressive, pro-tumorigenic microenvironment.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b56f421b008f9fd171284dfd7fddcbd5bc0f429e" target='_blank'>
              Decoding the Prognosis-Related S100A9high Monocyte in Glioblastoma Using Single-Cell and Spatial Transcriptome Sequencing
              </a>
            </td>
          <td>
            Xiucan Li, Ying Qin, Pengfei Gao, Huixue Wang, Yanling Liu, Lian Ren, Dongdong Wu, Xueyuan Heng
          </td>
          <td>2025-11-01</td>
          <td>OncoTargets and Therapy</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Inflammatory responses including glial activation, and upregulated inflammatory factors occurred after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected central nervous system. Blood-brain barrier (BBB) disruption has been implicated in coronavirus disease 2019 (COVID-19) pathogenesis and may predispose to the long-lasting neurological damage even after the epidemic ends. The BBB is a highly selective dynamic interface to protects the brain from neurotoxins and the elimination of byproducts of brain metabolism via efflux transporters. The COVID-19 pandemic has introduced new challenges in managing neurological conditions, and understanding SARS-CoV-2 journey through BBB and the interconnections between the members of BBB is crucial. This review aims to summarize and elucidate the damage to the main constituent cells of BBB, including brain microvascular endothelial cells, astrocytes, and microglia and its contribution to COVID-19. Further understanding of these interactions may facilitate the development of improved treatment options and preventative measures of central nervous system injury due to COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/85e1f8e6db59f325d648f88b5923eb205b1a3a64" target='_blank'>
              Exploring SARS-CoV-2 impact on blood-brain barrier and its composition: A review
              </a>
            </td>
          <td>
            Jin Li, Shangfu Xu, Sixu Guo
          </td>
          <td>2025-11-21</td>
          <td>Medicine</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="A hallmark of COVID-19 patients is the reduction of the lymphocyte population accompanied by activation, senescence, and exhaustion markers. We investigated patients admitted to hospital wards who either recovered after a short hospitalization or progressed to critical illness. Patients (n=48) were recruited between May and September 2020; 19 healthy volunteers were enrolled as controls. Blood samples were collected on days 0, 3, and 7 of hospitalization and around 30 days after discharge (convalescence sample, CS30). Lymphocyte counts and extended immunophenotyping were performed by flow cytometry and analyzed using conventional and stochastic methods. At D0 and D7, total lymphocytes, natural killer cells, T cells, TCD4 cells, and TCD8 cells were lower in patients than in volunteers but were restored at CS30. The stochastic analysis identified 11 distinct clusters of lymphocytes, nine of them with significant differences between patients and healthy controls. Clusters of TCD8+ memory cells showing activation, senescence, and exhaustion were increased in patients during hospitalization and in the convalescence samples. In contrast, clusters 5 (TCD4+ Central Memory exhausted activated) and 7 (TCD4+ Central Memory exhausted) were decreased in patients during the disease compared to healthy controls. Overall, the conventional flow cytometry analyses corroborated the findings from the stochastic analysis, showing that effector memory (EM) and TEMRA subsets exhibited sustained markers of exhaustion and senescence, particularly in TCD8+ cells. Our findings reinforce lymphopenia, T cell activation, senescence, and exhaustion as essential immunological features of COVID-19; while cell counts fully recovered, lymphocytes remained dysfunctional in convalescent samples.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ccf36a0bfe213bfeb842f9d7a3a65163a5e63e4c" target='_blank'>
              Tracking immune dysregulation in COVID-19: lymphocyte dynamics from hospitalization to recovery
              </a>
            </td>
          <td>
            G.S. Eburneo, M.B. Sousa, M. Brunialti, S. Santos, J.G.D. Silva, P. Ferreira, N.C.J. Bellei, J.S.O. Arakaki, Giuseppe G F Leite, R. Salomão
          </td>
          <td>2025-11-14</td>
          <td>Brazilian Journal of Medical and Biological Research</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Disrupted in Schizophrenia 1 (DISC1) is essential for neuronal development and has been implicated in various psychiatric disorders. Our transcriptomic and proteomic analyses identified Zika virus (ZIKV) infection enhanced DISC1 expression, however, its functional role in ZIKV infection and caused congenital Zika syndrome (CZS) and ZIKV-induced long-term neurodevelopmental defects remain unexplored. In this study, we demonstrate that DISC1 attenuates ZIKV infection in human placental and neuroglia cells, as well as in murine macrophages and primary cortical cells. DISC1 also decreases ZIKV dissemination from peripheral tissues to key organs of mice, including the uterus, testis, and brain, thereby reducing fetal abortion rates and intrauterine growth restriction. Notably, DISC1 is associated with brain damage and long-term ZIKV effects, including memory loss, reduced anxiety and depression, declines in sociability and social novelty. Mechanistically, DISC1 activates autophagy by enhancing AMPKα phosphorylation and reducing mTOR phosphorylation, protecting against ZIKV infection. Additionally, DISC1 interacts with LC3 to further activate autophagy, partially contributing to reduce ZIKV infection. In conclusion, DISC1 plays a critical factor in controlling ZIKV infection and mitigating CZS and ZIKV-induced neurocognitive decline. DISC1 attenuates Zika virus infection and congenital Zika syndrome by promoting autophagy via AMPK-mTOR signaling and is implicated in ZIKV-induced long-term neurological deficits.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dd2313cde591dcc46ad3e54fde2879f20a282762" target='_blank'>
              DISC1 Protects Against Zika Virus Infection and Long-Term Neurological Damage Through AMPK-mTOR-Mediated Autophagy
              </a>
            </td>
          <td>
            Shengze Zhang, Haolu Zha, Qiqi Chen, Nina Li, Chengying Zheng, Ting Xie, Pengjie Ma, Weijian Tian, Shaohui Bai, Chuming Luo, Ning Wang, X. Zou, Shisong Fang, Ying Jiang, Jianhui Yuan, Nan Wu, Caijun Sun, Yuelong Shu, Huan-le Luo
          </td>
          <td>2025-11-07</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c16fa24cd98d9256f720e2572ee30a101c020f82" target='_blank'>
              Spatial analysis reveals the cellular microenvironments and mechanisms of inflammation and kidney injury in acute interstitial nephritis
              </a>
            </td>
          <td>
            Megan L. Baker, Vijayakumar R. Kakade, Tifanny Budiman, Marlene Weiss, Joseph M. Cunningham, Sagar Sadarangani, Gabriel Lerner, Gilbert W. Moeckel, Avi Z. Rosenberg, C. Parikh, Y. Kluger, D. Moledina, Lloyd G. Cantley
          </td>
          <td>2025-10-30</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>70</td>
        </tr>

        <tr id="


 SARS-CoV2 devastated the world in 2019, with over 774 million cases and around 7 million deaths. Our lab has previously reported the role Caspase-4/11 plays in the innate immune response against SARS-CoV2, associating it with exacerbated lung pathology and immunothrombosis, indicating its therapeutic potential. In a recent project, we investigated how Casp-11 affects the adaptive immune response. We infected C57/BL6 mice expressing or lacking Casp-11 with the mouse-adapted SARS-CoV-2 strain (MA10). We then assessed the mice for signs of severe disease, such as weight loss, and their localized and systemic immune responses, measuring virus-specific immunoglobulins, circulating or lung resident CD4+ and CD8+ T cells (Trm), and lung cytokines. Our results indicated that Casp-11-/- mice have faster recovery than wild-type mice, along with reduced proinflammatory cytokine levels, further confirming the role of Casp-11 in lung inflammation. Additionally, the number of virus-specific CD8+ Trm cells was significantly lower in Casp-11-/- mice’s lungs than in wild-type mice. However, both groups’ levels of virus-specific CD4+ Trm and lung IgGs remained comparable. Notably, Casp-11-/- mice had higher serum levels of spike-specific IgG, suggesting a potential dichotomy in the localized versus systemic immune responses. These findings indicate that targeting Casp-11 may effectively decrease disease severity while improving the acquired protective immune response.



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d1a9cc4379a0daa37f9489968ae37c42b020811d" target='_blank'>
              Caspase-4/11 induces lung inflammation and dampens the humoral immune response in SARS-CoV2 infected mice 3644
              </a>
            </td>
          <td>
            Mohamed Medhat Samir Ibrahim Ahmed Shamseldin, Mostafa Eltobgy, Heba M Amer, Owen Witham, Jihad Omran, Rabab Abdelaleem, Amal O Amer
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="Long COVID (LC) is characterized by a wide range of symptoms, the causes of which remain unclear. We investigated associations between inflammatory and coagulation factors, adaptive immune response to SARS-CoV-2, and LC. We enrolled 196 unvaccinated individuals with SARS-CoV-2 (March–June 2020). Blood samples were collected at three (T3M) and twelve (T12M) months post infection. Plasma concentrations of coagulation factors (D-Dimer, E-Selectin, ICAM-1, VCAM-1) and inflammatory markers (IL-6, IL-8, TNF-α, IL-1β) were measured by ELISA, and SARS-CoV-2-specific T-cell response was assessed by Elispot. LC occurred in 66/196 patients (34%); 77.8% had been hospitalized. Respiratory symptoms were present in 54%, fatigue in 30%, and neuropsychological symptoms in 14%. At T3M, hospitalized patients exhibited higher levels of ICAM-1, VCAM-1, and IL-6, along with increased immunoreactivity. LC patients exhibited elevated IL-8 and TNF-α and enhanced immunoreactivity at T3M, though these differences were not observed at T12M. Inflammatory and coagulation markers were altered at three months after acute infection, with some changes persisting at one year, suggesting a long-term immunological impact of SARS-CoV-2 on the inflammatory response. A SARS-CoV-2-specific T-cell response was still detectable at T12M, albeit at a lower level than at T3M, suggesting the persistence of protective memory T-cells beyond the acute phase.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/661662040cb49d22a81b08c21000921af6c27b9d" target='_blank'>
              Inflammatory Milieu and Specific T-Cell Response Observed Three Months and One Year After SARS-CoV-2 Infection in Long COVID Subjects
              </a>
            </td>
          <td>
            E. Cimini, A. Vergori, C. Cimaglia, Eleonora Tartaglia, S. Notari, F. Colavita, G. Matusali, I. Mastrorosa, V. Mazzotta, P. Chinello, P. Mencarini, M. L. Giancola, A. Abdeddaim, R. Casetti, G. Grassi, Simona Gili, Flavia Cristofanelli, F. Maggi, P. Piselli, E. Girardi, A. Antinori, M. Camici
          </td>
          <td>2025-10-27</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/23255e236b243137831746d2bc7daea27bf313a4" target='_blank'>
              Circulating cell-free RNA reflects inflammatory and airway remodeling signatures in an equine model of asthma
              </a>
            </td>
          <td>
            Birong Zhang, Hanna Agdour, M. Riihimäki, Sanni Hansen, Amanda Raine
          </td>
          <td>2025-10-26</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="
 Background:
 SARS-CoV-2 and influenza infections are associated with an increased risk of cardiovascular events. While the underlying mechanisms remain incompletely defined, mounting evidence points towards endothelial dysfunction and thrombotic activation, caused either directly or indirectly by viral infection.


 Aims:
 We sought to characterise the temporal effects of mild SARS-CoV-2 and H3N2 influenza infection on plasma biomarkers of endothelial, thrombotic and renal function.


 Methods:
 Plasma samples were collected from healthy volunteers enrolled in SARS-CoV-2 (n=7-10) and H3N2 (n=7-11) human challenge studies. Samples were taken at baseline (day 0/–1) and at days 3, 7, 10, 14, and 28 post-inoculation. Commercial ELISAs/colorimetric assays were used to quantify endothelial dysfunction using biomarkers of endothelial-mediated vasomotor control (endothelin-1, nitrate/nitrite, prostacyclin, ADMA, arginine), thrombosis (sCD40L, P-selectin, PSGL-1, tPA, PAI-1, D-dimer, factor IX), and renal function (uromodulin, NGAL, cystatin C, TFF3, OPN). One-way ANOVA, or a mixed effects model, and Dunnet’s test to correct for multiple comparisons, were used to compare baseline biomarker levels with levels at subsequent timepoints.


 Results:
 Infection with SARS-CoV-2 significantly increased thrombosis biomarkers (Figs. 1&2): P-selectin (p=0.025), PSGL-1 (p=0.024), sCD40L (p=0.048), PAI-1 (p=0.008) and tPA (p=0.006&0.008) at days 7 to 14. In contrast, infection with H3N2 resulted in a significant increase in D-dimer levels at day 14 (p=0.025) and no changes in other biomarkers of thrombosis. No changes from baseline were detected in biomarkers of endothelial dysfunction in either group. Uromodulin levels declined by day 28 in the SARS-CoV-2 group (p=0.034), otherwise no changes in biomarkers of renal function were noted in either group.


 Conclusions:
 There are two striking results of this study. Firstly, that for both H3N2 and SARS-CoV-2 infection, it was markers of platelet activation/thrombosis, without changes in endothelial or renal function, that increased after infection. Secondly, that a broader spectrum of these markers was increased in volunteers infected with SARS-CoV-2. These findings suggest distinct thrombotic mechanisms are activated by SARS-CoV-2 and H3N2 and support further investigation of thrombotic profiles in patients infected with other respiratory viruses allowing for strategies to identify and mitigate associated cardiovascular events.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/107604fa6ee17ee4f404ea6d1e3e14fcc6268770" target='_blank'>
              Abstract 4367854: The impact of viral infection with SARS-CoV-2 and influenza on plasma endothelial, thrombotic and renal biomarkers
              </a>
            </td>
          <td>
            Ahmed Bakr, Helen Wagstaffe, L. Papargyris, R. Vaja, Christopher Chiu, N. Kirkby, Jane A Mitchell
          </td>
          <td>2025-11-04</td>
          <td>Circulation</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a58fba004e210f5fb3d34a82aacc6e5e01bbeaba" target='_blank'>
              Systemic infections alter cortical transcriptionalsignatures in Alzheimer’s disease
              </a>
            </td>
          <td>
            Giulia Pegoraro, Lachlan F. MacBean, Adam R. Smith, Darren M. Soanes, Rebecca G. Smith, J. Imm, Joshua Harvey, Morteza Kouhsar, Valentin Laroche, Luke Stephen Weymouth, Isabel Castanho, Winston Hide, Laura Palmer, Debra J. Lett, Andrew C. Robinson, Natalie Woodman, Karina McDade, Delphine Boche, E. Pishva, K. Lunnon
          </td>
          <td>2025-10-24</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4b30b34de10d73c9f922bb678272c07c41f6fdb9" target='_blank'>
              Dysregulation of homeostatic cytokine receptors drives prolonged T cell activation following acute SARS-CoV-2 infection in humans.
              </a>
            </td>
          <td>
            Laura Ceglarek, Patrick Taeschler, Alp Inci, Yves Zurbuchen, Sarah Adamo, Carlo Cervia-Hasler, M. E. Raeber, O. Boyman
          </td>
          <td>2025-11-27</td>
          <td>Nature communications</td>
          <td>0</td>
          <td>63</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9f82ed18b01ce85ca6d33c26f7281540d94ac720" target='_blank'>
              Respiratory viruses induce ferroptosis-like features in lung epithelial cells
              </a>
            </td>
          <td>
            Ana L. Manzano-Covarrubias, Alessandra Tosato, C. H. Mol-van der Veen, Philip Ahmadyar, Jai Walia, J. De Vries-Idema, Anke Huckriede, Amalia Dolga, Martina Schmidt, Karim Rafie
          </td>
          <td>2025-10-29</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5ef12ccfc94e2ba4c20e626af383327318bb5809" target='_blank'>
              Persistent Spike antigenemia is not associated with Post-COVID condition
              </a>
            </td>
          <td>
            Lenny Coppens, Anna Górska, A. Hotterbeekx, L. Canziani, V. Mateescu, E. Gentilotti, Daniel Pirici, M. Berkell, Orchestra Biomarker Study Group, Surbhi Malhotra, E. Taconelli, Samir Kumar-Singh
          </td>
          <td>2025-10-30</td>
          <td>None</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="AIMS
Patients with cardiovascular disease (CVD) have an increased risk of developing severe respiratory infections, including COVID-19. However, the underlying molecular mechanisms are not completely understood. It has been previously shown that cardiovascular disease predisposes to an altered responsiveness to subsequent inflammatory triggers by an imprinted epigenetic memory in innate immune cells. Therefore, we hypothesized that patients with preexisting atherosclerotic cardiovascular disease (ASCVD) and COVID-19 display a dysregulated inflammatory response compared to patients without ASCVD due to epigenetically altered immune cells leading to increased disease severity.


METHODS AND RESULTS
Single-cell RNA sequencing revealed a dysregulated myeloid immune response with hyperinflammatory and immunosuppressive features in patients with ASCVD and moderate COVID-19. Assay for Transposase-Accessible Chromatin sequencing and in-vitro experiments with isolated monocytes infected with SARS-CoV-2 showed epigenetic priming of monocytes from patients with ASCVD towards increased expression of inflammatory mediators and type I interferon signalling. In a German nationwide cohort (NAPKON), using multiplex cytokine assays, enzyme-linked immunosorbent assays, and bulk-RNA-sequencing, we confirmed that patients with ASCVD display an exaggerated inflammatory response during moderate COVID-19.


CONCLUSIONS
This study demonstrates that patients with ASCVD show a dysregulated myeloid immune response in moderate COVID-19 disease. Mechanistically, epigenetic imprinting sensitizes myeloid cells of patients with ASCVD to an exaggerated type I interferon-associated immune response.


TRANSLATIONAL PERSPECTIVE
This study evaluates the underlying molecular mechanisms of worse outcomes of patients with atherosclerotic cardiovascular disease during respiratory infections, specifically COVID-19. Patients with atherosclerotic cardiovascular disease present with a dysregulated hyperinflammatory, type I interferon-driven immune response already during moderate COVID-19. This not only explains a major risk factor for severe COVID-19 but might also enable targeted therapies for this specific risk group.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/417901a925ab6ef7f438ab3c6409b92a5127c60d" target='_blank'>
              Atherosclerosis licenses for an exceeding immune response in COVID-19 disease by interferon priming in circulating myeloid cells.
              </a>
            </td>
          <td>
            J. Leberzammer, W. Abplanalp, Katharina Grikscheit, Emmanouil G. Solomonidis, S. Glaser, B. Schuhmacher, Maximilian Merten, Gligorije Jeremijev, A. Wilken-Schmitz, Lara Korth, David John, S. Günther, C. Kuenne, Mario Looso, C. Valasarajan, V. Beneš, Ferris Jung, Vivianne Niehaus, Gabriele Anton, Christoph Stellbrink, C. Römmele, S. Göpel, Soni S Pullamsetti, J. Vehreschild, M. Vehreschild, S. Ciesek, David M. Leistner, Andreas M. Zeiher, S. Dimmeler, S. Cremer
          </td>
          <td>2025-12-13</td>
          <td>Cardiovascular research</td>
          <td>0</td>
          <td>158</td>
        </tr>

        <tr id="Inflammation and excess cytokine release are hallmarks of severe COVID-19. While programmed cell death is known to drive inflammation, its role in SARS-CoV-2 pathogenesis remains unclear. Using gene-targeted murine COVID-19 models, we here find that caspase-8 is critical for cytokine release and inflammation. Loss of caspase-8 reduces disease severity and viral load in mice, and this occurs independently of its apoptotic function. Instead, reduction in SARS-CoV-2 pathology is linked to decreased IL-1β levels and inflammation. Loss of pyroptosis and necroptosis mediators in gene-targeted animals provides no additional benefits in mitigating disease outcomes beyond that conferred by loss of caspase-8. Spatial transcriptomic and proteomic analyses of caspase-8-deficient mice confirm that improved outcomes are due to reduced pro-inflammatory responses, rather than changes in cell death signalling. Elevated expression of caspase-8 and cFLIP in infected lungs, alongside caspase-8-mediated cleavage of N4BP1, a suppressor of NF-kB signalling, indicates a role of this signalling axis in pathological inflammation. Collectively, these findings highlight non-apoptotic functions of caspase-8 as a driver of severe COVID-19 through modulation of inflammation, not through the induction of apoptosis. During SARS-CoV-2 infection caspase-8 fuels harmful inflammation independent of apoptosis. Genetic loss of caspase-8 reduces cytokine levels, lowers viral load and mitigates disease severity, revealing non-apoptotic caspase-8 as a key driver of severe COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5fdd57c7d51f242c164bb60fdb057ec943038a10" target='_blank'>
              Non-apoptotic caspase-8 is critical for orchestrating exaggerated inflammation during severe SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Stefanie M. Bader, Lena Scherer, Reet Bhandari, Allan J. Motyer, James P. Cooney, Liana Mackiewicz, Merle Dayton, Dylan Sheerin, David V. L. Romero, Jan Schaefer, J. Pang, Siqi Chen, Kael Schoffer, Le Wang, Xinyi Jin, D. Batey, Raymond K. H. Yip, Ishrat Zaman, P. Rajasekhar, Matthew J. Gartner, Stephen Wilcox, Lachlan L Whitehead, S. R. Georgy, Ana Maluenda, Kathryn C. Davidson, C. Allison, R. Bowden, Kerstin Brinkmann, M.-L. Asselin-Labat, B. Phipson, Maria C. Tanzer, Marco J. Herold, A. Samson, J. Vince, Andreas Strasser, Marc Pellegrini, Marcel Doerflinger
          </td>
          <td>2025-11-13</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>51</td>
        </tr>

        <tr id="


 Long COVID (LC) is a debilitating condition characterized by neurological, respiratory and/or gastrointestinal symptoms persisting after the infection with SARS-CoV-2. It has been hypothesized that LC is caused by suboptimal immune responses failing to clear SARS-CoV-2. Memory B cells and antibody-secreting plasma cells with high affinity for viruses, which confer protection from infection and contribute to viral clearance, canonically originate from germinal center (GC) reactions in lymphoid organs. By using a Fine Needle Aspirate (FNA) approach, which we previously deployed to probe GC responses to vaccination (Lederer et al. Cell 2022), we collected biopsies from cervical lymph nodes of LC and healthy COVID-19 convalescents. High-parameter flow cytometry analysis of FNA samples showed that convalescents mounted efficient GC B cell responses to SARS-CoV-2 that correlated with the generation of neutralizing antibodies. Conversely, GC responses to SARS-CoV-2 were severely hindered in LC patients and linked to a decreased production of binding and neutralizing antibodies against SARS-CoV-2 that waned faster than in convalescents. CITE-seq analysis of FNA samples also revealed transcriptional alterations in GC B and memory B cells from LC patients that were coupled to inferior clonal expansion. Overall, the direct analysis of lymph nodes uncovered major abnormalities in B cell responses to SARS-CoV-2 that might be connected to the incomplete lack of viral clearance in LC.



 This work is supported by PolyBio Research Foundation and by NIH 2U19AI082630-16 grant



 Immune Mechanisms of Human Disease (HUM)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/24f5872cdd72612847ef9e146aeeb304ba0f7497" target='_blank'>
              Alterations of B cell responses to SARS-CoV-2 in Long COVID 2566
              </a>
            </td>
          <td>
            M. Locci, Hannah Sharpe
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="Persistent, unresolved inflammatory processes disrupt the complex homeostatic state and lead to severe disease, ultimately resulting in organ failure, shock, and death. The mediators that monitor and control the programmed mechanisms in tissue homeostasis and repair remain elusive. A recently discovered group of endogenous proteins, termed neuronal guidance proteins (NGPs), has gained attention as important mediators of immunoregulation and tissue homeostasis through their role in the complex interplay between metabolic reprogramming and immunity. In murine peritonitis, the deficiency of the NGP Plexin C1 (PLXC1−/−) led to an increase in neutrophil and Ly6Chi monocyte recruitment to the injury site and a decrease in the phagocytosis rate. This was accompanied by a decrease in the endogenous biosynthesis of specialized proresolving lipid mediators (SPMs) such as Maresin-1 and Protectin DX and finally by a lengthening of the resolution interval. Peritoneal macrophages (MΦs)PLXC1−/− followed specific strategies to adapt their metabolism to catabolic conditions, by reducing fatty acid oxidation and oxidative phosphorylation, increasing aerobic glycolysis and activation of the pentose phosphate pathway, and disrupting the tricarboxylic acid cycle. The decreased MΦsPLXC1−/− citrate levels corresponded with a lipid mediator profile in which PGD2 and PGE2 were greatly decreased in murine PLXC1−/− peritoneal exudates, indicating a lesser effect on lipid mediator class switching and ultimately the formation of SPMs. Analysis of the related signaling networks indicated mTOR and AKT2 phosphorylation pathways are critical determinants of metabolic reprogramming in activated MΦsPLXC1−/−. These findings highlight a novel role for PLXC1 in regulating the crosstalk between immunometabolism and inflammation resolution programs in severe inflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/142901da389dc4e201c184a92df6289f59bd6377" target='_blank'>
              Plexin C1 modulates metabolic programming for resolution of severe inflammation
              </a>
            </td>
          <td>
            Andreas Körner, Michael Koeppen, Jasvir Kaur, Julia C Fitzgerald, S. Kostidis, Torsten Kaussen, Christoph Trautwein, M. Giera, Tamam Bakchoul, Alice Bernard, V. Mirakaj
          </td>
          <td>2025-11-25</td>
          <td>Cell Communication and Signaling : CCS</td>
          <td>0</td>
          <td>39</td>
        </tr>

        <tr id="Monkeypox, a zoonotic disease caused by the monkeypox virus (MPXV), has significant global public health implications. Inflammasomes serve as crucial components of the innate immune system, detecting pathogens and triggering cell death in infected cells to eliminate harmful agents. However, the precise molecular mechanisms governing the activation of inflammasomes during MPXV infection remain largely unclear. Using CRISPR-knockout cytosolic innate immune sensor screening, we identified AIM2 as the sensor for MPXV within the inflammasome, a trigger for inflammatory cell death. Mechanistically, AIM2 forms a complex with essential cell death molecules, including ASC and caspase-1 (CASP1), without interacting with RIPK3 or CASP8. Loss of ASC, CASP1, or gasdermin D (GSDMD) reduced cell death following MPXV infection, whereas loss of GSDME, CASP3, CASP6, CASP7, CASP9, RIPK3, or MLKL did not. Pyroptotic cell death was predominantly observed in infected cells, whereas apoptotic and necroptotic signaling pathways were primarily activated in uninfected bystander cells. Furthermore, we found that the transcription factor IRF1 serves as an upstream regulator of AIM2, controlling AIM2-dependent cell death. In experiments involving AIM2-deficient mice infected with MPXV, we observed a decrease in proinflammatory cytokines, multiple inflammatory cell death pathways, and leukocyte migration, culminating in increased viral spread. CAST/EiJ mice succumbed to high-dose MPXV infection within 8 days, whereas AIM2 inhibition increased survival, with 10% of the mice treated with an AIM2 inhibitor surviving the infection. In a low-dose infection model, AIM2 inhibition reduced IL-1β and IL-18 production, LDH release, and tissue pathology. These findings highlight the critical role of AIM2-mediated inflammasome activation, along with multiple programmed cell death pathways, in shaping the innate immune response to MPXV infection, offering valuable insights for developing therapeutic strategies targeting AIM2 and the broader innate immune response against monkeypox.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d9255f9c0757211efce272667e049b82cca5937f" target='_blank'>
              AIM2 drives inflammatory cell death and monkeypox pathogenesis
              </a>
            </td>
          <td>
            Jueun Oh, Yun-Ho Hwang, Jihye Lee, Cheong Seok, SuHyeon Oh, Hye Yoon Kim, Nabukenya Mariam, Jaeyoung Ahn, Gyoengju Yu, Jaewoo Park, Hayeon Kim, Suhyun Kim, Seyun Shin, Min-Chul Jung, Jinwoo Gil, Joo Sang Lee, Y. Choi, Dokeun Kim, Daesik Kim, You-jin Kim, SangJoon Lee
          </td>
          <td>2025-11-12</td>
          <td>Cellular and Molecular Immunology</td>
          <td>1</td>
          <td>9</td>
        </tr>

        <tr id="Despite heavy exposure to Mycobacterium tuberculosis (Mtb), some individuals are resistant to TST and IGRA conversion (RSTRs). The functional and immunological mechanisms governing resistance are poorly understood. We hypothesized that RSTR and LTBI alveolar macrophages (AMs) respond differently to Mtb infection with transcriptional programs that are distinct from peripheral blood monocytes. We examined media and Mtb-infected AMs from bronchoalveolar lavage fluid collected from a RSTR cohort in Uganda with over 10 years of clinical follow-up. With transcriptional profiles of BAL cells analyzed immediately after collection, gene set enrichment analysis (GSEA) revealed 13 differentially expressed gene sets between RSTR (n = 19) and LTBI (n = 26) groups, including one (Hallmark E2F targets) which was positively enriched in the RSTR group (FDR < 0.3). In a subset of this cohort (n = 7 RSTR and 8 LTBI), AMs were examined with and without Mtb infection. When comparing the RSTR and LTBI groups, we identified 52 DEGs including 22 in the media condition, 15 with Mtb stimulation, and 11 with the interaction term (FDR < 0.2, Log 2-fold change > 1/<-1). Notably, RSTR AMs appear to upregulate inflammation more strongly than LTBI counterparts, including Hallmark inflammatory response (FDR < 0.2), IFNγ response (FDR < 0.1), and IFNα response (FDR < 0.1) while existing in a more non-inflammatory state at baseline (Hallmark TNF signaling via NF-kB (down, FDR < 0.1), inflammatory response (down, FDR < 0.1). In a comparison of peripheral blood monocyte gene expression profiles from the same cohort, there were both shared and AM-specific RSTR profiles detected. Together, these results suggest that RSTR and LTBI AMs have different basal and Mtb-induced transcriptional profiles, including some that differ from peripheral blood monocytes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/74f6f6a91106ca8fedadea27abfb904beaf5f882" target='_blank'>
              Alveolar macrophage transcriptional signatures associated with resistance to TST/IGRA conversion following Mycobacterium tuberculosis exposure
              </a>
            </td>
          <td>
            Austin M. Haynes, Cristian Ovadiuc, G. Peterson, W. Worodria, Sophie Nalukwago, Timothy Muwanguzi, M. Nsereko, Catherine M. Stein, Kimberly A. Dill-McFarland, Harriet Mayanja-Kizza, W. H. Boom, R. M. Segnitz, T. Hawn
          </td>
          <td>2025-10-31</td>
          <td>BMC Genomics</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="ABSTRACT Staphylococcal enterotoxins (SE) crosslink the MHC‐II on antigen‐presenting cells (APC) with the T‐cell receptor, inducing a polyclonal T‐cell response. Although APCs are the initial targets of SE and are critical in shaping subsequent T‐cell activation, the effects of SE on APC function remain poorly understood. This study investigates the immunomodulatory effects of staphylococcal enterotoxin A (SEA) on monocytes and their differentiation into monocyte‐derived dendritic cells (moDC) or macrophages (MDM). Transcriptomic analyses of human monocytes via RNA sequencing revealed SEA‐induced enrichment of gene pathways associated with inflammation, infection, and dermatitis, effects that were amplified in the presence of T cells. Phenotypic and functional characterization showed that SEA‐primed monocytes differentiated into MDM with an altered polarization, deviating from classical M1/M2 pathways. SEA‐primed MDM exhibited downregulation of key markers, including HLA‐DR, CD80, CD86, and PD‐L1. Functional assays demonstrated that SEA‐primed MDM pushed hyperinflammatory T‐cell responses, with significantly enhanced proliferation and IFN‐γ secretion. In contrast, following SEA‐priming, moDC retained robust antigen‐presenting capabilities and displayed enhanced expression of molecules involved in T‐cell interactions. These findings provide mechanistic insights into SEA‐mediated immune modulation, illustrating how SEA reprograms MDM functions and amplifies proinflammatory T‐cell responses. This advances our understanding of superantigen‐driven immune interactions, offering a foundation for developing therapeutic strategies to mitigate superantigen‐mediated immune conditions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/31b8b3bf0438451c3b982c5f615c660d9c3ce361" target='_blank'>
              Staphylococcal Enterotoxin A Shapes Monocyte Transcription and Macrophage Polarization: Implications for Immune Responses in Infection and Inflammation
              </a>
            </td>
          <td>
            C. Arasa, Khaleda Rahman Qazi, David Brodin, Manuel Mata Forsberg, E. Sverremark-Ekström
          </td>
          <td>2025-12-01</td>
          <td>European Journal of Immunology</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="


 While many patients only experience flu like symptoms after contracting SARS-CoV-2, a small subset of patients will go on to develop acute respiratory distress syndrome (ARDS). ARDS is characterized by an overzealous inflammatory response brought on by downstream signaling of pattern recognition receptors. One such receptor, NLRX1, is shown to negatively regulate downstream inflammatory signaling during viral infections. However, its actions can be dichotomous depending on cellular context. ssRNA can be sensed by the C-terminal of NLRX1 implicating it in the host response of ssRNA viruses, such as SARS-CoV-2. The exact role of NLRX1 during SARS-CoV-2 infection remains unclear. We show NLRX1 to be protective in SARS-CoV-2 pathology. snRNA data taken from COVID-19 positive lung autopsy samples showed a down regulation of NLRX1 in airway epithelial cells while pathways modulated by NLRX1 were shown to be deferentially enriched. Nlrx1-/- mice infected with the mouse adapted SARS-CoV-2 virus had a greater viral titer and airway inflammation, including increased cellular denuding at 2 days post infection compared to wild-type animals. Furthermore, human airway epithelial cells over-expressing NLRX1, not only had decreased viral replication but may be protecting against a viral shift of host metabolism to limit viral replication. Our results suggest NLRX1 antagonizes SARS-CoV-2 through multiple pathways. With more research, NLRX1 could be a promising drug target for Covid-19.



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ae354c65901bd74c8236f5f8ee4e01955dd63dbe" target='_blank'>
              Fighting Covid-19 with NLRX1 9340
              </a>
            </td>
          <td>
            Mackenzie K Woolls, Hannah M. Ivester, Julia A Gregory, I. Allen
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0a891d2740ad2db98b44c1bca0f35faa07a82811" target='_blank'>
              Spatial and Single-Cell Transcriptomics Decipher the Crosstalk Environment of DEFB1+ Cancer Cells and IFI30+ Macrophages in Intrahepatic Cholangiocarcinoma
              </a>
            </td>
          <td>
            Guoliang Wang, Hang Meng, Meng Li, Xiangdong Fang, Weilong Zou, H. Qu
          </td>
          <td>2025-11-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Viral encephalitis, characterized by inflammation of the brain parenchyma, poses a significant threat to public health due to its high rates of morbidity and mortality. Microglia, the central nervous system’s resident immune cells, are crucial in the pathophysiology and development of this condition. These microglia exhibit a dual function, being involved in both neuroprotection and neurotoxicity during viral encephalitis. To address this complex interplay, targeted therapeutic strategies that modulate microglia activation state have emerged as a promising approach. These strategies aim to either inhibit excessive microglia activation or promote their neuroprotective functions. By targeting microglia, these therapies hold the potential to improve outcomes for patients with viral encephalitis. This review synthesizes current evidence revealing that microglial responses during viral encephalitis exhibit context-dependent heterogeneity that extends beyond traditional M1/M2 paradigms. Critically, our review reveals a significant translational gap, with no current clinical trials investigating microglial-targeted therapies for viral encephalitis despite promising preclinical evidence. This review provides a comprehensive framework for understanding microglial complexity in viral encephalitis and establishes research priorities for advancing these insights toward clinical application.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7e0caaffaa21a65c0a881f9db458d953a11cab66" target='_blank'>
              Dual immune modulation of microglia in viral encephalitis: current understanding and future perspectives
              </a>
            </td>
          <td>
            Li Zong, Pei Chen, Jing Shi, Huijie Chen, Wen-wen Lin, Guanyong Ou, Xuxiang Chen
          </td>
          <td>2025-10-27</td>
          <td>Frontiers in Molecular Biosciences</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="


 Recent studies suggest respiratory infections like SARS-CoV-2 can influence brain glial cell behavior. Early-life stress, such as neonatal stress, may predispose the nervous system to an exacerbated response during immune challenges. Thus, we investigated how early-life stress modifies glial cell activation and function during Sendai virus-induced lung inflammation, and assess its impact on neuroimmune responses and susceptibility to respiratory diseases in adulthood.



 This study used a neonatal maternal separation (NMS) rat model in which Sprague Dawley rats were separated from their mother for 3 hours daily from postnatal days 3 to 12. At 8-10 weeks, rats were infected intranasally with Sendai virus, and brain glial cells were analyzed by flow cytometry post-infection.



 Activation markers of the microglia and astrocytes are modulated by Sendaï infection differently in response to stress and sex. Viral infection increased CD200 on astrocytes 4 days post-infection. At the same time, activated microglia MHCII levels were lower, with differences across sexes and between NMS and control groups.



 Respiratory viral infections may affect glial cell activation, showing a pattern aligning with human SARS-CoV-2 observations. Early-life stress may further influence the glial response to such infections, emphasizing the role of developmental factors and immune challenges in shaping neuroimmune responses.



 Supported by CIHR, FRQS, Quebec Respiratory Health Network and Fondation IUCPQ.



 Neuroimmunology (NEUR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bffc63259177c779d5068e71a7d6a6f22be2dddc" target='_blank'>
              Sex-specific impacts of lung viral infection on brain microglia and astrocytes 2565
              </a>
            </td>
          <td>
            J. Lauzon-Joset, Karine Bouchard, Joanny Roy, Danuzia Ambrozio-Marques, Richard Kinkead, Dany Patoine
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="


 MIS-C is a pediatric hyperinflammatory disease characterized by inflammatory shock involving multiple organ systems. MIS-C is linked with prior SARS-CoV-2 infection, approximately 4-6 weeks before symptom onset. Acute patients display distinct circulating immune cell profiles, marked by an increase in inflammatory cytokines and chemokines. Here, we used single-cell RNA- and TCR-sequencing paired with multiplexed cytokine profiling and mass cytometry to characterize the immune signatures of PBMCs and plasma in 8 acute MIS-C patients, 15 recovered MIS-C follow-ups over a range of time points (“early”: 1-3 months, “late”: 6-18 months), and 10 healthy pediatric controls. Levels of various proinflammatory cytokines and chemokines, including IL-6, IL-15, and IL-1β, were elevated in the plasma of early follow-ups; similarly, perforin, pSTAT-3, and pSTAT-4 protein expression was higher in PBMCs within this 3-month follow-up window. Multiome analysis of 151,420 PBMCs revealed an enrichment of inflammatory pathways in genes more highly expressed in early compared to late follow-ups, specifically in monocytes. Significant expansions of various paired TCR α/β-chains were also observed in acute patients, which persisted in early follow-ups. Together, our findings establish a prolonged inflammatory phenotype up to 3 months after MIS-C resolves, suggesting that the effects of SARS-CoV-2 infection-caused MIS-C may linger well after the virus is cleared despite fast clinical resolution.



 Supported by NIH/NICHD R01HD108467-01; Helen Hay Whitney Fndn. Fellowship.



 Computational and Systems Immunology (COMP)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/700fb0f1fd9b6efe4945ffb81edc27b02688ee5b" target='_blank'>
              Disseminated autoimmunity is associated with MIS-C pathogenesis 2925
              </a>
            </td>
          <td>
            Haley E. Randolph, Ashley Richardson, S. Buta, Julie Samuels, Sarah S Geisler, Mark W Russell, R. Trachtman, Dusan Bogunovic
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="A Proliferation-Inducing Ligand (APRIL) is a tumour necrosis factor superfamily member with multiple effector roles in the peripheral and central nervous system (CNS). In the CNS, APRIL helps maintain immune homeostasis and supports neuronal survival, yet whether it can therapeutically modulate acute neuro-inflammatory and neurodegenerative processes is unclear. To investigate this in a severe neuro-inflammatory context, we tested whether local APRIL delivery can influence microglial/astrocytic responses and demyelination in the cuprizone (CPZ) mouse model of neuro-inflammation and demyelination. We applied adeno-associated virus (AAV)–mediated gene transfer to drive APRIL expression by cortical neurons positioned directly above the splenium of the corpus callosum. Following CPZ intoxication, we evaluated microglial and astrocytic activation and myelin content by in vivo T2 and diffusion magnetic resonance imaging (MRI), and validated them by post-mortem quantitative immunohistochemistry (IHC) and bulk transcriptomic and proteomic profiling. T2 and diffusion MRI, corroborated by quantitative IHC, demonstrated that secretion of APRIL by cortical neurons attenuated CPZ-induced microglial recruitment and demyelination in the splenium, but not in the cortex. Integrated transcriptome-proteome analysis of splenium and cortex, further supported by IHC, highlighted astroglial lipid-metabolic circuitry - marked by the astrocytic fatty-acid-binding protein 7 (Fabp7) - as a candidate axis underlying APRIL’s effects to reduce inflammatory cell recruitment and myelin preservation. AAV-mediated expression of APRIL by cortical neuron counteracted microglial recruitment and demyelination in the splenium of CPZ-treated mice. Our multi-omics integration analysis nominated several pathways, including Fabp7-linked astrocytic lipid metabolism, to elucidate APRIL’s mechanism of action. Together, these findings provide a framework for the mechanistic dissection of APRIL’s therapeutic potential and further translational evaluation in CNS pathologies characterised by acute neuro-inflammatory responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b73ba8336580ec9e7f5e7539d0fbcc48e4944d3b" target='_blank'>
              AAV-mediated delivery of a proliferation inducing ligand (APRIL) to cortical neurons limits inflammation and demyelination in the corpus callosum of the cuprizone mouse model
              </a>
            </td>
          <td>
            Leonardo Ricciardi, Federica Di Marco, Marion Decrop, Julia Di Stefano, Tejaswini Kakunuri, Joëlle van Rijswijk, N. Vidas-Guscic, Yousra El Ouaamari, Alexandro A. Bufi, Ignace Van Spilbeeck, Johan Van Audekerke, Carole Faghel, Esther Bartholomeus, Eva Lion, Nathalie Cools, Steven Van Laere, I. Cicalini, Vincenzo de Laurenzi, Una FitzGerald, D. Pieragostino, B. Huard, P. Del Boccio, Peter Ponsaerts, M. Verhoye
          </td>
          <td>2025-10-27</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="


 The immune system is essential to control and eliminate pathogens such as SARS-CoV-2, the agent of COVID-19. Studying the differential responses of individuals exposed to the same viral strain within discordant couples (one partner infected, the other not) can enhance our understanding of infection responses. This study focuses on the neutrophil response in such couples, aiming to identify and evaluate resistance and susceptibility markers through the expression of ACE2, TLR4, and TLR9 receptors, cytokine production, and NETs release following different stimuli. Our findings reveal significant differences in responses. When COVID-19-negative cells were stimulated with ODN CpG, the percentage of ACE2+ neutrophils were increased, being higher than positive individuals. COVID-19-positive individuals have higher expression of TLR4+ in neutrophils without stimulation and after stimulation with LPS, ODN CpG, and inactivated SARS-CoV-2 in different concentrations. For TLR9 expression, this behavior is maintained in COVID-19-positive groups, except for those stimulated with ODN CpG. Regarding NETs release, COVID-19-positive individuals showed higher levels of NETs produced by neutrophils, even without acute infection, mainly at serum levels. After stimulation, COVID-19 negative have the highest levels comparatively and were also able to produce more IL-8. These differences in neutrophil responses may indicate potential resistance and susceptibility factors to SARS-CoV-2 infection.



 Funding: Supported by The São Paulo Research Foundation, FAPESP (process number 2021/13354-1)



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dc25fff247ac3b1005ac3dd50861c2c33b641107" target='_blank'>
              Resistance and susceptibility markers of SARS-CoV-2 infection in neutrophils response from discordant couples 4014
              </a>
            </td>
          <td>
            L. A. Dias-Melicio, Thayná Ruiz Ferreira, Ana Laura Ortega Dezen, Fernando Couso Correa, Larissa Ragozo Cardoso de Oliveira, C. Simeoni, José Luiz, Proença Módena
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/275812dc3294ac678dbefad1e9f5e6d112d20c5e" target='_blank'>
              SP140 limits type I interferon–driven pathology, preserving T cell motility and promoting resistance in tuberculosis
              </a>
            </td>
          <td>
            Maxime Caouaille, Léa Fromont, Tomoyo Shinkawa, Marion Faucher, Aizat Iman Abdul Hamid, Serge Mazères, Yaël Duvergé, Yohan Lorreyte, Emmanuelle Näser, S. Behar, Emma Lefrançais, O. Neyrolles, Denis Hudrisier
          </td>
          <td>2025-12-09</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>64</td>
        </tr>

        <tr id="The NLRP3 inflammasome is a key sensor of cellular stress and pathogen-associated signals in the innate immune system. Using confocal fluorescence microscopy in microvascular lung endothelial cells, we examined ASC speck formation following expression of the SARS-CoV-2 ORF3a protein. ORF3a engaged caspase-1 through dual architectural modes: alongside the canonical pyroptosome-like pathway, a novel distributed, multifocal inflammasome pathway emerged. Multiple ASC specks were observed at later time points, yet caspase-1 activation could occur in their absence, indicating that visible speck assembly is not strictly required for inflammasome signalling. These observations provide insight into the spatiotemporal dynamics of ASC during viral protein expression. The findings contribute to a better understanding of NLRP3 inflammasome regulation under conditions of viral replication.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cbba9d13b01cc2270c55a23acc740928adf06f2d" target='_blank'>
              ASC Dynamics Associated with ORF3a Protein Expression in Microvascular Lung Endothelial Cells
              </a>
            </td>
          <td>
            Yuliia Mariienko, Diana Pendicheva, S. Hayrabedyan, K. Todorova
          </td>
          <td>2025-10-26</td>
          <td>Proceedings of the Bulgarian Academy of Sciences</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="


 Our goal was to understand the host immune response following the SARS-CoV-2 infection and finding an effective immune-therapeutic intervention. Mice infected with a mouse-adapted strain of SARS-CoV-2 (MA-10) showed increased CXCR3 signaling compared to sham-challenged mice, as observed by the increased expression of CXCR3 and its ligands CXCL9, CXCL10, and CXCL11 in lungs. Flow cytometry revealed that CXCR3+ T cells, Innate lymphoid cells, and macrophages were associated with the recovery following MA-10 infection. Interestingly, blocking CXCR3 signaling with monoclonal antibodies worsened disease outcomes measured by survival (P = 0.02), clinical scores (P = 0.006 on day 5 pi), and weight loss (P = 0.002 on day 5 pi). A plaque assay of lung lysates showed that aCXCR3 treated mice had impaired viral clearance (P = 0.02). Administering aCXCR3 showed a similar phenotype in Rag2-/- mice, suggesting that the CXCR3-mediated protection was conferred by innate immune cells. To investigate the role of alveolar macrophages, we stained for CD169, CD11c, and the SARS-CoV2 nucleocapsid. Immunostains confirmed that aCXCR3-treated mice had higher viral loads in the lungs. Although CD169+CD11c+ alveolar macrophages were comparable between the groups, the number of alveolar macrophages that phagocytosed viruses were significantly lower in aCXCR3 treated mice (P < 0.0001). We conclude that CXCR3 signaling in alveolar macrophages is indispensable to clear viral load during SARS-CoV2 infection.



 Innate Immune Responses and Host Defense: Cellular Mechanisms (INC)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c93327417a4edf7f16144b0bb41ca1916c870d3f" target='_blank'>
              CXCR3+ Alveolar macrophages help to clear viral load during SARS-CoV-2 infection 9049
              </a>
            </td>
          <td>
            Md Jashim Uddin
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Long COVID has emerged as a major global health concern, yet the long-term trajectory of immune recovery and its contribution to persistent symptoms remain to be elucidated. Here, we conducted a three-year longitudinal follow-up of the 47 COVID-19 patients and applied single-cell RNA sequencing (scRNA-seq) and multiplex cytokine profiling to comprehensively characterize the peripheral immune landscape during convalescence. We observed persistent immune dysregulation up to three years post-infection, characterized by chronic inflammation and impaired restoration of naïve CD4⁺ T cells, naïve CD8⁺ T cells, and SLC4A10⁺ MAIT cells—features reminiscent of immunosenescence. Notably, Th17 cells, rather than monocytes, emerged as key drivers of chronic inflammation beyond one year. We identified two distinct Th17 subsets: RORC⁺ Th17 cells and LTB⁺ Th17 cells. While RORC⁺ Th17 cells were negatively correlated with inflammatory cytokine levels, LTB⁺ Th17 cells showed proinflammatory features and were positively associated with long COVID symptoms. Sustained elevation of S100A8 and IL-16 in follow-up patients may contribute to the persistent presence of LTB⁺ Th17 cells. Together, our study provides an in-depth longitudinal map of immune remodeling in COVID-19 convalescents, revealing key cellular and molecular drivers of sustained inflammation up to three years post-infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f682ef5df5972e318b0093c3cf2459508e92d089" target='_blank'>
              T cell-driven sustained inflammation and immune dysregulation mimicking immunosenescence for up to three years post-COVID-19
              </a>
            </td>
          <td>
            Tian Zheng, Ru Gao, Yiwei Liu, Ye-ming Wang, Chao Wu, Li Guo, Lan Chen, Xinming Wang, Yan Xiao, Jingchuan Zhong, Rongling Zhang, Ying Wang, Xianwen Ren, Bin Cao, Lili Ren, Jianwei Wang
          </td>
          <td>2025-11-20</td>
          <td>Immunity & Inflammation</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="The coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has become a global pandemic with over 778 million confirmed cases and over 7 million deaths. Chronic obstructive pulmonary disease (COPD) mainly developed by cigarette smoke (CS), is considered as a risk factor for COVID‐19 severe symptoms. However, there is a gap in our knowledge of host‐viral interactions for susceptibility to SARS‐CoV‐2 infection and disease severity. Equal numbers (n = 14) of K18‐h (angiotensin‐converting enzyme) ACE2 transgenic mice were randomized for sham air (SA) exposure as control group or CS group (2‐h CS exposure per day) for 7 days. On Day 8, mice were randomly subdivided into mock infection (n = 6) and SARS‐CoV‐2 infection (n = 8) for 3 days. Lung tissues were harvested after sacrifice for analysis of viral susceptibility, morphological changes, host immune response, and endoplasmic reticulum (ER) stress. CS exposure increased viral susceptibility by upregulating virus binding receptors ACE2 and binding immunoglobulin protein (BiP), subsequently causing ER stress via activation of activating transcription factor (ATF)6 pathway and protein kinase R (PKR) pathway, resulting in greater immune response and apoptosis. Prior CS exposure caused further deterioration of SARS‐CoV‐2‐induced epithelial damage via the loss of epithelial junctions, ciliary dysfunction, mucus hypersecretion, and lung fibrosis. The current findings suggest that ER stress is likely to play a role in the deterioration of SARS‐CoV‐2‐induced lung injury prior CS exposure. This study provides a better understanding of the pathogenesis of SARS‐CoV‐2 infection in smokers and possible therapeutic targets for treatment.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/201af962cdfb60e71ffa2792bb03696f75633e38" target='_blank'>
              Cigarette Smoke Deteriorates SARS‐CoV‐2 Infection‐Induced Lung Injury
              </a>
            </td>
          <td>
            Rui Chen, Kenrie P. Y. Hui, John M Nicholls, Mary S M Ip, M. Peiris, Michael C. W. Chan, J. C. Mak
          </td>
          <td>2025-10-30</td>
          <td>Journal of Medical Virology</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Background Severe COVID-19 is frequently associated with acute respiratory distress syndrome (ARDS) and prolonged pulmonary sequelae. Persistent immune activation, including dysregulated B cell responses and increased proinflammatory chemokines, has been linked to the post-acute sequelae of SARS-CoV-2 infection. However, the mechanisms linking these factors remain poorly defined. Methods Sixty patients were studied four months after acute COVID-19, including 34 who developed ARDS, 26 who did not develop ARDS, and 12 healthy controls. Clinical, computed tomography scan (CT), and diffusion capacity of the lungs for carbon monoxide (DLCOc) assessments were performed. Anti-SARS-CoV-2 IgM/IgG levels were quantified, circulating B cell subsets were characterized, and circulating cytokines and chemokines were measured. CXCR3 expression on B cells was analyzed by spectral flow cytometry. In vitro assays were performed to evaluate the effects of CXCL9 and CXCL10 on B cell activation, plasma cell differentiation, IgG production, and CD40L expression on CD4+ T cells. Associations between immunological markers and pulmonary sequelae were assessed. Results IgG, but not IgM, levels were significantly higher in patients with ARDS than in patients without ARDS. Both COVID-19 groups showed a reduction in CD19+CD20+ B cells and an increase in plasmablasts compared to controls. Serum levels of CXCL9 and CXCL10, but not other cytokines, positively correlated with IgG levels. In vitro, CXCL9 increased CD86 expression on B cells, while both chemokines promoted plasma cell differentiation (CD27+CD38+, CD138+) and increased total IgG secretion. CXCL9 also increased the expression of CXCR3 and CD40L on activated CD4+ T cells. Clinically, patients with combined CT abnormalities and reduced DLCO had the highest levels of IgG, CXCL9, and CXCL10. Conclusion Four months after COVID-19, patients with prior ARDS and persistent pulmonary sequelae exhibit sustained elevations of anti-SARS-CoV-2 IgG and chemokines CXCL9 and CXCL10. Both chemokines directly enhance B cell differentiation into IgG-secreting plasma cells in vitro, while CXCL9 also increases CD4+ T cell help, suggesting a mechanistic link between chronic inflammation, increased humoral responses, and long-term lung impairment. Targeting CXCL9/CXCL10–CXCR3 signaling could offer therapeutic potential to mitigate post-COVID pulmonary complications.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1f87e4a08188abb1875547220225dd7d5712072b" target='_blank'>
              CXCL9 and CXCL10 support the exacerbated humoral response in recovered COVID-19 patients who developed acute respiratory distress syndrome by promoting plasma cell differentiation, whereas CXCL9 also induces CD40L and CXCR3 upregulation on T helper cells
              </a>
            </td>
          <td>
            R. Quiroga, Sergio Sanhueza, Catalina Sepúlveda, Bárbara Antilef, C. Munoz, Camilo Cabrera, M. Fraga, Faryd Llerena, L. Lamperti, M. I. Barria, Alicia Colombo, Gonzalo Labarca, Mario Henriquez-beltran, Luciano Ferrada, Estefanía Nova-Lamperti
          </td>
          <td>2025-12-04</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5e22d77c1e5e4f3c3da3acb1323e1ee60ce0289a" target='_blank'>
              Core Activation Program and Selective Regional Responsiveness of Microglia in Aging and Parabiosis
              </a>
            </td>
          <td>
            Huma Naz, Róbert Pálovics, Shinnosuke Yamada, Nannan Lu, T. Wyss-Coray, Qingyun Li, Guoyan Zhao
          </td>
          <td>2025-10-31</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="BACKGROUND: The COVID-19 pandemic, caused by SARS-CoV-2, has led to the first approval of mRNA vaccines in humans. By producing the full-length SARS-CoV-2 Spike protein, they induce protective antiviral immunity. Acute myopericarditis (AMP) development after vaccination has repeatedly been reported; however, the pathogenesis of this complication remains elusive. METHODS: In-depth phenotyping of peripheral blood T cells was undertaken in cohorts of patients who developed AMP after mRNA vaccination, patients hospitalized for severe COVID-19, and healthy subjects with no cardiac side effects after mRNA vaccine. Validation studies were carried out using an experimental model of cardiac inflammation, in which a shared epitope elicits functional responses in patients and mice and induces AMP. RESULTS: We show that T cells from patients with AMP recognize vaccine-encoded Spike epitopes homologous to those of cardiac self-proteins. One of these epitopes, mimicking an amino acid sequence from a cardiomyocyte-expressed K+ channel, induced AMP in mice. When functional responses to the Kv2 were analyzed, patients with AMP after mRNA vaccination, but not patients with COVID-19, displayed an expanded pattern of cytokine production similar to that observed in AMP mice and in autoimmune myocarditis. Crucially, T-cell autoimmunity segregates to cardiotropic cMet (c-mesenchymal epithelial transition factor)–expressing T cells and is prevented by cMet inhibition, suggesting that heart homing imprinting, permitted by the unique mRNA vaccine biodistribution, is required for AMP development. CONCLUSIONS: AMP development after mRNA vaccines is mediated by distinct immune components, including molecular mimicry, T-cell receptor affinity, and, importantly, homing imprinting.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7a2c7768da7a26c5948ed8c2a53768a7ad48ff71" target='_blank'>
              Combined Adaptive Immune Mechanisms Mediate Cardiac Injury After COVID-19 Vaccination
              </a>
            </td>
          <td>
            Silvia Fanti, Carlene Dyer, I. J. Ingimarsdóttir, Daniel Harding, Guosu Wang, Antonio d'Amati, Eriomina Shahaj, Aðalbjörg Ýr Sigurbergsdóttir, Helga Thorsdottir, Oddný Brattberg Gunnarsdóttir, S. Kanoni, Paul Wright, John Martin, J. Chorlton, Zoe Hollowood, S. F. Brynjólfsson, Bjorn Rúnar Lúdvíksson, Egle Solito, Serena Bert, Jack M. Keane, S. Mohiddin, M. Longhi, F. Marelli-Berg
          </td>
          <td>2025-10-30</td>
          <td>Circulation</td>
          <td>0</td>
          <td>70</td>
        </tr>

        <tr id="


 Obesity is a significant risk factor for worse clinical outcomes in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Although obesity is known to alter immune function, the mechanisms by which it affects local and systemic SARS-CoV-2 immunity and worsens disease severity remain unclear. Here, we compared virus–host dynamics in genetically obese Lepob (ob/ob) mice and lean control mice after intranasal infection with SARS-CoV-2 Beta (B.1.351). Obese mice exhibited delayed viral clearance from the lungs, worse histopathologic pulmonary injury, and worse clinical outcomes compared with infected lean mice. Pulmonary CD8+ T cells in obese mice displayed an exaggerated SARS-CoV-2-specific cytokine response and a marked shift in energy metabolism towards preferential fatty acid utilization. SARS-CoV-2 clearance from the lungs of obese mice was normalized by adoptive transfer of CD8+ T cells from SARS-CoV-2-immune lean mice. Collectively, these data suggest that obesity is associated with cell-autonomous metabolic and immunologic abnormalities in pulmonary SARS-CoV-2-specific CD8+ T cells that contribute to delayed viral clearance and worse clinical outcomes in infected obese mice.



 This study was funded by National Institutes of Health grants U19 AI142790-02S1 (to SS and EOS), the GHR Foundation (to SS and EOS), the Arvin Gottleib Foundation (to SS), and the Overton family (to SS and EOS). This research was also supported by a La Jolla Institute for Immunology (LJI) /Kyowa Kirin Inc. (KKNA) Interactive Fund.



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fa87bcd3d35d948a0e1cb2e9e259c54c267d8b95" target='_blank'>
              Obesity Alters the Metabolic and Immunologic Response of Pulmonary T Cells to SARS-CoV-2 Infection 2143
              </a>
            </td>
          <td>
            Shailendra Kumar Verma, Julia Timis, Erin Maule, A. E. Ngono, Fernanda Ana-Sosa-Batiz, Robyn Miller, Kathryn Hastie, E. Saphire, Kenneth Kim, Thomas Riffelmacher, S. Shresta
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>54</td>
        </tr>

        <tr id="Background. Asthma is a chronic progressive heterogeneous respiratory disease accompanied by the development of a systemic inflammatory response. Due to the widespread prevalence of the novel coronavirus infection, there is concern about the impact of COVID-19 on patients with asthma. Current evidence suggests that SARS-CoV-2 activates the inflammasome response, triggering a hyperinflammatory reaction in patients with asthma, but the long-term consequences are still insufficiently studied. 
Purpose. To study the features of the systemic inflammatory process over six months after SARS-COV-2 infection in individuals with asthma. 
Materials and methods. In patients with mild, partially controlled asthma after mild COVID-19 infection (n = 52) and individuals with asthma (n = 34) who did not contract COVID-19, an assessment of inflammatory markers in peripheral blood was performed. Patients were examined immediately after recovery and confirmation of a negative SARS-COV-2 test result; one month, three months, and six months after the infection. The control group included conditionally healthy volunteers (n=15) who did not contract COVID-19. The cellular composition of peripheral blood, ESR, CRP, D-dimer levels were determined by classical methods; interleukin concentrations: (IL)-1β, IL-6, IL-18, NOD-like receptor protein 3 (NLRP3) inflammasome, gasdermin D (GSDMD) were measured by ELISA methods. 
Results. It was revealed that for all studied parameters, there is a slow decrease in the level of indicators by six months. The levels of GSDMD, platelets, IL-1β, D-dimer, ESR, IL-6, NLRP3 after six months do not reach the values of the control group, which indicates a persistent hyperinflammatory response of the immune system. 
Conclusion. Activation of NLRP3 and gasdermin D by the SARS-CoV-2 virus directly or indirectly can lead to dysregulation of inflammasome-mediated mechanisms, triggering and maintaining a hyperinflammatory reaction for six months, prolonging the recovery process in patients with asthma. The study of these processes will expand the understanding of the pathological mechanism. This will allow the development of new therapeutic strategies for asthma patients who have suffered from the novel coronavirus infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4989330952617c30321fd95e1d3a822ad386e019" target='_blank'>
              Dynamics of inflammatory markers over six months in patients with asthma who underwent COVID‑19
              </a>
            </td>
          <td>
            T. G. Lobova, T. Vitkina
          </td>
          <td>2025-10-31</td>
          <td>Siberian Journal of Life Sciences and Agriculture</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Extensive studies have demonstrated the relationship between metabolic reprogramming and the tumor microenvironment. Here, we characterized the head and neck squamous cell carcinoma (HNSCC) evolutionary landscape using spatial metabolomics/transcriptomics, single-cell transcriptomics, and bulk multi-omics. Metabolic heterogeneity during HNSCC malignant transformation was identified, with significant enrichment in the purine metabolism. Integrating single-cell and bulk data, we developed a robust ligand-receptor-based signature (LRS) linked to NT5E, a key upstream regulator of purine metabolism, which served as an independent prognostic indicator. The low LRS subtype was associated with a high proportion of immune cell infiltration and improved response to immunotherapy. Notably, in vitro and in vivo experiments demonstrated that AMIGO2, a core molecule within the LRS, regulates tumor-associated purine metabolism, and that its downregulation suppresses tumor cell invasion and migration, inhibits myofibroblast differentiation, and promotes immune effector cell infiltration. Moreover, combining AMIGO2 targeting with anti-PD-1 therapy yielded superior efficacy. Consistent validation was also obtained in a clinical cohort of HNSCC and premalignancy patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f2ca668a38f0d67d558807d21d034edd4de991a2" target='_blank'>
              Metabolomic and transcriptomic profiling of HNSCC identifies AMIGO2 as a therapeutic target modulating tumor microenvironment
              </a>
            </td>
          <td>
            Gan Liu, Xinfeng Yao, Yuchen Hou, Wentao Deng, Liyu Zhang, Shutong Li, Panpan Huang, Wenjiao Chang, Haiyan Huang, Lan Shi, Qianqian Zhou, Yanqing Wang, Jia Chen, Wenchao Gu, Xiaoling Ma, Yu Zhou, Honghong Liu, Shanshan Zhang, Zongcheng Yang
          </td>
          <td>2025-11-18</td>
          <td>NPJ Precision Oncology</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="Five years ago, we launched the COVID Human Genetic Effort. Our goal was to explain the clinical variability among SARS-CoV-2-exposed individuals by searching for monogenic inborn errors of immunity (IEI) and their phenocopies. We deciphered the pathogenesis of critical COVID-19 pneumonia and multisystemic inflammatory syndrome in children (MIS-C) in ~15% and 2% of cases, respectively, thereby revealing general mechanisms of severe disease. We also defined neuro-COVID-19 genetically and immunologically in one child, while we delineated the immunological mechanisms of COVID-toes in healthy children and young adults, paving the way for their genetic study. Understanding the human genetic and immunological basis of resistance to SARS-CoV-2 infection, long COVID, and myocarditis post mRNA vaccination, has been challenging and investigations remain ongoing. This work highlights the power of patient-based basic research and large-scale international collaborative efforts to discover human genetic and immunological drivers of infectious disease phenotypes, with implications for the timely development of new medical strategies before the next pandemic arrives.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/33c1dd728132f42ffee69c7f2731779fab0acc3c" target='_blank'>
              The seven enigmas of SARS-CoV-2: from the past to the future
              </a>
            </td>
          <td>
            E. Andreakos, L. Arkin, P. Bastard, A. Bolze, A. Borghesi, Petter Brodin, J. Casanova, Giorgio Casari, A. Cobat, Beth A. Drolet, J. Fellay, Elena W. Y. Hsieh, I. Meyts, T. H. Mogensen, V. Sancho-Shimizu, A. Spaan, H. Su, Donald C. Vinh, Ahmad Yatim, Qian Zhang, Shen-Ying Zhang
          </td>
          <td>2025-10-24</td>
          <td>Journal of human immunity</td>
          <td>0</td>
          <td>67</td>
        </tr>

        <tr id="Stress and inflammation are interconnected in Parkinson’s disease (PD), both potentially accelerating neurodegeneration. The COVID-19 pandemic offered a unique context to study how external stress impacts inflammation in PD. We analyzed clinical and plasma data from 256 PD patients in the longitudinal Personalized Parkinson’s Project, assessed both before and during the pandemic. Mixed-effects models assessed associations between stress-related symptoms and inflammatory markers, and the effects of stress reactivity (high vs. low) and time (pre- vs. during-pandemic) on inflammatory markers. Depressive symptoms were positively associated with CRP and IL-6 levels. CRP levels increased during the pandemic compared to pre-pandemic levels, especially in highly stress-reactive individuals. MMP-10 was upregulated during the pandemic, unrelated to stress or disease severity. These findings support the link between depression and low-grade inflammation in PD and suggest pandemic-related stress may exacerbate inflammatory responses. Future research may address the causal links between stress, inflammation, and PD disease progression.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ccf9a64dcbf241be34123648ccae6d31dc4b2524" target='_blank'>
              The interplay between stress, inflammation and Parkinson’s disease: insights from the COVID-19 pandemic
              </a>
            </td>
          <td>
            A. van der Heide, Brenda Kischkel, Chantal P. Rovers, M.I. de Jonge, B. Bloem, Marcel M. Verbeek, L. A. Joosten, Rick C. Helmich
          </td>
          <td>2025-11-21</td>
          <td>NPJ Parkinson's Disease</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Tuberculosis (TB) remains a major global health challenge. Peripheral blood immune cell composition provides valuable insights into TB progression and management. In this study, we analyzed cellular dynamics across the TB disease spectrum using 43 global transcriptomic datasets encompassing 5,902 blood samples. Distinct immune changes were identified during the early stages of TB progression. Transition from latent infection to incipient TB was associated with reduced proportions of natural killer (NK) cells. In subclinical TB, monocyte proportions increased further, accompanied by additional reductions in NK cells and B cells. These early immune shifts preceded the pronounced alterations observed in active TB, characterized by elevated monocytes and neutrophils alongside markedly decreased lymphocyte populations. During successful anti-TB treatment, immune profiles gradually normalized. Cellular dynamics were also influenced by TB burden, age, and HIV coinfection, with stronger immune responses observed in adults and in regions with lower TB burdens. Overall, this study highlights early-stage peripheral blood biomarkers, particularly NK cell changes, as potential indicators of TB progression and targets for preventive interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f8574e17dda1b09d6c703a7d3ef93ad3a9f3cdff" target='_blank'>
              Peripheral blood cellular dynamics during the progression of human tuberculosis
              </a>
            </td>
          <td>
            Shanshan Zhu, Qiuchen Dai, Kai Wang, Hanlin Yan, Yuexuan Ma, Yayan Niu, Cheng Chen, Meiying Wu, Xueying Xie, Wanjun Gu
          </td>
          <td>2025-10-27</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Introduction Tuberculosis (TB) rema\ins a major global health challenge. Mycobacterium avium (M. avium), a non-tuberculosis mycobacterium, causes pulmonary infections and can evade host immune surveillance by persisting within macrophages. MicroRNAs (miRNAs) are key regulators of host immunity; however, their roles in mycobacterial pathogenesis are not fully understood. This study investigated the role of miR-17-5p in macrophage-mediated immune responses during M. avium infection, with a focus on MAP3K2-mediated MAPK signaling. Methods Differentially expressed miRNAs were identified through small RNA sequencing of exosomes from M. avium-infected THP-1 macrophages. Candidate miRNAs were validated by RT-qPCR in THP-1 derived exosomes and serum samples from TB patients. MAP3K2 was evaluated as a miR-17-5p target using bioinformatics prediction, dual-luciferase reporter assays, and expression analysis. Effects on immune responses and MAPK signaling were assessed using qPCR, ELISA, Western blotting, ROS measurement, and CFU assays. Results miR-17-5p expression was significantly elevated in M. avium–infected macrophages, as well as in serum and peripheral blood mononuclear cells (PBMCs) from TB patients. Increased miR-17-5p suppressed MAP3K2 expression and attenuated MAPK signaling, reducing phosphorylation of ERK, JNK, and p38. This resulted in decreased production of inflammatory mediators (TNF-α, IL-6, IL-1β), reduced iNOS and ROS levels, and impaired bacterial clearance. Discussion miR-17-5p promotes M. avium survival by targeting MAP3K2 and suppressing MAPK-dependent immune functions in macrophages. These findings highlight miR-17-5p as a potential diagnostic biomarker and therapeutic target in TB and related mycobacterial infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e5593bb9a5c120c9ad14e43731e720b3da48b783" target='_blank'>
              Elevated miR-17-5p facilitates mycobacterial immune evasion by targeting MAP3K2 in macrophages
              </a>
            </td>
          <td>
            Md Shoykot Jahan, Jinlan Yang, Yiyue Tang, Dehui Xiong, Peilei Hu, Xichang Tang, Lijun Tang
          </td>
          <td>2025-12-04</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="ABSTRACT Biological sex significantly influences susceptibility to tuberculosis (TB), with males typically experiencing a greater disease burden than females. However, the mechanisms underlying sex-specific immune regulation during TB pathogenesis remain incompletely understood. In this study, we examined sex-based differences in pulmonary immune cell composition, inflammatory signaling pathways, and macrophage transcriptomic responses in C57BL/6 mice infected with the Mycobacterium tuberculosis (Mtb) HN878 strain during the sub-acute stage of infection. Our results show that female mice had significantly lower pulmonary Mtb burdens and enhanced protein kinase B (AKT)–interferon gamma (IFN-γ) signaling, which is associated with autophagy, lysosomal activation, and effective intracellular bacterial clearance. In contrast, male mice exhibited higher bacterial loads and elevated IL-6 signaling, a pathway linked to exacerbated inflammation and impaired pathogen control. Histological analysis revealed greater lymphocytic aggregation in female lungs, despite comparable levels of pulmonary macrophages between sexes. Importantly, transcriptomic profiling of lung macrophages uncovered distinct sex-specific gene expression patterns, wherein female macrophages upregulated genes involved in tissue remodeling, phagocytosis, autophagy/lipophagy, and cell survival, whereas male macrophages showed enrichment of genes related to pro-inflammatory and adaptive immune responses. Notably, male macrophages expressed higher levels of Ighg1 (Immunoglobulin Heavy Constant Gamma 1), suggesting a potential sex-dependent modulation of humoral immunity during TB. Together, these findings demonstrate that biological sex shapes immune cell programming and host-pathogen interactions during TB, underscoring the importance of incorporating sex as a biological variable in TB research and therapeutic development. IMPORTANCE Men and women often respond differently to diseases like tuberculosis (TB), with men typically facing more severe illness, though the underlying reasons are unclear. To this end, our study investigated how male and female mice combat TB infection at a cellular and molecular level. We discovered that female mice controlled TB more effectively, as their immune systems activated specific pathways to break down and clear bacteria efficiently. Conversely, male mice showed higher bacterial loads and triggered more inflammatory, yet less effective, immune responses. Crucially, despite similar numbers of key immune cells (macrophages) in the lungs, their functional responses differed significantly by sex. These findings underscore that biological sex profoundly impacts the immune system’s fight against TB, paving the way for more personalized treatments and improved outcomes for all. Men and women often respond differently to diseases like tuberculosis (TB), with men typically facing more severe illness, though the underlying reasons are unclear. To this end, our study investigated how male and female mice combat TB infection at a cellular and molecular level. We discovered that female mice controlled TB more effectively, as their immune systems activated specific pathways to break down and clear bacteria efficiently. Conversely, male mice showed higher bacterial loads and triggered more inflammatory, yet less effective, immune responses. Crucially, despite similar numbers of key immune cells (macrophages) in the lungs, their functional responses differed significantly by sex. These findings underscore that biological sex profoundly impacts the immune system’s fight against TB, paving the way for more personalized treatments and improved outcomes for all.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a4287a0838a97c49b64dc2f6538c24df65cefe80" target='_blank'>
              Sex-specific transcriptional regulation in lung macrophages during sub-acute Mycobacterium tuberculosis infection
              </a>
            </td>
          <td>
            D. Dhanyalayam, Hariprasad Thangavel, Kezia Lizardo, Jigar V. Desai, J. Nagajyothi
          </td>
          <td>2025-11-12</td>
          <td>Microbiology Spectrum</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="The Natterin protein family represents an evolutionarily conserved group of immune effectors in teleosts, yet its broader regulatory role in host defense remains poorly understood. Here, we demonstrate that Natterin functions as a master upstream regulator, orchestrating a critical immune network that integrates type I interferon (IFN-I) signaling with non-canonical inflammasome activation during Salmonella Typhimurium (ST) challenge. Using wild-type embryos treated with IFN-I neutralizing antibody followed by the use of natterin (loc795232) knockout (KO) embryos generated by CRISPR/Cas9 and integrated approaches—including RT-qPCR, Western blotting, immunohistochemistry, and behavioral assays—we found that its absence completely abrogates the ST-induced IFN-I response, including the ablation of the interferon regulatory factors irf3 and irf7 and the IFN-φ1 receptor crfb1. Consequently, Natterin deficiency prevented the expression of the LPS sensor GBP4 and the proteolytic maturation of the inflammatory caspases Caspy and Caspy2. This disruption abolished downstream gsdme-a/b expression, which may result in the non-formation of pores. The critical role of IFN-I signaling was independently confirmed by its neutralization in wild-type embryos, which abolished the protein-level localization of IL-1β and IFN-β and mirrored the KO phenotype. Functionally, this disruption led to a sixfold increase in mortality and exacerbated ST-induced pathogenesis. Our results establish Natterin not merely as an effector molecule but as a pivotal regulator that integrates IFN-I and inflammasome signaling, orchestrating a coordinated immune response essential for host survival. This work reveals a previously unrecognized level of regulation in teleost innate immunity with significant evolutionary parallels to mammalian defense mechanisms.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/50b7032e9ba4954a47afe09a04d6af4c891a32f1" target='_blank'>
              Natterin bridges IFN-φ1 and non-canonical inflammasome pathways via CRFB1/Gbp4 to license Caspy2-mediated antibacterial immunity
              </a>
            </td>
          <td>
            Darlan Gusso, Felipe Justiniano Pinto, Aline Ingrid Andrade-Barros, Jefferson Thiago Gonçalves Bernardo, Carlos DeOcesano-Pereira, M. Lopes-Ferreira, Carla Lima
          </td>
          <td>2025-10-27</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="Background
Little information is available on the immune signaling pathway that drives severe COVID-19 in asthma. Our study evaluates the association between immune dysfunction and progression to severe COVID-19 in asthma using single-cell RNA sequencing.


Methods
Four patients with asthma and eight patients without asthma from three centers in South Korea were used for this analysis. For each patient, samples were collected over three-time points: at the time of COVID-19 infection, one week later, and two weeks later.


Results
They were classified into four groups according to the presence or absence of asthma and COVID-19 severity; non-asthma/mild COVID-19 (n=5), non-asthma/severe COVID-19 (n=3), asthma/mild COVID-19 (n=3), and asthma/severe COVID-19 (n=1) groups. A high-quality scRNA-seq dataset composed of 155,565 cells was generated that characterized peripheral immune cells. When the proportion of cell type was analyzed by time points, a decrease in T-cells was shown at the second time point in asthma/severe COVID-19 group compared to other groups. When the proportion of T-cell subtype was analyzed by time points, an increase in the proportion of CD8+ T cell was shown at the second time point in asthma/severe COVID-19 group than in other groups: in DEG analysis, notably, we observed relatively higher levels of cytotoxicity-related genes in asthma/severe COVID-19 compared to other groups.


Conclusion
Our study provides new insights into the mechanisms underlying the progression of COVID-19 infection in patients with asthma. A reduction in the proportion of T cells while expanding cytotoxic CD8+ T cell proportion was associated with severe COVID-19 presentation in asthma.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/024d563473f02b1257c1b2dc0e7510521f7669e6" target='_blank'>
              T cell immune dysfunction and progression to severe COVID-19 in asthma revealed by single-cell RNA sequencing.
              </a>
            </td>
          <td>
            B. Kim, Youlim Kim, Sang Hoon Lee, Siyoung Lee, Minjun Choi, Byeongchan Lee, Jae Seok Jeong, Sang-Heon Kim, Hyun Lee, Kwang Ha Yoo
          </td>
          <td>2025-11-18</td>
          <td>Tuberculosis and respiratory diseases</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Sepsis remains a leading global cause of death, with immune heterogeneity’s molecular mechanisms poorly understood. This study analyzed 1,862 human peripheral blood samples, constructing a molecular interaction disturbance network that first revealed the network biology underlying sepsis immune heterogeneity. We identified 3 sepsis subtypes with marked different prognostic characteristics, with the C1 subtype showing the worst prognosis characterized by severe CD4+ T cell exhaustion—validated across 10 independent cohorts. Integrating single-cell transcriptomics from over 450,000 cells, proteomics, and functional validation, we identified monocyte-derived matrix metalloproteinase-9 (MMP9) as a key regulator driving CD4+ T cell dysfunction. Mechanistically, MMP9 modulates T cell exhaustion through dual mechanisms: promoting leukocyte-associated immunoglobulin-like receptor-1 (Lair-1) aggregation on T cell membranes, directly inhibiting zeta chain of T cell receptor associated protein kinase 70 (ZAP70) phosphorylation in T cell receptor signaling, while impairing Ca2+-release-activated Ca2+ channel function and intracellular calcium clearance, causing calcium dysregulation that blocks nuclear factor of activated T cells (NFAT) activation and nuclear translocation. The selective MMP9 inhibitor MMP9-in-1 effectively reversed T cell dysfunction, restored calcium homeostasis and NFAT nuclear translocation, markedly enhanced CD4+ T cell interleukin-2 and interferon-γ production, and reduced programmed cell death protein 1 expression. This work establishes a comprehensive translational framework from molecular network disturbances to clinical phenotypes, advancing sepsis immunopathophysiology understanding and providing effective targets for the treatment of sepsis patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/669347da1bb81250d0a1cfa9e2302d53bc332296" target='_blank'>
              Targeting Matrix Metalloproteinase-9 to Alleviate T Cell Exhaustion and Improve Sepsis Prognosis
              </a>
            </td>
          <td>
            Xuan Wang, Jingyuan Ning, Liang Zhou, Hongru Li, Jinlei Cui, Jiachao Wang, Xiangyang Liang, Jinquan Li, Miao Li, Xue Gao, Wen-jian Li, Xing Chen, Fei Yu, Lin Wei, Cuiqing Ma
          </td>
          <td>2025-11-02</td>
          <td>Research</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="COVID‐19 research now provides a coherent picture of the virus's immunological impacts, highlighting immune‐evasion mechanisms, the particular vulnerabilities of patients with inborn errors of immunity (IEI), and evolving therapeutics for severe disease. SARS‐CoV‐2 exploits ACE2 for cell entry and can utilise CD147 to infect immune cells, undermining antiviral defences; recent work details cytokine storm biology, NLRP3 inflammasome activation, and suppression of type I interferon responses. IEI patients are disproportionately affected, often with severe, prolonged courses and persistent PCR positivity. Therapeutic approaches such as convalescent plasma, anti‐cytokine agents interferon alpha‐2b, and plasma exchange show variable effectiveness, while vaccine performance is challenged by ongoing viral evolution. Together, these insights underscore the need for tailored treatment strategies for IEI populations, vigilant monitoring for immune‐escape variants, and continuous adaptation of therapeutic and preventive measures. The aim of this review is to synthesise these findings, evaluate their implications for clinical management, and highlight future directions for research and patient care.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1f582b3a29cce6c91c09a0b1c7c85ccffbfc52a0" target='_blank'>
              Lessons From COVID‐19 on Inborn Errors of Immunity: A Five‐Year Narrative Review
              </a>
            </td>
          <td>
            Gamze Sonmez, Gizem Gunduz, S. Esenboğa, D. Çağdaş
          </td>
          <td>2025-10-28</td>
          <td>Scandinavian Journal of Immunology</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="Background Recurrent miscarriage (RM), characterized by the loss of two or more consecutive pregnancies, is a significant challenge in reproductive medicine. While immunological dysregulation is increasingly recognized as a key contributor, the role of innate immunity, particularly neutrophils, remains underexplored. Understanding neutrophil-driven immune mechanisms may provide novel diagnostic and therapeutic insights for RM. Methods We integrated bulk transcriptomic datasets from RM, autoimmune diseases, and decidua single-cell RNA sequencing data. Differentially expressed genes (DEGs) and enriched pathways were identified, and intercellular communication was analyzed using CellChat. Key genes (KGs) were validated through ROC analysis, nomogram modeling, and experimental validation in trophoblast cells. Results Single-cell profiling revealed increased neutrophil proportions and distinct activation states in RM. Neutrophils exhibited a TNF-α-driven polarized phenotype with upregulated oxidative stress and antigen presentation. Intercellular communication analysis identified the APP-CD74 axis as a key signaling pathway. CXCL1 and related genes were consistently upregulated and showed strong diagnostic performance. Molecular docking identified potential therapeutic compounds targeting CXCL1, and in vitro assays confirmed immune-mediated trophoblast injury. Conclusions Neutrophil-driven immune dysregulation, with TNF-α-polarized neutrophils and APP–CD74 signaling, contributes to RM pathogenesis. CXCL1 and related genes serve as promising biomarkers, offering new opportunities for early diagnosis and therapeutic intervention.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/260d710e2e29f18d73188670fe733dcdddcf047d" target='_blank'>
              Neutrophil-mediated immune dysregulation in recurrent miscarriage: implications of APP–CD74 signaling and CXCL1 as diagnostic biomarkers
              </a>
            </td>
          <td>
            Shan He, Fei Ma, Meng Yu, Jia-man Wu, , Ke-wang Luo, Hong Chang, Qi Liang, Yan Ning
          </td>
          <td>2025-12-04</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="The effects of antiretroviral therapy (ART) and treatment interruption on myeloid cell egress from the central nervous system (CNS) during human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infection remain poorly defined. We hypothesized that CNS macrophages normally traffic out of the CNS, accumulate during viral infection and inflammation, and are released as inflammation resolves. To test this, we administered intracisternal (i.c.) injections of two different colored fluorescent superparamagnetic iron oxide nanoparticles (SPION) to SIV-infected macaques either early in infection (12–14 dpi) or 30 days before necropsy. SPION are preferentially taken up by perivascular, meningeal, and choroid plexus macrophages, enabling us to track macrophage turnover, infection, and migration. In non-infected macaques, SPION+ macrophages trafficked from the CNS to peripheral sites including the deep cervical lymph node (dCLN), lumbar lymph nodes, spleen, and dorsal root ganglia (DRG). With SIV infection, these cells accumulated in the CNS and showed reduced peripheral trafficking. ART decreased the number of SPION+ perivascular macrophages, and to a lesser extent, meningeal or choroid plexus macrophages. After ART interruption, SPION+ perivascular and choroid plexus macrophage numbers remained stable, whereas SPION+ meningeal macrophages increased. ART eliminated SIV-RNA+ perivascular macrophages, leaving few- scattered SIV-RNA+ cells in the meninges and choroid plexus. Following ART interruption, perivascular macrophages remained virus-negative, but scattered viral RNA+ meningeal macrophages persisted. In non-infected macaques, SPION+ macrophages trafficked to the dCLN, spleen, and DRG, but this trafficking diminished with SIV infection and AIDS with SIVE. Importantly, SIV-RNA+ SPION+ macrophages that exited the CNS were cleared by ART and did not reappear after treatment interruption. Using two differently colored SPION to assess establishment of CNS viral reservoirs, we observed higher numbers of early-labeled macrophages within and outside the CNS in animals with AIDS and SIVE, ART treatment, and ART interruption. These findings support a model in which SIV-infected perivascular macrophages seed an early CNS viral reservoir, while the meninges and choroid plexus undergo continual viral seeding during infection. ART reduces trafficking of infected macrophages out of the CNS and clears the perivascular macrophage reservoir, but SIV-RNA+ meningeal macrophages can persist, in low numbers, and can rebound after ART interruption.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/978817c1cd51902524161c071846dc82c1a681a8" target='_blank'>
              Resolving inflammation: The impact of antiretroviral therapy on macrophage traffic in and out of the CNS
              </a>
            </td>
          <td>
            Zoey K. Wallis, C. Midkiff, Miaoyun Zhao, P. Autissier, Soon Ok Kim, Addison Q. Amadeck, Yiwei Wang, M. Jakubowski, Tricia H Burdo, Andrew D. Miller, Qingsheng Li, Xavier Alvarez, Robert V. Blair, Kenneth C Williams
          </td>
          <td>2025-12-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Macrophages are crucial for neuroinflammatory responses following traumatic brain injury (TBI), encompassing various subtypes, such as border-associated macrophages (BAMs) that contribute to both brain damage and repair. However, the pathophysiological relevance of subtype-specific molecular markers is poorly understood. This study investigated the role of the BAM marker mannose receptor C-type 1 (MRC1, also known as CD206) during the early phase of TBI using controlled cortical impact (CCI). MRC1 gene expression was up-regulated, peaking between 3 to 7 days post-injury (dpi), and MRC1 protein expression predominantly localized to BAMs. To assess pathophysiological relevance, MRC1-deficient (MRC1-KO) and wild-type littermates (MRC1-WT) were examined following CCI for early neurological deficits, brain structural damage, intracerebral hematoma, and neuroinflammatory marker expression. At 5 dpi, MRC1-KO mice showed increased brain lesion volume and hippocampal neuron loss, with minor differences in neurological deficits compared to MRC1-WT mice. Intracerebral hematoma size increased in male but remained unchanged in female MRC1-KO mice. Immunostaining revealed no genotype-specific effects on GFAP+ astrocytes, while the number of perilesional CD68+ macrophages/microglia were reduced in MRC1-KO mice. Analysis of neuroinflammatory gene markers revealed an overall reduction in MRC1-KO mice. Sex-specific regulation was observed for the M2-like macrophage/microglia marker Arg1, with decreased expression in male and increased expression in female MRC1-KO compared to MRC1-WT mice. In conclusion, lack of MRC1 exacerbated brain tissue damage following experimental TBI. Reduced CD68+ macrophages/microglia and neuroinflammatory marker expression suggests impaired neuroinflammatory response in MRC1-KO, indicating MRC1 expression on BAMs contributes to beneficial early neuroinflammatory response following TBI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1ac5ec2bb9a4f897f1ee154ba78ff99b4c7b8daa" target='_blank'>
              The border-associated macrophage marker MRC1 contributes to an early neuroprotective inflammatory response to traumatic brain injury in mice
              </a>
            </td>
          <td>
            Jenny Strehle, Pawit Somnuke, Shuailong Li, Sudena Wang, Tobias Hirnet, Yong Wang, Michael K. E. Schäfer
          </td>
          <td>2025-10-30</td>
          <td>Acta Neuropathologica Communications</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="


 Background SARS-CoV-2 causes a severe pulmonary infection. Few studies to date have addressed the immune response in the lungs of human cases of COVID-19 or longitudinally sampled at intervals of time from symptom onset. To address this we performed Imaging Mass Cytometry (IMC) on lung tissue from fatal cases of COVID-19. Methods Lung tissue from 45 autopsy cases of COVID-19 was labeled with a 39-marker panel of metal-conjugated antibodies for IMC. Adjacent tissue was used for nucleic acid extraction to quantify SARS-CoV-2 nucleocapsid RNA by digital droplet PCR and SARS-CoV-2 sub-genomic RNA (sgRNA). Results Patients with positive SARS-CoV-2 sgRNA had a higher viral burden (414.9 vs 0.0126 copies/ng RNA, p < 0.0001) and a shorter interval to death (7.5 vs 29 days, p < 0.0001). Patients with positive sgRNA had fewer CD4 T cells (33.5 vs 103, p = 0.0029), CD8 T cells (25 vs 91, p = 0.0098), and B cells (19.5 vs 52, p = 0.0145) per lung region of interest (ROI). There was no significant difference between the number of neutrophils (422 vs 742, p = 0.0623) or macrophages (390 vs 567, p = 0.397) per ROI. Conclusions We found that lymphocytes significantly increase in the lungs of patients who died from COVID-19 after viral replication ceases. This may be due to inhibition of cellular immunity by actively replicating virus or reflect clearance of the virus by lymphocytes. Additional work is required to characterize the phenotype and activation status of immune cells in these tissues.



 This work was supported by the Intramural Research Program, NIAID, NIH



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4a5bef4f1a984300b936791ad4900d2916514b1e" target='_blank'>
              Lymphocytic infiltration in the lungs of fatal cases of COVID-19 coincides with cessation of viral replication 4444
              </a>
            </td>
          <td>
            Andrew P. Platt, Paul Mallory, Sabrina C. Ramelli, Ashley Cardamone, Christine Newkirk, Sydney R. Stein, Manmeet Singh, Kevin M. Vannella, Devynn Breen, Abigail Atkinson, E. de Wit, D. Kleiner, Stephen M. Hewitt, M. Pore, Daniel Chertow
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>62</td>
        </tr>

        <tr id="The Coronavirus Disease 2019 (COVID-19) pandemic, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has revealed the virus's ability to induce multi-organ damage, including significant liver injury. The molecular mechanisms of liver dysfunction in COVID-19 patients are explored, focusing on direct viral infection, immune-mediated damage, and the gut-liver axis. SARS-CoV-2 enters liver cells through the Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2) receptors, but alternative pathways, such as CD209/Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin (DC-SIGN) and AXL receptors, can also contribute to viral entry. Additionally, immune responses, particularly the cytokine storm, exacerbate liver inflammation, leading to hepatocyte damage. Pre-existing liver conditions, such as metabolic-associated fatty liver disease (MAFLD), alcohol-related liver disease (ALD), and liver fibrosis, heighten the risk of severe outcomes in COVID-19 patients. Post-COVID-19 liver complications, including fibrosis progression and persistent liver damage, have been reported, with emerging evidence suggesting chronic inflammation, viral persistence, and autoimmune reactions as potential contributors. Furthermore, Drug-Induced Liver Injury (DILI) from COVID-19 treatments remains a concern, highlighting the need for careful management. Consequently, understanding the interplay between SARS-CoV-2 and the liver is critical for improving patient outcomes and developing targeted therapies to mitigate liver-related complications in both acute and Long COVID-19 phases. This article is categorized under: Infectious Diseases > Molecular and Cellular Physiology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d8e7ab48363fa154c104250ae482911ee316a6df" target='_blank'>
              SARS-CoV-2: A Liver Brief.
              </a>
            </td>
          <td>
            Youness Limami, Hicham Wahnou, Martin Ndayambaje, Soufyane Hba, Oumaima Chgari, Mounia Ammara, Riad El Kebbaj, Abdallah Naya, M. Oudghiri, Raphael Georges Duval
          </td>
          <td>2025-11-01</td>
          <td>WIREs mechanisms of disease</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c50d95b7ee1f0918516a315eb52760cde23237c7" target='_blank'>
              Ferrapoptosis: Discovery of a Hybrid Programmed Cell Death
              </a>
            </td>
          <td>
            Qiuyun Yang, Yang Chen, Yang Shen, Xiao Zhang, Xianliang Chen, Xinnan Zhao, Ruixuan Yuan, Manrui Li, Yang Xu, Xilong Lin, Yihan Sun, Shengyuan Zuo, Xinyang Liu, Zhuo Li, Ying Chen, Shichun Wang, Meili Lv, Lin Zhang, Weibo Liang, Xiameng Chen
          </td>
          <td>2025-11-27</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Neurotropic viruses, such as Japanese encephalitis virus (JEV), trigger central nervous system (CNS) inflammation primarily through disruption of the blood–brain barrier (BBB) and infiltration of peripheral immune cells. Although the gut microbiota is known to regulate diverse immunopathological processes, its contribution to CNS neuroinflammation and systemic immune responses during neurotropic viral infection remains poorly understood. Here, we show that depletion of gut microbiota by antibiotic cocktail treatment markedly increases susceptibility to CNS neuroinflammation following JEV infection. Loss of microbiota promoted viral dissemination into extraneural tissues, aggravated systemic inflammation and organ damage, and impaired tonic type I interferon (IFN-I) responses and hematopoietic differentiation during disease progression. Remarkably, fecal microbiota transplantation (FMT) restored resistance to CNS neuroinflammation, highlighting the protective role of the microbiota. Moreover, ampicillin-mediated depletion of specific gram-positive bacteria—including Bifidobacterium, Faecalibaculum, Ligilactobacillus, and Turicibacter—was associated with enhanced viral spread, systemic inflammation, and organ injury, accompanied by distinct shifts in fecal metabolites. Collectively, these findings demonstrate that gut microbiota–driven tonic IFN-I responses limit viral dissemination in extraneural tissues, thereby attenuating systemic inflammation and protecting against CNS neuroinflammation, particularly viral encephalitis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/05dc7ecb536c1f8f63866db104e2581d4fc3e266" target='_blank'>
              The gut microbiota limits systemic inflammation during neurotrophic viral CNS infection by priming tonic type I interferon signaling
              </a>
            </td>
          <td>
            Hye Won Cho, Hee Won Byeon, S. Park, Erdenebileg Uyangaa, Jin Young Choi, Koanhoi Kim, S. Eo
          </td>
          <td>2025-11-04</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/96d3861c110e5ae3f35e700cedd4412c7f059c98" target='_blank'>
              T-cell Multiomic Analysis Identifies Subsets and Mechanisms of Interaction with Epithelial Cells in Idiopathic Pulmonary Fibrosis
              </a>
            </td>
          <td>
            A. Serezani, Julia M. R. Bazzano, B. Pascoalino, Ludmilla da Silva, Abigail J. Dietrich, Chase J. Taylor, T. Sherrill, C. Calvi, Paula I. Gonzalez-Ericsson, E. Wilfong, Matthew D Bacchetta, C. Shaver, Lorraine B. Ware, M.L. Salisbury, Luc Van Kaer, N. Banovich, JA Kropski, Timothy S. Blackwell
          </td>
          <td>2025-11-19</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="


 Peroxisomes are vital yet often overlooked metabolic organelles. Here we demonstrate that exuberant interferon signaling remodeled the macrophage peroxisome compartment after severe COVID-19. Lack of macrophage peroxisomes resulted in impaired inflammation resolution and defective lung repair, causing heightened acute morbidity and mortality during SARS-CoV-2 infection. Peroxisomes exhibited cell-type specific modulation of lipid metabolism, enhancing mitochondrial health critical for lung macrophage repair program and alveolar cell self-renewal. Peroxisomes also prevented excessive inflammasome activation and IL-1β release, thereby limiting the accumulation of KRT8high dysplastic epithelial progenitors and facilitating their proper differentiation into functional alveolar cells post viral injury. Dysfunction in macrophage peroxisomes contributed to chronic lung pathology and fibrosis post SARS-CoV-2 infection. Furthermore, pharmacologically enhancing peroxisome biogenesis mitigated acute symptoms and limited chronic sequelae post SARS-CoV-2 infection (PASC). Our data reveal a peroxisome-centric pro-recovery therapeutic strategy for managing both acute and chronic conditions after respiratory viral infections.



 The study was in part supported by the US National Institutes of Health grants AI147394, AG069264, AI112844, HL170961, AI176171 and AI154598 to J.S, R01HL132287, R01HL167202 and R01HL132177 to Y.M.S, F31HL170746 and T32AI007496 to H.N, R01HL155759 and R01HL159953 to P.C, P01-HL108793 to D.J, and HL159675, HL152293 and AI163753 to J.Q.



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/31916c623de231a4bb589cd8541da198e144c336" target='_blank'>
              Macrophage peroxisomes guide alveolar regeneration and limit post-acute sequelae of SARS-CoV-2 infection (PASC) 2101
              </a>
            </td>
          <td>
            Xiaoqin Wei, Jie Sun
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Sepsis, a life-threatening organ dysfunction caused by a dysregulated host response to infection, affects over 19 million people annually world-wide [1–3]. It involves excessive immune activation, leading to systemic inflammatory response syndrome (SIRS) and a potential multiple organ failure [4]. Current treatments include antibiotics, fluid resuscitation, and mechanical ventilation; however, management challenges persist [5]. Neutrophils play a crucial but incompletely understood role in sepsis pathogenesis [6]. Recent advances in single-cell sequencing and Mendelian randomization have offered new opportunities for investigating disease mechanisms [7]. These technologies enable a comprehensive analysis of neutrophil function and regulatory networks at an unprecedented resolution [8]. This study integrated single-cell RNA sequencing with Mendelian randomization to elucidate neutrophil-associated molecular mechanisms in sepsis. By analyzing neutrophil transcriptomics and applying causal inference approaches, we aimed to uncover the functional alterations and regulatory networks">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c7a41bbca9fa203ba63933b88a084809a69a23b3" target='_blank'>
              Molecular mechanisms related to neutrophils in sepsis using single-cell sequencing combined with Mendelian randomization analysis
              </a>
            </td>
          <td>
            Ran Li, Yiwen Wang, Simiao Chen, M. Zhuang, Yong Sun
          </td>
          <td>2025-10-31</td>
          <td>Archives of Medical Science : AMS</td>
          <td>1</td>
          <td>8</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0e2cd0bbb1e59a38e076fba7a9569f36e691a9aa" target='_blank'>
              SARS-CoV-2 infection induced alterations in ADAR editing patterns differ between patients who developed critical compared to non-critical COVID-19
              </a>
            </td>
          <td>
            A. M. Nair, H. Piontkivska
          </td>
          <td>2025-10-24</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ff36a4b1a6924bc75f6af8503f56e2c97056bea0" target='_blank'>
              Dormant viral pathways underlie space-induced neural senescence – a neuroprotective strategy for spaceflight and neurological diseases
              </a>
            </td>
          <td>
            A. M. Martins, Hideyuki Nakashima, Angela Macia, Taichi Umeyama, Satoshi Miyashita, Livia Luz de Souza Nascimento, Luisa Bulcao Vieira Coelho, Pinar Mesci, Erik Viirre, Nicole Suarez, Aurian Saleh, Alex Savchenko, Beatriz Freitas, Aline L. Leite, Diego M. Assis, Masataka Ishizu, Tomoo Owa, Mikio Hoshino, John R. Yates, Kinichi Nakashima, A. Muotri
          </td>
          <td>2025-11-04</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>68</td>
        </tr>

        <tr id="A major health challenge resulting from the COVID-19 pandemic is the manifestation of post-acute sequelae of SARS-CoV-2 (PASC). PASC (or long COVID) is a collective term used for clinical symptoms, various pathologies, and life-quality-changing functional impairment that persist for months to years after the initial SARS-CoV-2 infection. The mechanisms underlying PASC are not understood, although advances have been made in identifying factors that may contribute to long-term pathology. Recent data have emerged, showing an association between SARS-CoV-2 viral persistence and non-SARS-CoV-2 infections (pre-existing, viral reactivation, or new infections) in facilitating or mediating PASC. However, the heterogeneous nature and timing of co-infections have made it challenging to understand, interpret, and contextualize their contribution to PASC. Here, we summarize the impact of potential viral, bacterial, and fungal infections on SARS-CoV-2 pathogenesis, with a focus on their possible roles in the development of PASC. We also provide a framework to understand the mechanisms of PASC and inform basic, translational, and clinical research initiatives, including RECOVER, a large and ongoing research initiative to understand, treat, and prevent long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/000f98d578723e631538234351febf6a80fd995b" target='_blank'>
              The role of co-infection in the pathogenesis of acute SARS-CoV-2 infection and development of post-acute sequelae: A perspective
              </a>
            </td>
          <td>
            T. Henrich, Christopher P Montgomery, Joerg Graf, Nahed Ismali, S. Mohandas, Mehul Suthar, Hassan Brim, John M Coffin, Aayush Pagaria, Jeisac Guzmán Rivera, Urmila Vudali, P.S. Keim, Guangming Zhong, Rebecca McGrath, Belinda Edwards, Adolfo García-Sastre, M. Gennaro
          </td>
          <td>2025-11-17</td>
          <td>eLife</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/730bda77c6f77da1330b66ac6126520d39d7c77d" target='_blank'>
              Longitudinal gene expression analysis in COVID-19 sepsis highlights dynamic immune, cellular, and metabolic dysfunction in high severity patients.
              </a>
            </td>
          <td>
            Andy An, Arjun Baghela, Peter Zhang, Travis M. Blimkie, Jeff Gauthier, Daniel E Kaufmann, E. Acton, Amy H. Lee, Roger C. Levesque, Robert E. W. Hancock
          </td>
          <td>2025-12-19</td>
          <td>Scientific reports</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/29fe25ea72e27bc7febd50ceacab0f0b8d2a1098" target='_blank'>
              SARS-CoV-2 infection and gut-lung axis: the potential role of rifaximin.
              </a>
            </td>
          <td>
            T. N. Almanaa, H. Al-kuraishy, A. Al-Gareeb, Maii A. Abdelnaby, A. Alexiou, M. Papadakis, Islam E Abo-ElFetoh, G. Batiha
          </td>
          <td>2025-12-18</td>
          <td>Inflammopharmacology</td>
          <td>0</td>
          <td>52</td>
        </tr>

        <tr id="Influenza A virus (IAV) is a prevalent pathogen that causes severe respiratory infections worldwide. Currently, the incidence of coinfections between IAV and Gram-negative bacteria has been steadily increasing, and the synergistic interaction between IAV infection and bacterial exposure represents a pivotal risk factor for disease exacerbation. Lipopolysaccharide (LPS), a major Gram-negative bacterial virulence factor, is hypothesized to regulate IAV-induced immune response intensity and disease severity by reshaping the pulmonary immune microenvironment. Here, we established an in vivo coadministration model via intratracheal instillation of low-dose LPS and H1N1 to dissect their synergistic pathogenesis. LPS exposure potentiated H1N1-induced severe lung injury, manifested as persistent neutrophil and monocyte infiltration, elevated levels of cytokines (e.g., CXCL1, CCL2, and IL-6), and alveolar damage without affecting viral replication. Mechanistically, LPS triggered immune hyperactivation through early neutrophil recruitment, neutrophil extracellular trap (NET) formation, and a self-sustaining positive feedback loop. Intervention experiments revealed that the degradation of NETs by DNase I or neutrophil inhibition significantly alleviated lung damage and systemic inflammatory responses. This study establishes NET-driven innate immune amplification as a key mechanism underlying LPS-enhanced H1N1 pathogenicity, offers an immunomodulatory approach for severe bacterial-viral coinfections, and underscores the parity of immunomodulatory therapy with anti-infective treatment.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8a8204eba4e3f2c05f83c187d56985bc21d9c8f7" target='_blank'>
              Exposure to bacterial lipopolysaccharide aggravates H1N1-mediated lung immunopathology via neutrophil extracellular trap formation
              </a>
            </td>
          <td>
            Guiling Yan, Zhongwen Hu, Yuanyuan Peng, Yuqin Tu, Jingling Xie, Yuchao Zhong, Changchun Niu, Yang Luo
          </td>
          <td>2025-11-18</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="


 Vaccination is essential for preventing viral infections and promoting public health; however, its efficacy may vary due to factors such as the nature of the pathogen, vaccine type, and individual immune response. It is known that intranasal immunizations can enhance the immune response by stimulating tissue-resident memory T cells (TRMs), which promote early viral clearance at the infection site. Our study aims to optimize the generation and maintenance of TRMs in the lungs using purinergic signaling components as adjuvants. For this, we crossed B knockout mice with hACE2 mice, generating a B cell-deficient lineage capable of internalizing active SARS-CoV-2 (BKO-hACE2). C57BL/6 and BKO-hACE2 mice were immunized with inactivated SARS-CoV-2 receiving one intravenous dose followed by three intranasal booster doses. After 30 days, lungs were analyzed by flow cytometry and histopathology. Additionally, we evaluated the effects of ATP (0.5 mM to 10 mM) during immunizations, finding that lower doses (0.5 mM) increased the frequency of TRMs (CD4+ and CD8+), while higher doses reduced this population. This suggests that ATP may interact with the P2X7 receptor, promoting either proliferation or cell death. Although infection data did not provide conclusive evidence of T cell-mediated protection in the absence of antibodies, the potential of ATP as a possible adjuvant opens new avenues for enhancing immune responses in experimental models.



 FAPESP - 2023/15373-9



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/988c1a539848238549c2d61fd24576f4f991f375" target='_blank'>
              Enhancing lung immunity against COVID-19: the role of ATP in TRM cell generation 9389
              </a>
            </td>
          <td>
            Marcos Vinícios Pinheiro Cione, Igor Santiago-Carvalho, Luciana dos Santos Barros Manhaes, Rodrigo Jose Rocha Xavier Freitas, Rogério Silva do Nascimento, Viviane Fongaro Botosso, Ana Marcia Sá Guimarães, Henrique Borges da Silva, Jose Maria Alvarez Mosig, M. R. D'Império Lima
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Respiratory syncytial virus (RSV), a filamentous, enveloped, negative-sense, single-stranded RNA virus, is a common cause of respiratory infections in pediatric and elderly populations, often leading to severe inflammation and lung damage. To date, there is no effective treatment for RSV infection. Therefore, elucidating the antiviral mechanism in RSV infection is critical for identifying potential effective therapeutic targets. Type I interferons (IFN-Is), especially IFN-β, play a key role in the immediate immune response against viral infection by inhibiting viral load and spread. Current studies have shown that ARCN1 (archain 1), the δ subunit of the coat protein complex I complex, is involved in intra-Golgi trafficking and protein transport from the Golgi apparatus back to the endoplasmic reticulum. In this study, we demonstrate that ARCN1 suppresses the anti-RSV innate immune response by promoting E3 ubiquitin ligase STUB1-mediated K48-linked polyubiquitination and subsequent proteasomal degradation of IKKε. Mechanistically, ARCN1 recognizes and binds to the δL motif of STUB1 via its flexible MHD domain while interacting with IKKε. This finding provides a theoretical basis for the development of new antiviral treatment strategies targeting ARCN1.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/32c87ced4d49da7da6a4806fe632d757e2e9e8ee" target='_blank'>
              ARCN1 suppresses innate immune responses against respiratory syncytial virus by promoting STUB1-mediated IKKε degradation
              </a>
            </td>
          <td>
            Jiamin Cai, Yunfei Ye, Zhengrong Chen, Fei Xu, Xiaoping Li, Mengyun Wu, Ji Zhou, Yu Shao, Peijie Zhu, Jing Zhao, Jingjing Hu, Yufeng Wang, Cancheng Li, Xiaoyu Tian, Beibei Huang, Tian Xia, Wenjun Wang, Chuangli Hao, Yi Yang, Jinping Zhang
          </td>
          <td>2025-12-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="T-cell exhaustion is a terminal state of immune dysfunction characterized by impaired proliferation and effector functions, diminished cytokine secretion, and sustained expression of inhibitory receptors. In coronavirus disease 2019 (COVID-19), increasing evidence links exhausted T-cell phenotypes with poor clinical outcomes, including severe disease, delayed viral clearance, and persistent symptoms associated with Long COVID. Exhaustion results from prolonged antigenic stimulation and inflammatory signals and is marked by transcriptional reprogramming, metabolic and epigenetic dysregulation, and co-expression of inhibitory receptors such as programmed cell death protein-1 (PD-1), T-cell immunoglobulin and mucin-domain containing-3 (TIM-3), and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Notably, exhausted phenotypes in COVID-19 frequently coexist with hyperactivation, raising the unresolved question of whether inhibitory receptor expression reflects transient activation or irreversible dysfunction. Emerging therapeutic strategies to reverse these dysfunctional states include immune checkpoint inhibitors, cytokine modulation, metabolic interventions, and epigenetic therapies, although their clinical translation remains at an early stage. Critical research gaps include the scarcity of longitudinal data, incomplete profiling of T-cell subsets across disease stages during COVID-19 and Long COVID-19, and contradictory evidence of vaccine-induced exhaustion with limited understanding of its consequences. This non-systematic literature review synthesizes current advances in COVID-19 immunopathology and therapeutic strategies, underscoring that understanding T-cell exhaustion is crucial to improving outcomes and shaping next-generation immunotherapies and vaccines.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fcda848fedb31d45bcaf7a6be07292887c93eed0" target='_blank'>
              T-cell exhaustion in COVID-19: what do we know?
              </a>
            </td>
          <td>
            Roderick Chen-Camaño, Rodrigo DeAntonio, S. López-Vergès
          </td>
          <td>2025-10-29</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="


 The COVID-19 pandemic remains a significant global challenge, with comorbidities like obesity and diabetes exacerbating the severe outcomes. However, the mechanisms driving heightened susceptibility in these populations are poorly understood. SARS-CoV-2 infection disrupts lipid metabolism pathways regulated by Phospholipase A2 and 12-Lipoxygenase (12-LOX), an enzyme producing pro-inflammatory lipids such as 12-S-hydroxy eicosatetraenoic acid (12-HETE). This study examined the role of 12-LOX in severe COVID-19-associated hyperinflammation and evaluated the therapeutic potential of 12-LOX inhibition. We found elevated 12-LOX expression in lung and pancreatic tissues of diabetic COVID-19 decedents compared to the diabetic individuals with non-COVID-respiratory deaths. In SARS-CoV-2-infected K18-hACE2 mice, 12-LOX expression increased in lung and pancreatic tissues, even without diabetes, mirroring human findings. Treatment with the 12-LOX inhibitor VLX-1005 improved survival in mice receiving high-challenge doses of SARS-CoV-2. VLX-1005 treatment downregulated 30 pro-inflammatory cytokine and chemokine genes while upregulating four anti-inflammatory genes. Treated mice exhibited reduced inflammation and lower viral loads in the lungs. Notably, 12-HETE was undetectable in VLX-1005-treated mice but significantly elevated in controls. These findings demonstrate that 12-LOX inhibition mitigates hyperinflammation and improves survival against severe COVID-19 infection.



 Veralox Therapeutics funded this research.



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f3243933421cc39c9103bb70aec0f64509f1226f" target='_blank'>
              12-Lipoxygenase Drives Hyperinflammatory Responses and Enhances COVID-19 Severity 9032
              </a>
            </td>
          <td>
            Chandra Shekhar Bakshi, M. D'Silva, Jerry L. Nadler, Dave Meloney
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="In nature, animals encounter diverse pathogens that trigger specific peripheral defense programs and elicit sickness behavior, a set of stereotyped physiological and behavioral changes thought to promote host fitness. Most studies to date have relied on one or a few mouse models of infection, limiting insights into pathogen-specific neuroimmune interactions that generate sickness. We hypothesized that different pathogens might elicit distinct sickness states by engaging different cell types and brain circuits. Using inflammatory models representing bacterial, viral, allergic, parasitic or colitis conditions, we assessed sickness across scales: organismal – behavior and physiology; cellular – brain-wide neural activity; and molecular – single-cell in situ transcriptomics in hypothalamus areas associated with social and homeostatic functions affected during sickness. Remarkably, immune challenges elicited unique repertoires of changes across all scales. Our findings reveal pathogen-specific sickness states encoded by the brain across scales, thereby broadening our understanding of how infections make us sick.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a973ce07eaa0ba52a5d26dc1ae4c7f5dadb199db" target='_blank'>
              Brain-immune interactions generate pathogen-specific sickness states
              </a>
            </td>
          <td>
            Zuri A. Sullivan, Bertrand J. Wong, Vikrant Kapoor, Paula Kathleen Vincze, Harris S. Kaplan, Pia Giraudet, Brianna R. Watson, Adel Misherghi, Sebastian Lourido, Jeffrey R. Moffitt, Catherine Dulac
          </td>
          <td>2025-12-08</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="


 Recent advances in single-cell transcriptomics have revealed significant heterogeneity in microglia, brain-resident macrophages that monitor the brain microenvironment. Disease-associated microglia (DAM), a unique transcriptional state, have been implicated in neurodegeneration and aging. Despite their critical role, the signaling pathways regulating DAM development and their function remain unclear. By overexpressing α-synuclein in neurons, our lab established a mouse model of Parkinson’s Disease (PD) that recapitulates microglial activation, immune cell infiltration, and dopaminergic neuron loss. In our model, we observed an expansion of the DAM transcriptional state and successfully characterized DAM accumulation at the protein level throughout PD progression. This accumulation coincides with reduced immune cell infiltration, linking DAM to chronic neuroinflammation. Using scATAC-seq, we identified transcription factors enriched in distinct microglial states: RelA motifs in acutely activated microglia and Irf4 motifs in DAM. Conditional knockout (cKO) of RelA in microglia reduced immune cell infiltration, whereas IRF4 cKO reduced protein expression of Clec7a, a DAM marker. By blocking transitions between different microglial states, our research aims to elucidate the function and role of α-synuclein-mediated DAM in PD progression and potentially establish DAM as a therapeutic target in neurodegenerative disorders.



 Aligning Science Across Parkinson’s: ASAP



 Neuroimmunology (NEUR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4da3d370218c60ccf242a6e1d980c70ae41a4936" target='_blank'>
              The role of α-synuclein-mediated disease-associated microglia in Parkinson’s disease 3319
              </a>
            </td>
          <td>
            Ya-Ting Yang, David A. Figge, Jhodi M. Webster, Aidan T. Miller, Asta Zane, A. Harms
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Objective Thyroid hormones (TH) are well-known regulators of the immune system. However, the precise immunomodulatory mechanisms of TH action in immune cells remain elusive. In a previous study, an essential role of the TH receptor α (TRα) in regulatory T cell (Treg) immunity was demonstrated, affecting Treg activation at steady state. The present study therefore aimed to unravel the biological relevance of altered TRα action in protective immune responses during disease. Methods To assess the role of TRα action in immune responses, especially T cell responses, during disease, different TRα signaling mouse models (TRαKO, complete lack of TRα signaling; TRαGS, lack of canonical signaling) were challenged with influenza virus A/PR8/34, and in-depth immune phenotyping was performed. Results Upon influenza virus infection, TRαGS mice, which lack canonical TRα signaling, showed prolonged survival and reduced disease severity, correlating with enhanced anti-inflammatory Treg and decreased pro-inflammatory CD4 and CD8 T cell responses. The loss of TRα action in TRαKO mice was related to elevated viral titers upon influenza virus infection, which correlated with increased inflammatory monocyte responses early during infection. Conclusion The present study demonstrates a complex role of TRα signaling in protective immune responses during disease, with distinct effects on innate and adaptive immune cells. By exploring the understudied link between the endocrine and immune systems, this study provides novel evidence for the role of TH as modulators of immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a7d2ba259d2172edff4c6833e354709fd3242434" target='_blank'>
              Thyroid hormone receptor α signaling shapes innate and adaptive immune responses during viral infection
              </a>
            </td>
          <td>
            Christina Wenzek, T. Knuschke, G. S. Hönes, A. Boelen, R. Klopfleisch, Denise Zwanziger, Heike Heuer, A. Westendorf, L. C. Moeller, Dagmar Führer
          </td>
          <td>2025-10-27</td>
          <td>European Thyroid Journal</td>
          <td>0</td>
          <td>48</td>
        </tr>

        <tr id="


 Foodborne Salmonella is a human health concern through consumption of contaminated products. However the pig immune response to Salmonella is minimally understood. To delineate the cell-type specific immune response toSalmonella, we used scRNA-seq analysis of peripheral blood mononuclear cells(PBMCs, n = 103,075) collected from five young pigs inoculated with Salmonella enterica serovar I 4,{5},12:i:- at day 0, 2 and 8. Nine major cell types were identified, including monocytes, pDCs, B, T, and NK cells. Differentially expressed (DE) genes were identified due to time after infection in many cell types. Gene ontology (GO) enrichment analysis of DE genes identified immune response-associated GO terms. For genes DE at day 2 versus day 0, examples (n=DEGs) include monocytes (4,718) with significant positive enrichment (SPE) of “innate immune response”; pDCs (48) had SPE of “negative regulation of viral process”; B cells (5,880) had SPE of “response to bacterium”; and CD4+ T cells (7,753) had SPE of “cellular response to cytokine stimulus”. DE genes in monocytes (d8/d2, n = 7,148) had significant depletion of the GO term “regulation of innate immune response”. We also have preliminary evidence of differential abundance of monocytes and other cell types at day 2 versus 0, which had substantially returned to baseline by day 8. Cell-type specific transcriptomic responses to Salmonella in porcine PBMCs can be mined to identify pathways for targeted enhancement of host response.



 USDA –NIFA AFRI Grant 2022-67015-37055



 Veterinary and Comparative Immunology (VET)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/58b5c47467a241d772aa1e68e6d4b9aac9a93673" target='_blank'>
              Single-cell transcriptomic analysis of PBMCs derived from salmonella-challenged pigs 2681
              </a>
            </td>
          <td>
            Carrie S Meeks, Mehak Kapoor, Kristen A. Byrne, J. Dekkers, Crystal L. Loving, Christopher K. Tuggle
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="


 Pathogenic human coronaviruses (hCoVs) cause severe respiratory illness and continue to challenge global public health. These hCoVs suppress anti-viral immunity and elicit excessive inflammation (dysregulated immunity) resulting in acute lung injury and fatal pneumonia. However, the key PAMPs and host factors that facilitate dysregulated immunity are not well understood. Therefore, using murine bone-marrow derived macrophages, we evaluated the mechanistic basis of SARS-CoV-2-induced dysregulated immunity. In novel findings, we show that SARS-CoV-2 structural protein- and viral-RNA-induced toll-like receptor (TLR)-extracellular regulated kinase (ERK)1/2 activity promotes dysregulated immunity in macrophages. Notably, blocking ERK1/2 activity not only reduced inflammatory cytokine response in viral RNA mimic and SARS-CoV-2 structural proteins-stimulated macrophages but also enhanced antiviral IFN-I response, whereas blocking other key inflammatory pathways such as p-38 MAPK, NF-kB, and JNK only suppressed inflammation, highlighting the unique role of ERK1/2 in facilitating hCoV-induced dysregulated immunity. We further show that inhibiting ERK1/2 activity reduced viral titers in SARS-CoV-2 infected human airway epithelial cells and improved survival in MA-CoV-2 infected mice. Collectively, we identify TLR-ERK1/2 signaling as novel pathway that drives SARS-CoV-2-induced dysregulated immunity and blocking this pathway will likely facilitate protective immunity to hCoV infections.



 NIH R21AI186028-01; NIH R01HL165423-01A1; NIH: P30GM149368-02



 Innate Immune Responses and Host Defense: Cellular Mechanisms (INC)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6727d234f219dfc749f31f2e6c430b70223abdc8" target='_blank'>
              Novel role of TLR-ERK1/2 activation in SARS-CoV-2-induced dysregulated immunity 3869
              </a>
            </td>
          <td>
            Rakshya Shrestha, Roshan Ghimire, Cody Whitley, P. Johnson, Rudra Channappanavar
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f6015d74c03081f1756895ea39d8fb38a3dc11ac" target='_blank'>
              Tissue-embedded CD4⁺ plasticity defines mucosal immunity in Inflammatory Bowel Disease
              </a>
            </td>
          <td>
            Q. Jiang, V. Merkus, C. Lindelauf, Nannan Guo, L. Ouboter, T. Höllt, P. Voorneveld, C. Meijer-Boekel, F. Koning, A.E. van der Meulen-de Jong, M. F. Pascutti, Vincent van Unen
          </td>
          <td>2025-12-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c22f0b52ca39d4620e978e81f4637672c39caa1d" target='_blank'>
              Cerebrospinal fluid transcriptional immune pathways linked to survival in HIV-associated tuberculous meningitis
              </a>
            </td>
          <td>
            Martineau Louine, Ravi Dandekar, Sumanth P. Reddy, Mary Karalius, Greer Waldrop, Shinyin Wang, J. Gakuru, S. Kimuda, T. Mugabi, A. Musubire, E. Kagimu, M. Abassi, M. Kabahubya, Darlisha A Williams, H. Phan, B. Dai, Maham Zia, K. Zorn, C. Fouassier, Chloe Gerungan, Pedro S. Marra, C. Skipper, N. C. Bahr, Charles Langelier, F. Creswell, David R Boulware, D. Meya, Michael R. Wilson, San Francisco
          </td>
          <td>2025-11-06</td>
          <td>None</td>
          <td>0</td>
          <td>46</td>
        </tr>

        <tr id="Abstract Introduction. Six to seven million individuals are infected with Trypanosoma cruzi, the causative agent of Chagas disease. With 12,000 deaths annually, chronic Chagas disease remains a significant global health challenge due to persistent vector transmission, increasing non-vector transmission and limited therapeutic options. Chronic Chagas cardiomyopathy is a leading cause of morbidity and mortality, yet the underlying mechanisms remain poorly understood. Gap Statement. Since its initial description more than 100 years ago, research efforts into the cardiomyopathy found in chronic Chagas disease have primarily focused on the contributions of immune cells, cardiomyocytes and cardiac fibroblasts, leaving a significant gap in understanding the role of microvascular endothelial dysfunction in disease progression. Aim. The aim of this study was to identify any morphological or functional changes to cardiac microvascular endothelial cells induced by T. cruzi infection with the potential to contribute to the pathologies found in chronic Chagas disease. Methodology. We cultured primary cardiac microvascular endothelial cell monolayers in vitro and infected them with T. cruzi trypomastigotes or exposed them to conditioned media collected from control or infected endothelial cells. Cells were analysed for changes in morphology and proliferation, by wound healing assays for measurements of migratory capacity and by tube-forming assay to characterize their ability to form capillary-like structures. Results. We show that T. cruzi infection leads to the development of hypertrophic multinuclear cells, inhibits endothelial proliferation, increases endothelial migration and results in changes in several aspects of angiogenesis. Conclusion. We present data to demonstrate morphological and functional changes in cardiac endothelial cells that occur as a result of T. cruzi infection and propose that these changes may contribute to endothelial dysfunction and the development of chronic Chagas cardiomyopathy.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4d363cfd484de981cde91418bbc3b956d87c21a2" target='_blank'>
              Trypanosoma cruzi infection-induced changes in cardiac microvascular endothelial cell morphology and function
              </a>
            </td>
          <td>
            Lyndsey N Gisclair, Douglas A Johnston
          </td>
          <td>2025-11-01</td>
          <td>Journal of Medical Microbiology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4344a3caab5690ca285cfeeb41c13e886e533ceb" target='_blank'>
              Arsenic Trioxide Underpins Delayed Neuroinflammation and Impaired Synaptic Integrity involving Integrative Stress Response Signaling
              </a>
            </td>
          <td>
            Jasim Khan, Sazzad Khan, Himanshi Singh, Jianfeng Xiao, Daniel Johnson, Md Athar, Mohammad Moshahid Khan
          </td>
          <td>2025-12-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="Alveolar echinococcosis (AE) is a fatal foodborne parasitic disease caused by the larvae of Echinococcus multilocularis. The disease primarily affects the liver. Previous studies have found that Kupffer cells have an immune protective effect, but in the late stages of AE, they are associated with parasite immune escape. The present study analyzed the effects of Echinococcus multilocularis protoscoleces (PSCs) infection on the mitochondrial morphology and function of macrophages, as well as their phagocytic function and apoptosis. Infection with PSCs has been shown to result in the fragmentation of the macrophage mitochondrial network, the impairment of mitochondrial membrane potential, the elevation of mitochondrial reactive oxygen species, and the reduction in mitochondrial DNA copy number. This cascade of events, consequent to the infection, has been demonstrated to promote the apoptosis of macrophages and impair their phagocytic function. Inhibiting mitochondrial fission during PSCs infection has been shown to mitigate mitochondrial dysfunction, suppress macrophage apoptosis, and enhance macrophage phagocytic function. This discovery provides insights into improving macrophage function during the progression of AE.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b98c066005cc1b2d7f5d5a3b885fbfd5fcf5b095" target='_blank'>
              Mitochondrial Network Fragmentation Leads to Dysfunction of Macrophages During Echinococcus multilocularis Protoscoleces Infection
              </a>
            </td>
          <td>
            Zihan Yang, YaoGang Zhang, Tao Zhang, J. Hou, M. Tian, Dengliang Huang, Yuan Jiang, Li Sun, Panlong Wei, Yanyan Ma
          </td>
          <td>2025-10-28</td>
          <td>Pathogens</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Acute neuroinflammation rapidly activates brain immune responses, but its lasting effects on microglia are unclear. Using systemic LPS administration and LCMV-Armstrong infection, we found that blood–brain barrier disruption and cytokine shifts resolved within 30 days, yet microglial recovery was incomplete—marked by persistent numerical loss and an IFN-γ–low phenotype in the LPS model and reduced relative abundance in the LCMV model. Single-cell RNA sequencing revealed sustained transcriptional alterations, including disease-associated microglia (DAM) features and a distinct recovery-biased population. These acute signatures overlapped with profiles from Alzheimer’s model mice and were enriched in human microglia from multiple sclerosis, Alzheimer’s disease, and other neuroinflammatory conditions. Although our observation period was shorter than the chronic course of these diseases, the persistence of disease-like microglial states suggests that transient inflammation can prime the brain for long-term vulnerability. Targeting this primed state may offer new strategies to prevent or mitigate neurodegenerative pathology. Supplementary Information The online version contains supplementary material available at 10.1186/s12974-025-03572-7.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8721848b4335622c9d56e1c1301ae59339a8f8e0" target='_blank'>
              Acute neuroinflammation induces prolonged transcriptional reprogramming in microglia
              </a>
            </td>
          <td>
            Sehoon Moon, Cheol Gyun Kim, Young-Kwang Kim, Cheol-Heui Yun, Min-Kyoo Shin, Hyungseok Seo
          </td>
          <td>2025-12-10</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Post-viral neuroinflammatory syndromes, particularly those occurring after SARS-CoV-2 infection, have received increasing attention due to their complex and persistent neurological manifestations. The aim of this narrative review is to integrate current evidence on the molecular and cellular mechanisms underlying chronic neuroinflammation following viral infections, with a focus on dysregulated innate immune responses, macrophage–microglia interactions, oxidative–mitochondrial stress, and impaired inflammation resolution pathways. Our synthesis shows that prolonged activation of macrophages and glial cells promotes the continuous release of pro-inflammatory mediators, while defective phagocytosis and inadequate clearance of cellular debris maintain an inflammatory microenvironment. Mitochondrial dysfunction further amplifies immune activation by stimulating metabolic stress and reactive oxygen species production. In parallel, deficiencies in mediators specialized in inflammation resolution impede the transition from inflammation to resolution, allowing neuroimmune imbalance and nociceptive sensitization to persist long after virus clearance. Key conclusions indicate that these interconnected mechanisms collectively contribute to the long-term neurological symptoms observed in post-viral states, including cognitive impairment, neuropathic pain, and fatigue. Emerging therapeutic strategies targeting cytokine signaling, microglial reactivity, mitochondrial function, and resolution pathways are promising, but remain insufficiently validated in clinical practice. Overall, evidence suggests that post-viral neuroinflammation results from the convergence of sustained immune activation and failure of endogenous resolution mechanisms, highlighting the need for further mechanistic studies and targeted interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1486b2a0665ed52ccf9a17b86e0809646ad8755a" target='_blank'>
              Dysregulated Resolution of Inflammation After Respiratory Viral Infections: Molecular Pathways Linking Neuroinflammation to Post-Viral Neuropathic Pain—A Narrative Review
              </a>
            </td>
          <td>
            A. Popa, Elena Popa, Tatiana Dramba, Elena-Adorata Coman, Mihaela Poroch, M. Ungureanu, A. Bacușcă, Ana-Maria Slanina, Gema Bacoanu, V. Poroch
          </td>
          <td>2025-11-25</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="The COVID-19 pandemic has disproportionately affected elderly individuals, who exhibit higher risks of severe disease and mortality. Although the precise molecular mechanisms underlying this disparity remain unclear, we employed an integrative multi-omics approach to analyze lung tissues from young, adult, and aged mice infected with the SARS-CoV-2 Beta variant (B.1.351). Conserved molecular signatures across age groups included the activation of antiviral immune response pathways (such as antigen processing and presentation, and cytokine-cytokine receptor interaction), and downregulation of metabolic regulatory pathways (such as cGMP-PKG signaling). Concurrently, we observed activation of three proinflammatory kinases-p38 delta mitogen-activated protein kinase (p38D), mechanistic target of rapamycin (mTOR), cytoplasmic tyrosine kinase (CTK)-along with inhibition of the antiviral kinase mammalian Ste20-like kinase 4 (MST4) across all age groups, suggesting conserved therapeutic targets. Our results also revealed age-dependent characteristics, with aged mice showing severe weight loss (> 15% by day 4 postinfection) and hyperactivation of complement and coagulation cascades compared to their younger counterparts. The upregulation of complement system proteins, including complement component 3 (C3), complement component 4b (C4b), and neutrophil/M1 macrophage markers S100 calcium-binding protein A8/A9 (S100A8/A9) in aged mice, coupled with a strong positive correlation (R² = 0.89) between C3 and S100A8, suggested S100A8-mediated complement activation. These findings elucidate how aging exacerbates SARS-CoV-2 pathogenesis through dysregulated immune and inflammatory responses, providing potential targets for age-tailored therapies to mitigate severe COVID-19 outcomes in the elderly.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e0fe6305dd6a280dbd86cc633d792e9ee1a3012a" target='_blank'>
              Integrative Multi-Omics Analysis Reveals Age-Associated Molecular Mechanisms in SARS-CoV-2 Infection.
              </a>
            </td>
          <td>
            Xiaoyue Tang, Yan Xiao, Jingchuan Zhong, Tao Ding, Qiaochu Wang, Chunmei Shi, Zhiyi Zhang, Yehong Yang, Yue Wu, Jiangfeng Liu, Lili Ren, Juntao Yang
          </td>
          <td>2025-12-01</td>
          <td>Journal of medical virology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Highlights What are the main findings? COVID-19 patients show a unique DNA methylation profile in the upper airway, with over 510,000 differentially methylated CpGs affecting antiviral, interferon, and immune response genes. Some methylation changes are temporary, normalizing after 6 weeks, while key immune regulators (e.g., IL17A, ERK1/2, OAS1, MX1) remain significantly involved. What is the implication of the main finding? SARS-CoV-2 may reprogram immune and repair pathways in the airways, influencing recovery and susceptibility to future respiratory infections. These findings provide potential targets for biomarkers and therapeutic strategies to modulate post-COVID-19 airway health. Abstract SARS-CoV-2 infection remains a global health concern, with its impact on host immune responses not fully understood. In a case–control study, we examined how COVID-19 affects DNA methylation patterns in the upper respiratory airway of hospitalized individuals. DNA methylation arrays were performed on nasopharyngeal samples at inclusion/hospitalization and 6 weeks post-inclusion. We found a distinct DNA methylation pattern in COVID-19 patients compared to healthy controls, identifying 510,099 differentially methylated CpGs. Within the transcription start sites (TSSs) and gene body, COVID-19 patients displayed a higher number of genes/CpGs with elevated methylation levels. Enrichment analysis of TSS-methylated genes revealed effects of SARS-CoV-2 on genes associated with type I interferons, anti-viral and inflammatory responses, and immune functions. Some CpG methylations were transient, and normalized at group level by 6 weeks post-inclusion. Several IFN-regulated genes, including OAS1, OAS3, IFIT3, and MX1, were identified. Among the top regulators were IL17A and ERK1/2, both involved in inflammatory processes. Networks nodes included IGF1 and EGF, associated with processes including tissue repair and activation of immune responses. Overall, our data suggests that COVID-19 can impact the upper airway by modifying gene methylation patterns. This could have implications for conditioning of the airways, how individuals respond to future airway infections, and therapeutic interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c17feb2000b785e79540fe240ded0e083db9f8dc" target='_blank'>
              Altered DNA Methylation Pattern Contributes to Differential Epigenetic Immune Signaling in the Upper Respiratory Airway of Unvaccinated COVID-19 Patients
              </a>
            </td>
          <td>
            Melissa Govender, Jyotirmoy Das, Francis R. Hopkins, Cecilia Svanberg, Johan Nordgren, M. Hagbom, Jonas Klingström, Åsa Nilsdotter-Augustinsson, Y. Yong, V. Velu, S. Raju, Johanna Sjöwall, Esaki M. Shankar, Sofi A Nyström, Marie Larsson
          </td>
          <td>2025-10-27</td>
          <td>Cells</td>
          <td>0</td>
          <td>33</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6f9c933a473e49313c32514553adbf6d9c17d2eb" target='_blank'>
              IFNγ-associated immune–metabolic remodeling drives serotonin–kynurenine imbalance with cortical vulnerability in lupus-prone mice
              </a>
            </td>
          <td>
            Karim Matmat, R. Guéant-Rodriguez, Emmanuel Darcq, Okan Baspinar, J. Alberto, J. Guéant, A. Mensah-Nyagan, Hélène Jeltsch-David
          </td>
          <td>2025-11-19</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>41</td>
        </tr>

        <tr id="The OPTN gene, which encodes the adaptor protein optineurin, is genetically linked to amyotrophic lateral sclerosis and frontotemporal dementia, diseases characterized by chronic microglial activation. Optineurin regulates inflammatory signaling, autophagy, and trafficking, but its role in microglia remains incompletely understood. Here, we used bulk RNA sequencing to profile CRISPR-Cas9-mediated optineurin knockout (KO) and wild-type BV2 microglia under basal conditions and upon LPS stimulation. At baseline, optineurin KO altered ~7% of the transcriptome, with a predominant downregulation of type I interferon and antiviral pathways, suggesting its role in maintaining basal immune readiness. LPS stimulation reprogrammed ~35% of genes in wild-type microglia, inducing immune effectors and suppressing cell cycle regulators, whereas in optineurin-deficient cells, the response was blunted with only ~16% of genes changing relative to the KO baseline. Furthermore, LPS-treated optineurin KO microglia notably diverged from LPS-treated wild-type cells, with ~26% differentially expressed genes (DEGs). This included impaired induction of inflammatory programs and persistence of cell cycle-associated transcripts. Most DEGs in LPS-treated KO cells were unique to this condition, highlighting optineurin-dependent pathways specific to inflammatory challenge. Overall, our study provides a systems-level framework for investigating optineurin in microglia and neurodegeneration, establishing it as a key regulator of the microglial transcriptome, with its loss reshaping innate immune and cell cycle programs.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8b5dfaf631e3130d923e28e621ce58d0fa2217b9" target='_blank'>
              Optineurin Shapes Basal and LPS-Induced Transcriptomes in BV2 Microglia
              </a>
            </td>
          <td>
            S. Cappelli, Josip Peradinovic, Nikolina Mohovic, Purba Mandal, C. Stuani, Alessandra Longo, Jason R. Cannon, Priyanka Baloni, Benedetta Leoni, Tamara Krsmanović, Katica Stojanov, G. Apic, Robert B. Russell, M. Romano, E. Buratti, Ivana Munitic
          </td>
          <td>2025-10-28</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>69</td>
        </tr>

        <tr id="
 Neuroinflammation is central to temporal lobe epilepsy, yet the specific role of myeloid cells remains unclear. In status epilepticus (SE) models, circulating monocytes infiltrate the brain, although distinguishing them from microglia is challenging. Using a rat model, we traced infiltrating monocytes post-SE to investigate their persistence, phenotypic evolution during epileptogenesis and contribution to neuroinflammation. By tracking phagocytosed fluorescent nanoparticles and performing CD68 immunohistochemistry, we confirmed that monocytes entered the brain in significant numbers 24 hours post-SE, after the inflammatory peak occurred (7 hours). Their long-term presence and evolution into monocyte-macrophages (mo-mΦs) up to 7 weeks were monitored histologically using CD68. Distinct inflammatory profiles were further characterized after cell enrichment and fluorescence-activated cell sorting (FACS) distinguishing monocytes/mo-mΦs (CD11b
 +
 CD45
 hi
 CD11a
 hi
 ) from microglia (CD11b
 +
 CD45
 lo
 CD11a
 lo
 ). Microglia were the main drivers of the early pro-inflammatory response, with TNFα transcript levels nearly 14-fold higher in microglia than in monocytes 24h post-SE. In contrast, 24h post-SE, infiltrating monocytes transiently displayed an anti-inflammatory and neuroprotective phenotype, being the main source of IL-10, showing ~4-fold higher CD206, and expressing Arg1 absent in microglia. Tracked up to 7 weeks, these cells progressively adopted a microglia-like phenotype, contributed to the microglial scar and, although their expression of pro-inflammatory markers resembled nonactivated microglia, we hypothesize that their persistent presence might fuel the low-grade inflammation typical of chronic epilepsy. Importantly, since infiltrating monocytes initially engage in a transient anti-inflammatory response, strategies aiming to sustain or enhance this protective role in the context of epileptogenesis and epilepsy may open promising avenues for therapeutic intervention.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/02c806a83f638c1285535ef7275370c54df9b01e" target='_blank'>
              Brain-infiltrated monocyte macrophages in a rat model of temporal lobe epilepsy: revisiting the pro-inflammatory paradigm
              </a>
            </td>
          <td>
            Wanda Grabon, N. Gasmi, Anatole Lang, Anne Ruiz, Béatrice Georges, Victor Blot, M. Ogier, S. Rheims, Fabrice P. Navarro, Laurent Bezin
          </td>
          <td>2025-12-09</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Post-COVID cardiac complications have emerged as a significant and persistent clinical concern, yet their underlying mechanisms remain poorly understood. Animal models can act as proxies to investigate the pathophysiology of the human, post-acute sequelae of SARS-CoV-2 infection (PASC). The aim of this experimental study was to evaluate the expression of inflammatory biomarkers in cardiac tissue 28 days after SARS-CoV-2 infection in a female hACE2 mouse model, with a focus on chemokine-mediated immune activation. Twelve female C57BL/6 hACE2 mice were infected with the Omicron variant (BA.1.17 lineage) of SARS-CoV-2, and eleven non-infected mice served as controls. Cardiac tissue was analyzed via Western blot for markers of innate immune activation (TLR4, MyD88, NF-κB) and pro-inflammatory cytokines (IL-6, IL-18, IL-1β, TNF-α, CD11d). Cardiac tissue injury markers (iNOS, PAI-1 and Connexin43) were also analyzed. Compared to non-infected mice, cardiac tissue from infected mice showed significantly higher expression of IL-6 (p = 0.028), indicating an inflammatory state, and CD11d (p = 0.016), suggesting an inflammatory stage accompanied by sustained activation of chemokine-mediated inflammatory signaling. No significant differences in TLR4 (p = 0.340), MyD88 (p = 0.410), NF-κB p65 (p = 0.780), IL-18 (p = 0.548), IL-1β (p = 0.455), and TNF-α (p = 0.125) expressions were observed Similarly, no changes in cardiac damage markers (iNOS: p = 0.4684; PAI-1: p = 0.5345; Connexin 43: p = 0.2879) were found. The results of this experimental study would support the hypothesis of persistent low-grade inflammation as a contributor to post-COVID cardiac sequelae in females that is not accompanied by severe tissue damage, as also observed in clinical studies. This study also reinforces the need for studies evaluating the functional and structural evolution of the myocardium after an acute SARS-CoV-2 infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8c71f525771ab829c5b8bbcdcdb88fac1b05cc46" target='_blank'>
              Cardiac Tissue Damage in a Female Animal Post-COVID Model: Relevance of Chemokine-Mediated Inflammation
              </a>
            </td>
          <td>
            Silvia Flaj-Prados, Esperanza Herradón Pliego, Carlos Goicoechea Garcia, Eva M. Sánchez-Robles, L. Arendt-Nielsen, C. Fernández‐de‐las‐Peñas, Visitación López-Miranda
          </td>
          <td>2025-12-16</td>
          <td>Viruses</td>
          <td>0</td>
          <td>87</td>
        </tr>

        <tr id="


 TAFA4, also known as Fam19a4, is a neuropeptide secreted by C-low-threshold mechanoreceptors (C-LTMRs) and has been reported to attenuate inflammation-induced mechanical hypersensitivity. However, its immunological role in the central nervous system (CNS) remains unclear. We found that TAFA4 is predominantly expressed in the CNS, including C-LTMRs, the habenula-fasciculus retroflexus, hypothalamus, and olfactory bulb. In experimental autoimmune encephalomyelitis (EAE), TAFA4-knockout (TAFA4-/-) mice exhibited reduced disease severity, characterized by decreased immune cell infiltration and demyelination in the spinal cord, suggesting a pro-inflammatory role for TAFA4 in EAE progression. Further analysis revealed that TAFA4 promotes the recruitment of monocytes, macrophages, and neutrophils—but not CD4+ T cells—via the formyl peptide receptor 1 (Fpr1), as shown by in vitro migration assays. Intraperitoneal injection of TAFA4 also recruited neutrophils within 5 hours. Additionally, TAFA4 treatment increased Akt, Erk, and Fak phosphorylation in macrophages, highlighting its role in chemotaxis and inflammatory signaling. In conclusion, our study identifies a novel mechanism by which TAFA4 exacerbates neuroinflammation by promoting immune cell migration in CNS diseases, such as multiple sclerosis.



 X



 Neuroimmunology (NEUR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8282405dad6a98645d17f02ee6384ab19c3b262b" target='_blank'>
              TAFA4 regulates CNS immune cell recruitment and inflammation 3455
              </a>
            </td>
          <td>
            Xin-Mei Yeh, Hwa-Sung Tso
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="SARS-CoV-2 disrupts cellular homeostasis, including the autophagy-lysosome pathway (ALP), a critical component of innate immunity and viral clearance. By subverting autophagy, SARS-CoV-2 proteins such as ORF3a, ORF7a, and NSP6 inhibit autophagosome-lysosome (APG-L) fusion, generating “incomplete autophagy” that permits viral persistence and drives hyperinflammation. Transcription factor EB (TFEB), a master regulator of lysosomal biogenesis and autophagy, has emerged as a central player in the host response to coronavirus infection. TFEB orchestrates the expression of genes required for lysosomal function and autophagic flux while also shaping immune processes, including cytokine production, interferon-stimulated gene expression, and inflammasome clearance. This mini review synthesizes current knowledge on the TFEB-ALP axis in COVID-19 pathogenesis, highlighting its influence on acute immunopathology and its potential contribution to post-acute sequelae (Long COVID). Restoring TFEB activity and autophagic flux may counteract SARS-CoV-2 evasion strategies and restrain aberrant inflammatory responses. Harnessing the TFEB-autophagy pathway as a host-directed therapeutic strategy could help rebalance immune homeostasis, limit tissue damage during acute infection, and mitigate persistent inflammatory sequelae in Long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/16fa03377df001310b096f5bc84f1cdb14cf36a8" target='_blank'>
              Dysregulated TFEB–autophagy-lysosome pathway links acute COVID-19 immunopathology to Long COVID sequelae
              </a>
            </td>
          <td>
            Magdalena Gabig-Cimińska
          </td>
          <td>2025-11-28</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Severe Coronavirus disease 2019 (COVID-19) is associated with abnormal innate and adaptive immune responses, as well as systemic alterations, including a shift in lipid network. A case–control study was conducted to describe the systemic lipidomic profile in COVID-19 according to disease severity. Selected polyunsaturated fatty acids (PUFAs), oxylipins, and endocannabinoids were analysed using a targeted liquid chromatography coupled to mass spectrometry in tandem method. Multivariate receiver operating characteristic curve-based model evaluation was performed to define a lipidomic signature for the disease. A total of 135 hospitalized COVID-19 patients, of whom 85 had severe form, and 134 healthy individuals were included. Patients exhibited increased levels of free PUFAs, proinflammatory and pro-resolving oxylipins, and endocannabinoids compared to controls. A combination of five lipid mediators, i.e., prostaglandin D2, prostaglandin E2, thromboxane B2, lipoxin B4, and 2-archidonylglycerol, discriminates patients from control individuals with excellent accuracy [AUC, 0.977 (0.950–0.995)]. The severe form is characterized by an imbalance between proinflammatory and pro-resolving oxylipins and increased endocannabinoids. COVID-19 is associated with a lipid storm that conditions disease severity. Targeting lipid mediators-related metabolic and signalling pathways could be an interesting therapeutic option in severe forms.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a5fb8bf52683c50e4277c9e8f4f3b1e200f52531" target='_blank'>
              COVID-19 is Associated with a Lipid Storm that Worsens in Cases of Severe Pneumonia
              </a>
            </td>
          <td>
            A. Bouabdallah, M. K. Ben-Fradj, Mohamed Bessem Hammami, Rim Abdelmalek, H. Sanhaji, T. Klopfenstein, Moncef Feki
          </td>
          <td>2025-11-01</td>
          <td>Microorganisms</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a860b1f890cd6919e6ed4f49c16018a6906fcd8a" target='_blank'>
              Exaggerated IFN-I Response in Long COVID PBMCs Following Exposure to Viral Mimics.
              </a>
            </td>
          <td>
            Bart Humer, J. Berentschot, C. V. van Helden-Meeuwsen, L. Bek, Maaike de Bie, Tobias M Defesche, Chantal A Boly, Manon Drost, M. Hellemons, W. Dik, M. Versnel
          </td>
          <td>2025-12-10</td>
          <td>Journal of clinical immunology</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has led to a global health crisis by triggering extensive systemic and immune dysregulation. Granulocytes, including neutrophils, eosinophils, and basophils, are critical components of the innate immune system that play dual roles in protection and pathogenesis during infection. In this review, we examine the multifaceted roles of granulocytes in COVID-19 and their impact on disease severity through excessive inflammation, cytokine storm, and tissue damage. Neutrophil extracellular traps (NETs) and the overactivation of neutrophil subtypes contribute to the development of thrombosis and acute respiratory distress syndrome. In contrast, eosinophils and basophils modulate T helper 2-type and allergic responses that may influence recovery or disease progression. We further summarize the therapeutic strategies targeting granulocyte activation and signaling pathways, including IL-1, IL-6, IL-17, IL-5 receptor, granulocyte-macrophage colony-stimulating factor inhibitors, and antihistamines, emphasizing their clinical outcomes, approval status, and the global regions in which they are studied. Understanding the regulatory mechanisms of granulocyte activation and inhibition provides new insights into COVID-19 immunopathology and opens pathways for targeted immunomodulatory therapy. These findings underscore the importance of balancing protective immune functions with controlled anti-inflammatory interventions to mitigate the severe complications of SARS-CoV-2 infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c1949f61557e86e96575d6b1c878127a5eaa2ccc" target='_blank'>
              COVID-19: Understanding the Granulocyte Response and Exploring Their Therapeutic Interventions.
              </a>
            </td>
          <td>
            Zahra Farjami, Mina Moradi, Neshat Ebrahimi, Mohammad Mehdi Akbarin
          </td>
          <td>2025-10-31</td>
          <td>Viral immunology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="


 Metabolomics provides a comprehensive analysis of small molecules, crucial for understanding immune responses to COVID-19 vaccination. This study explores metabolic changes induced by mRNA COVID-19 vaccines in patients with lymphoid malignancies (LM) compared to healthy controls. In a prospective cohort study, 41 LM patients and 28 healthy adults were enrolled. Plasma samples were collected at pre- and post-vaccination. Immunoglobulin G antibodies against the Spike protein were quantified using a single-molecule array assay. Untargeted metabolomics analysis via ultra-performance liquid chromatography-mass spectrometry identified a range of metabolites. Statistical analyses identified relevant metabolic pathways associated with immunogenicity. The median fold change of anti-Spike titers from baseline to 1-month post-series in the healthy cohort was 404.8 and 179.5 for the LM cohort. The study identified 1,492 metabolites across 121 metabolic subpathways. The LM cohort showed distinct metabolic clustering from healthy controls, suggesting a differentiated immune response. This was further emphasized with dynamic metabolic shifts found one month after the first dose. Acyl Carnitine and Lysophospholipid, crucial lipid metabolites for immune response, were perturbed indicating that LM patients respond differently to vaccination than healthy individuals. Our findings highlight the potential of metabolomics to elucidate vaccine response mechanisms among different populations.



 NIH/ NIAID U19AI168643 ; 3U01AI67892-03S2



 Vaccines and Immunotherapy (VAC)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/34d1125bc4eaeca7b61d8c12e0cc121758c4c38c" target='_blank'>
              Impact of COVID-19 mRNA vaccination on metabolic profiles in patients with lymphoid malignancies 3780
              </a>
            </td>
          <td>
            J. Diray-Arce, Meagan Karoly, Jing Chen, Alexandra Tong, Hannah Levine, Zoe N Swank, Nicolas C. Issa, David R Walt, Lindsey Baden, S. V. van Haren, Ofer Levy, Amy C. Sherman
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="


 Sepsis is a life-threatening condition caused by an extreme immune response to infection, often resulting in organ dysfunction and death. Clinical variability, influenced by pathogens, infection sites, and genetic differences in immune responses, complicates the identification of universal biomarkers and treatments. Additionally, the availability and quality of single-cell RNA sequencing (scRNA-seq) datasets for sepsis are limited, often lacking appropriate control groups. To address these gaps, this study analyzed publicly available scRNA-seq data from peripheral blood mononuclear cells of septic (S) patients and patients with cardiogenic shock (SC) as controls. A robust pipeline was developed, combining quality control in R with large-scale data integration in Python using Scanpy and Scanorama. Nine immune cell clusters (macrophages, monocytes, dendritic cells, B cells, NK cells, mucosa-associated T, naïve T, CD4+ T, and CD8+ T cells) were present in both groups. However, reduced proportions of T cells expressing CD4, ADRB2, CD8A, EOMES, CD28, CD69, and GATA3 were found in the S compared to CS, suggesting their role in immune paralysis. Pathway enrichment analysis identified unique pathways implicated in sepsis pathology, including macrophage migration inhibitory factor, CD99, annexins, resistin, and selectin P ligand. Targeting these pathways could provide a means to refine inflammatory responses and restore immune balance in sepsis.



 Author Marina Ninkov was supported by The American Association of Immunologists through an Intersect Fellowship for Computational Scientists and Immunologists.



 Computational and Systems Immunology (COMP)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f2acc8728c0b545654f170634e5fbd18208140eb" target='_blank'>
              Immune Cell Profiling in Clinical Sepsis: Insights from scRNA-seq Meta-Analysis of publicly available datasets 4438
              </a>
            </td>
          <td>
            Marina Ninkov, Mahmoud Bagheri, S. M. Haeryfar, Tallulah Andrews
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="


 Neuroinflammation is typically attributed to the sustained activation of resident immune cells in the brain, such as microglia. However, in acute inflammation, cells are activated rapidly and reconstruct the blood-brain barrier (BBB) in order to prevent further damage. Given that acute inflammation causes significant damage to the brain in a short period of time, the impact on the immune system may persist for an extended duration. In this study, we observed a significant infiltration of monocytes and macrophages into the brain following the induction of acute inflammation by LPS. This infiltration was accompanied by a reduction in IL-10 and an increase in IL-1β levels one day after injection, which then returned to baseline within a week. The number of microglia decreased transiently; however the cytokine expression pattern was comparable to that of macrophages. Notably, despite restoring motor and memory functions in mice, the microglial phenotype remained unresponsive even after one month. Also, those microglia exhibited numerous similarities with the chronic Alzheimer’s model at the gene level. Furthermore, acute inflammation induced by LCMV also results in temporal BBB impairment and persistent microglial phenotype alteration. In conclusion, our findings verified that acute inflammation affects the immune microenvironments of the brain in a long-lasting way, suggesting that severe inflammation may increase the risk of developing neurodegenerative disease in the future.



 Neuroimmunology (NEUR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fbbbe2df01483e14f37d0ce2b02a958d1cfe3f64" target='_blank'>
              The impact of acute inflammation on the brain immune environment 2896
              </a>
            </td>
          <td>
            Sehoon Moon, Cheol Gyun Kim, Min-Kyoo Shin, Hyungseok Seo
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Background Sepsis is a complex and heterogeneous syndrome characterized by dysregulated immune responses and multiple forms of programmed cell death (PCD). Comprehensive understanding of the PCD landscape may provide insights into prognosis and therapeutic targets, whereas its role in sepsis is not well-explored. Methods Using the microarray dataset for sepsis (GSE65682), we systematically profiled 14 PCD patterns in sepsis and stratified patients into molecular subtypes with distinct immune landscapes and clinical outcomes. PCD-related prognostic signature was developed and validated across multiple cohorts. Single-cell and multi-organ transcriptomic analyses were conducted to elucidate cellular heterogeneity and temporal dynamics. Molecular docking was used to explore interactions between active compounds of Simiao Yongan Decoction (SMYAD) and key PCD-related proteins. Results Two clusters with differential transcriptional programs and immune infiltration patterns were identified, in which Cluster 1 showed poorer prognosis. We then developed a seven-gene signature (ELANE, CTSG, MPO, CAMP, TFRC, IL1B, CASP5) that effectively stratified patients by survival outcomes, with robust predictive performance across independent datasets. Neutrophils, monocytes, plasma, and dendritic cells were major mediators of PCD-associated immune dysregulation, in which neutrophils showing the strongest response. Temporal transcriptomics revealed peak expression of prognostic genes in bone marrow and peripheral blood within three days post-onset, suggesting an early therapeutic window. Finally, molecular docking indicated that SMYAD compounds may target PCD proteins (MPO, ELANE, IL1B) and modulate immune responses. Conclusion This study delineates the multi-dimensional role of PCD in sepsis, establishes a reliable prognostic model with strong predictive value, and highlights SMYAD as a potential multi-target therapy. These findings provide new avenues for risk stratification and suggest the promise of integrating PCD biology with adjunctive immunomodulatory strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/abc3f6144dc62b87c22b5c340cf92d304ec7f958" target='_blank'>
              Multi-Dimensional Characterization of Programmed Cell Death Patterns for Prognostic Stratification and Therapeutic Insights in Sepsis
              </a>
            </td>
          <td>
            Chen Zhou, Yunmeng Bai
          </td>
          <td>2025-11-01</td>
          <td>ImmunoTargets and Therapy</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Introduction Chronic low-grade inflammation has been associated with the development and progression of depression. However, its impact on neuronal development and connectivity remains poorly understood. In this study, we investigated how chronic and acute inflammation may influence early neurite development in neuronal-like cells (monocyte-derived neuronal-like cells, MDNCs). Methods Circulating monocytes were obtained from healthy controls (HC, n = 5), patients with major depression (MD, n = 4), patients with depression and elevated peripheral inflammatory markers (MD-INF, n = 4) and patients with schizophrenia (SZ, n = 5). Monocytes were transdifferentiated into MDNCs and either left untreated (CTRL) or exposed to lipopolysaccharide (LPS, 100 ng/mL) to induce an acute inflammatory response. Neurite morphology was quantified using MAP2 immunofluorescence staining and microscopic analysis. Results Transdifferentiation rates were significantly higher in MD-INF cultures compared with HC, MD and SZ. Sholl analysis demonstrated that MD-INF MDNCs treated with LPS exhibited a significantly greater neurite ending radius than MD and SZ cells or MD-INF under control conditions. Similarly, MD-INF cells treated with LPS showed more Sholl intersections compared with SZ cells treated with LPS and MD-INF cells under control conditions. Furthermore, the average neurite length of MD-INF cells treated with LPS exceeded that of MD and SZ cells treated with LPS and MD-INF cells under control conditions. Discussion These findings suggest a hyperresponsive phenotype to inflammatory stimulation in vitro in early neurons from patients with depression and elevated peripheral inflammation. Our results may provide novel insights into how inflammation could influence neurodevelopmental processes relevant to depression and may serve as a model for further investigations regarding targeted interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9ea2384d3246c9273f9136338578d14f211881a8" target='_blank'>
              Hyperresponsiveness to inflammatory stimulation in human neuronal-like cells from patients with inflammation-associated depression
              </a>
            </td>
          <td>
            Susanne Schillo, C. Schiweck, M. Aichholzer, Anna Y. Yotova, Tsendmaa Tsengenbayar, S. Edwin Thanarajah, Andreas Reif, Florian Freudenberg
          </td>
          <td>2025-10-29</td>
          <td>Frontiers in Psychiatry</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="


 Neutrophils heavily infiltrate the brain following acute and chronic brain insults. Neutrophils infiltrating brain tumors display a prolonged lifespan compared to blood neutrophils. We investigated presence and potential function of neutrophils in the brain following infection with Theiler’s Murine Encephalomyelitis (TMEV) and kainic acid-induced seizures. Both total myeloid cells and neutrophils started infiltrating the brain as early as day 1, peaked at day 3, and remained elevated at least 7 days post-infection. Further characterization of the neutrophils revealed upregulation of MHC-II, indicating a potential role in antigen presentation. We detected similar accumulation of total myeloid cells and neutrophils in the brain of mice following seizures. MHC-II expression was upregulated on infiltrating neutrophils. Given the sustained and unusual accumulation of neutrophils in the brain past innate time points, we evaluated the bone marrow niche for evidence of myelopoiesis. Frequencies of Lin-Sca-1+c-Kit + (LSK) were significantly higher in all bone marrow compartments in mice infected intracranially with TMEV. This increase in LSK cells concurred with an increase in frequencies of total myeloid cells. These changes were not observed when mice were infected with TMEV systemically. Our data highlights dysregulation of bone marrow hematopoiesis and a potential novel role of neutrophils in response to neuroinflammation following intracranial pathologies.



 Neuroimmunology (NEUR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/07628d2a8c082d3276b9f4ff08b030b0c457e760" target='_blank'>
              Brain injuries lead to sustained neutrophil generation in the bone marrow and infiltration into the brain 3257
              </a>
            </td>
          <td>
            Eliese M. Moelker, Alexandra M. Hoyt-Miggelbrink, R. Reesman, Delaney M. Anani-Wolf, Anthony D. Umpierre, Pamela K. Norberg, Aaron J. Johnson, K. Ayasoufi
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="


 PLCG2, a critical immune regulator, has emerged as a key factor in Alzheimer’s disease, with genetic variants conferring both risk and protection. In the brain, PLCG2 is mainly expressed in microglia, influencing cellular functions including calcium signaling. We investigated PLCG2’s role in neuroinflammation using constitutive and inducible knockout mouse models with LPS-induced acute inflammation. In the constitutive KO, LPS treatment induced >200 differentially expressed genes in the brain, altering pathways related to innate and adaptive immune responses, inflammatory signaling, and microglial function. KO mice exhibited a distinct gene signature in response to LPS, with upregulated genes associated with interleukin signaling, prostaglandin response, and interferon pathways. Interferon-responsive genes were upregulated in homozygote KO mice post-LPS treatment, a phenotype that has been linked to white matter pathology. Consistently, principal component analysis of myelin-enriched genes revealed LPS-treated homozygote KO samples clustering separately from other genotypes. Behaviorally, LPS-treated KO mice displayed reduced locomotion in open field tests, correlating with expression of sickness behavior-related genes. These findings suggest PLCG2 deficiency enhances interferon responses, potentially driving behavioral changes and myelin pathology phenotypes. Inducible KO mice showed distinct behavior, with ongoing efforts focused on assessing their brain transcriptomes.



 This research was supported by the Alzheimer’s Association (AARG-21-846012, SH and JPP) the William and Ella Owens Medical Research Foundation (JPP), and intramural funding (SH and JPP).



 Neuroimmunology (NEUR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5a467f58282d37f7f95ab646aaa61616cbf597fc" target='_blank'>
              PLCG2 deficiency alters the neuroinflammatory transcriptome and sickness behavior response to LPS 9336
              </a>
            </td>
          <td>
            Eduardo Gutierrez Kuri, Juliet Garcia Rogers, Sabrina Smith, Kevin F. Bieniek, Ann Griffith, J. Palavicini, Sarah C. Hopp
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c18b6c3d94e0b245a2073ceeb35d02bd592fc6fc" target='_blank'>
              The compounding roles of gut-immune-brain axis and COVID19 in manifestation of idiopathic Parkinson’s disease
              </a>
            </td>
          <td>
            Ankita Das, Vani Vivek, P. Aich
          </td>
          <td>2025-11-08</td>
          <td>Discover Immunity</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="


 Persistent symptoms following SARS-CoV-2 infection, known as post-COVID syndrome (PCS), severely affect patients’ quality of life. Despite its prevalence, the underlying mechanisms and reliable biomarkers remain elusive. We investigated the antibody response and epitope recognition patterns in PCS to uncover potential biomarkers and pathophysiological links to immune dysregulation. Humoral immune responses were analyzed in PCS patients (n = 64) and convalescent controls (n = 64), matched for sex, age, and time since acute infection, further corroborated in three independent PCS validation cohorts (n = 420). PCS was associated with significantly elevated levels of neutralizing IgG, IgA and IgM antibodies targeting the SARS-CoV-2 receptor-binding domain and spike subdomains, but not against nucleocapsid or seasonal coronaviruses. Next, we identified three discriminatory PCS-specific spike epitopes, primarily located in the membrane-proximal region, as demonstrated by customized peptide microarray, ELISA and luminex methods. Binary logistic regression analysis revealed 82.8% specificity and 60.0% sensitivity for PCS diagnosis in seropositive patients. PCS-specific antibody levels correlated directly (D-Dimers) or inversely (6 min-walk distance, diffusion capacity) with clinical markers. These findings highlight enhanced spike-specific humoral responses in PCS and propose novel epitope-based biomarkers for PCS diagnosis and mechanistic insights.



 This project was supported by the German Ministry of Education and Research (BMBF; grant no. 01EP2105A).



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1a968b330b5ee6c0dc2d5adb08f94a3e06ce6039" target='_blank'>
              SARS-CoV-2 spike epitopes as a novel clinically-relevant biomarker for post-COVID syndrome 3558
              </a>
            </td>
          <td>
            C. L. Magnus, Annika J. Walter, Lars Klaphecke, Sandra Schaubschläger, Tabea Gerschütz, A. Plentz, J. Abel, Kerstin Renner, Vivian Glück, Ida Montanari, Stefan Blaas, Arno Mohr, T. Schmidt, V. Klemis, Romina Kardashi, Jan Medenbach, Bernd Salzberger, Michael Koller, C. Lensch, André Gessner, Katja De With, Thilo Hinterberger, Thomas Loew, Maximilian Malfertheiner, Michael Pfeifer, R. Bals, Matthias Mack, Thomas Glück, Martina Sester, P. Schuster, David Peterhoff, Barbara Schmidt, Daniel Schmalenberger
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="With the global rise in population aging, establishing effective strategies for the prevention and treatment of age-related neurodegenerative diseases, as well as their prodromal stage of cognitive frailty, has become an urgent challenge. Recent studies have revealed that the neural basis of both frailty and age-related disorders is closely associated with chronic neuroinflammation and impaired clearance of cellular debris, processes that are primarily regulated by microglia, the resident immune cells of the brain. As aging progresses, microglia exhibit reduced surveillance and motility, diminished phagocytic efficiency, and transition into a proinflammatory, hyperresponsive state. Such maladaptive microglia contribute to synaptic loss, white matter deterioration, and the spread of neurodegenerative pathology. Conversely, single-cell transcriptomic studies have identified distinct microglial subsets, including CD11c+ microglia, which show upregulation of lysosomal and lipid metabolism pathways, enhanced debris clearance, and elevated neurotrophic factor expression. These features suggest that certain microglial populations adopt protective or adaptive phenotypes that preserve neural integrity. However, under chronic inflammation or pathological conditions, even protective microglia may become inflammation-promoting. This review summarizes current evidence on microglial changes in aging, frailty, and neurodegeneration, emphasizing their dual roles and discussing strategies that modulate microglial function to maintain brain health and prevent or treat frailty and age-related diseases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/951a2bde7a1ce8313cd885132ad9f0b3d11cffc8" target='_blank'>
              Microglia in Brain Aging and Age-Related Diseases: Friends or Foes?
              </a>
            </td>
          <td>
            Kentaro Ishikawa, Risako Fujikawa, Kayoko Okita, Fumika Kimura, Takuya Watanabe, S. Katsurabayashi, Katsunori Iwasaki
          </td>
          <td>2025-11-27</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="


 The effect of COV-19 infection or post-acute sequelae of SARS-CoV-2 (PASC) increases risk of thrombotic events. The mechanism underlying cardiovascular complications post-COV-19 infections remains incompletely understood. During severe COV-19 infection, viral antigens trigger , initiating and amplifying the immune response. This cytokine storm serves to eliminate the virus but inflicts significant collateral damage on the surrounding cellular environment, especially the vascular endothelium. In this study, we hypothesized that the antibody-mediated response to COV-19 infection activates the vascular endothelium and alters endothelial barrier integrity. We also investigated the mechanism driving endothelial activation and dysfunction which fosters a procoagulant state during COV-19 infection and PASC.
 To assess endothelial dysfunction and creation of a procoagulant state post-severe COV-19 infection, primary human umbilical vein endothelial cells (HUVEC) were isolated and incubated with 100 µg/mL IgG for 12 h. We compared the effects of IgG from 56 COV-19 patients with IgG from 12 healthy donors (HD IgG), as controls. Relative to HD-IgG, COV-19 IgG increased surface expression of vascular cell adhesion molecule-1, VCAM-1 (A450nm = 0.491±0.09 in case of COV-19 IgG compared to A450nm= 0.15±0.02 in HD IgG; P<0.05) used as a marker of endothelial cell activation. Using an assay of plasma clot formation in which HUVEC treated with HD or COV-19 IgG was exposed to normal human plasma and clot formation measured by turbidity (A405nm), we observed that 11 COV-19 IgG that induced increased VCAM-1 expression caused enhanced clot formation on HUVEC with maximal Vmax of 55±18 and decreased lag time of 18±5 min compared to HD-IgG (Vmax=35±5; lag time= 43±7 min). Increased clot formation was associated with increased expression of tissue factor mRNA (fold change increase = 4), plasminogen activator inhibitor type 1, PAI-1 (fold change increase =30), and TMEM-16F mRNA (fold change increase=2.5), though the relative contribution of each of these mediators to the prothrombotic phenotype is under investigation. We also observed delayed clot lysis after initial clot formation on HUVEC, possibly reflecting the effects of PAI-1, which was the highest upregulated HUVEC gene after exposure to COV-19 IgG.
 COV-19 infection is also associated with increased vascular permeability that contributed substantially to the clinical manifestations of the disease. To investigate the potential effects of COV-19 on endothelial cell barrier function we stained COV-19 treated HUVEC for VE-cadherin, an important adhesion molecule in endothelial cells. We observed that COV-19 IgG induced internalization and nuclear localization of VE-cadherin, in association with the formation of extensive contractile stress fibers leading to destabilization of cell-cell contacts.
 In preliminary analyses we observed that the correlation (r2) between levels of CL IgG and LBPA IgG in CoV -19 IgG fraction was 0.6545, whereas that between the EC activation markers, VCAM-1 or PAI-1 and CL IgG was 0.5479 and 0.6066 respectively. The correlation between VCAM-1 or PAI-1 and LBPA IgG were 0.2256 and 0.3791 respectively.
 The nature of the endothelial cell reactive antibodies contained in COV-19 IgG is uncertain at this point, but the effects observed occurred in the absence of added β2GPI. Analysis of proteins immunoprecipitated by COV-19 IgG is currently being undertaken.
 Previous studies have shown that IgG fractions from COV-19 patients are prothrombotic, but the mechanisms of these antibodies and the cellular antigens they recognize are uncertain. Our studies begin to address these concerns on a molecular mechanistic level and may lead to better understanding of the endotheliopathy that may underlie several viral syndromes.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f6ebbe57cc1bb77e223e5d583feca3d2b468e47a" target='_blank'>
              COVID-19 IgG antibodies drive endothelial cell activation and dysfunction
              </a>
            </td>
          <td>
            Bhagwati Joshi, Charles Sukin, Wolfram Ruf, Keith R McCrae
          </td>
          <td>2025-11-03</td>
          <td>Blood</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Children with central nervous system malaria (CNS-M) have gene expression profiles and plasma biomarkers of malaria pathogenesis that differ from children with uncomplicated malaria (UM, malaria infection with fever and no systemic organ dysfunction) or acute febrile non-malaria illness (AFN). However, there is scant knowledge of the temporal dynamics of gene expression and plasma biomarkers during recovery from CNS-M. We compared serial changes of peripheral blood mononuclear cell transcriptomes at 6 weeks after recovery and plasma biomarkers of malaria pathogenesis at 6 weeks and 6 months after recovery in cohorts of Kenyan children who presented with CNS-M (n = 37), UM (n = 20) and AFN (n = 12). Upregulated genes and Reactome pathways of interleukin/cytokine signaling, neutrophil degranulation and innate immunity and downregulated pathways of protein biosynthesis of children presenting with CNS-M were partially reversed at hospital discharge 2–6 days later and 6 weeks. CNS-M and UM transcriptomes before treatment versus 6 weeks after recovery shared several pathways, but megakaryocyte/platelet production, IL-4/IL-13/IL-10 signaling and overexpression of LAG3, CCR5, PDGFRB and ICMT were specific to CNS-M. The Hemostasis Reactome pathway was uniquely downregulated in CNS-M at 6 weeks. Biomarkers of coagulation, fibrinolysis, neutrophil activation, endothelium integrity and cytokine signaling correlated with high plasma cell-free DNA in acute CNS-M and persisted for 6 weeks, whereas these values normalized at 6 weeks in UM and AFN. Recovery from pediatric CNS-M is associated with prolonged dysregulation of gene expression and biomarkers associated with coagulation, fibrinolysis and platelet activation. Future studies are needed to evaluate whether this dysregulation is associated with neurocognitive sequelae following recovery. Not applicable.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4942b63b4c5464413c8a8dbe8d60c3b063a47b28" target='_blank'>
              Prolonged dysregulation of gene expression and biomarkers of coagulation, fibrinolysis, and endothelium in pediatric central nervous system malaria
              </a>
            </td>
          <td>
            Arlene E. Dent, B. Rosa, K. Dobbs, Sidney Ogolla, D. Midem, P. Embury, Yelenna Skomorovska-Prokvolit, Emily R. Hannon, Emmily Koech, A. H. Schmaier, Walter Otieno, M. Mitreva, J. Kazura
          </td>
          <td>2025-11-05</td>
          <td>BMC Infectious Diseases</td>
          <td>0</td>
          <td>58</td>
        </tr>

        <tr id="


 As the number of COVID-19 survivors continues to rise, the rates of post-acute sequalae of COVID19 (PASC) have also increased, emerging as a major public health concern. However, the role of monocytes on PASC development has not been fully explored. In this study, we aimed to determine whether monocyte dysregulation persists and contribute to driving inflammation and fibrosis after COVID-19 infection. RNA was isolated from purified monocytes from study participants who had pulmonary PASC (PPASC), had COVID-19 infection but no residual symptoms (Recovered), and had no COVID-19 infection (Healthy). We performed bulk RNA sequencing to profile monocytes to identify dysregulated genes and pathways associated with inflammation and fibrosis. In comparison to Recovered and Healthy, PPASC had an enrichment of immune activation signatures, such as neutrophil degranulation, IL8/IL-6 signaling, and macrophage response genes, while IL-10 pathway was down-regulated. Furthermore, disease prediction analysis showed that enriched genes in PPASC were linked to lung diseases such as pneumonia and lower respiratory tract disorder compared to those in Recovered. Transcriptomic analysis revealed that monocytes from PPASC individuals were continuously dysregulated with up regulation of pathways associated with immune activation, inflammation, and fibrosis. Our data demonstrate that monocyte dysregulation persists after viral resolution, impacting the pulmonary sequelae in PASC individuals.



 NIH/NIMHD (U54MD007601)



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cc86198c15fa6664f1c94ceb5073217cc1f39b91" target='_blank'>
              Long-term consequence of SARS-CoV-2 on monocyte phenotype in COVID-19 survivors 3120
              </a>
            </td>
          <td>
            T. Awamura, Stefanos Giannakopoulos, N. Subia, V. Khadka, Domic Chow, Cecilia M. Shikuma, G. Devendra, Juwon Park
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/aef3340a61cdce0385f6dd2d911f9a1b6fe80ce1" target='_blank'>
              Early-Life Commensal Lung Bacteria Shape Immune Responses and RSV Susceptibility in Neonatal Mice
              </a>
            </td>
          <td>
            Q. Marquant, C. Chottin, C. Ferret, Eloi Poucet, Vinciane Saint-Criq, Daphné Laubreton, Carole Drajac, Edwige Bouguyon, A. Rémot, Samuel Constant, Song Huang, Edouard Sage, Isabelle Schwartz-Cornil, Muriel Thomas, S. Riffault, D. Descamps
          </td>
          <td>2025-12-09</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="Multisystem Inflammatory Syndrome in Children (MIS-C) is a serious condition emerging during the COVID-19 pandemic, strongly associated with prior SARS-CoV-2 infection. Characterized by systemic inflammation affecting multiple organs, MIS-C presents a complex clinical picture including fever, gastrointestinal distress, cardiac dysfunction, and neurological manifestations. Although its exact pathogenesis remains incompletely understood, immune dysregulation is recognized as a central mechanism. This review examines current understanding of MIS-C pathogenesis, focusing on immune dysfunction and viral triggers, particularly SARS-CoV-2. We analyze both innate and adaptive immune responses, cytokine storm dynamics, molecular mimicry, and virus-induced inflammatory cascades. Additionally, we discuss potential immunomodulatory therapeutic strategies and identify future research directions to improve MIS-C management and treatment outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fb906afaca8efa1a4927662eab78d7c57c8c42b9" target='_blank'>
              MIS-C pathogenesis: immune dysregulation & viral triggers
              </a>
            </td>
          <td>
            Tiantian Xu, Jiamin Zhang, Xiangyuan Hou, Xinyu Xie, Junye Qi, Chang-bing Wang, Yuqing Yan, Lu Kuang, Bing Zhu
          </td>
          <td>2025-11-26</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="ABSTRACT Talaromyces marneffei (T. marneffei) is an opportunistic, dimorphic fungus that has been clinically reported to involve the central nervous system (CNS). However, its neuroinvasive capacity and the underlying pathogenic mechanisms remain poorly understood. In this study, T. marneffei infection was found to impair learning, memory, and motor balance in mice, as demonstrated by Morris water maze and accelerating rotarod assays. Viable T. marneffei was subsequently isolated from hippocampus and cortex through fungal cultures, confirming its ability to invade the CNS. Histopathological analysis revealed CNS damage following infection, characterized by neuronal pyknosis, neurofibrillary tangles, and an increased presence of glial cells in the cortex. To investigate the underlying mechanisms, transcriptomic profiling showed significant enrichment of neurodegeneration pathways, with elevated Tau and GSDMD expression in hippocampal and cortical regions as well as N2a cells. Additionally, neuronal damage was exacerbated by indirect neurotoxicity mediated by microglial M1 polarization, accompanied by increased levels of pro-inflammatory cytokines (TNF-α, IL-6, and IL-1β). In conclusion, our findings uncover for the first time a dual-pathogenic mechanism by which T. marneffei induces CNS injury: direct neuronal damage via Tau pathology and GSDMD-dependent pyroptosis and indirect inflammation-mediated injury via M1-polarized microglia. These insights not only advance our understanding of fungal neuroinvasion but also provide a foundation for the development of targeted therapies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4d535583604940e83152cdf7b5514d60e076348a" target='_blank'>
              Mechanisms of Talaromyces marneffei induced CNS injury: Synergistic roles of tauopathy, pyroptosis, and microglial inflammation
              </a>
            </td>
          <td>
            Z. Yuan, Fengyi Wang, Hailun Wei, Xuanrong Li, Wudi Wei, Shengrui Luo, Yukai Zhang, Xueqin Wei, Gang Wang, Hao Liang, Junjun Jiang, Li Ye
          </td>
          <td>2025-10-27</td>
          <td>Virulence</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="


 SARS-CoV-2-induced excessive inflammation and cytokine storm cause acute lung injury and fatal pneumonia. We previously showed that an increased myeloid cell activity during coronavirus infections is highly inflammatory and causes severe lung pathology. However, the key myeloid cell factors that promote lethal inflammation are not well understood. Upon viral infection, myeloid cells elicit inflammatory response through TLR/TRAF6/NF-kB or MAPK pathway. Since TRAF6 is a common adapter molecule upstream of both MAPK and NF-kB, we examined the role of TRAF6 in SARS-CoV-2-induced lethal inflammation. Our preliminary work had showed that myeloid cell TRAF6 activity promotes robust SARS-CoV-2 structural protein induced inflammatory response. Therefore, we hypothesized that myeloid cell TLR-TRAF6 signaling is highly inflammatory and blocking TRAF6 suppresses inflammation while enhancing antiviral IFN response. We show that TRAF6 plays a critical role in viral RNA and protein induced dysregulated immunity and blocking TRAF6 activity specifically suppressed MAPK-ERK1/2 activity. Interestingly, decreased ERK1/2 activity upon blocking TRAF6 signaling correlated with significantly lower inflammatory cytokine and an improved antiviral IFN-I response in macrophages. In summary, our results show novel and contrasting role of TRAF6 activity in SARS-CoV-2-induced antiviral and inflammatory response and highlight therapeutic potential of blocking TRAF6 in host protection.



 NIH R21AI186028-01; NIH R01HL165423-01A1; NIH P30GM149368-02



 Innate Immune Responses and Host Defense: Cellular Mechanisms (INC)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a341e176bf297aee2aaec2915b5aa63c1ae31051" target='_blank'>
              Critical role of myeloid cell TRAF6 signaling in coronavirus-induced antiviral and inflammatory responses 3866
              </a>
            </td>
          <td>
            Roshan Ghimire, Cody Whitley, P. Johnson, Rudra Channappanavar
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="


 Many viral infections have been linked to the development of debilitating neurological disorders. However, the mechanism governing virus-induced neuropathology remains poorly understood, particularly when the virus is not directly neuropathic. Using a mouse model of Zika virus (ZIKV) infection, we find that brain ZIKV titers do not correlate with the severity of neurological disease. Instead, ZIKV-infected brains exhibit microglial activation and infiltration of ‘bystander activated’ CD8+ T cells expressing the NK cell receptor, NKG2D. To assess the role of these T cells in virus-induced neuropathology, we treated ZIKV-infected mice with antibodies to deplete CD8+ T cells or block NKG2D signaling. Both treatments completely prevented against the development of paralysis without altering the viral load in the serum or brain, suggesting that bystander activated T cells mediate virus-induced neurological disease. Interestingly, depletion of brain-resident microglia using the drug PLX3397 also prevented development of neurological disease. However, microglia depletion did not reduce bystander activated T cell numbers in the brain, suggesting that microglia influence bystander T cell function rather than recruitment. Overall, we have identified a novel mechanism where microglia promote bystander activation and function of CD8+ T cells neurological disease. Our findings reveal several strategies for further investigation of treatments for virus-induced neurological diseases.



 Canadian Institutes for Health Research



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fab2ac785254407a4aa683cd871f705bd8afc9fa" target='_blank'>
              Microglia promote bystander activated T cell-mediated neurological disease during viral infection 3059
              </a>
            </td>
          <td>
            Elizabeth Balint, Emily Feng, Amelia Montemarano, Jonathan K Monteiro, Elizabeth C Giles, Tyrah M. Ritchie, Alexander S Qian, Fatemeh Vahedi, Ana L. Portillo, Veronique Miron, Bernardo L. Trigatti, A. Ashkar
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>56</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f8602892f5a451d75b2917aa6aa3b1a249d99d98" target='_blank'>
              COVID-19-associated Autoimmune and Inflammatory Diseases: Molecular Mechanisms and the Role of IVIG Therapy
              </a>
            </td>
          <td>
            Sukanya Bordoloi, S. Singh, Jagadeesh Bayry
          </td>
          <td>2025-11-13</td>
          <td>Clinical Reviews in Allergy & Immunology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Neurotropic viruses infect the central nervous system (CNS) and can cause severe neurological disorders. Theiler’s murine encephalomyelitis virus (TMEV) infection in C57BL/6 mice serves as a model for virus-induced encephalitis and hippocampal damage. C-type lectin domain family 12 member A (CLEC12A) is an inhibitory receptor, which modulates immune responses during inflammatory processes. However, the role of CLEC12A during neurotropic virus infections remains unclear. In this study, CLEC12A-deficient (CLEC12A−/−) and wild type C57BL/6 mice were infected with TMEV. Neuroinflammatory responses, viral load, and immune cell infiltration were analyzed using immunohistochemistry, RT-qPCR, and flow cytometry. CLEC12A−/− mice exhibited increased T cell sequestration in the brain, along with a higher expression of pro-inflammatory cytokine (TNF-α, IL-1β) and antigen presentation genes (CD11c, CD80, MHC-I) during acute infection. This led to an improved viral clearance in the hippocampus. CLEC12A deficiency also activates splenic CD4+ T cells and CD8+ cytotoxic T cells upon infection. Despite increased peripheral T cell activation and neuroinflammation, CLEC12A−/− mice displayed less hippocampal damage with improved neuronal and axonal integrity. In conclusion, CLEC12A signaling in C57BL/6 mice contributes to suppressive immune modulation, delaying viral elimination and exacerbating brain damage during acute neurotropic virus infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0c06a34914feb56293f8f56d9bcc2e6259a3943c" target='_blank'>
              CLEC12A signaling represses protective immune responses and contributes to hippocampal pathology in neurotropic picornavirus infection
              </a>
            </td>
          <td>
            M. K. Ameen, M. Stoff, S. Pavasutthipaisit, T. Ebbecke, M. Ciurkiewicz, T. Störk, J. Ruland, B. Lepenies, A. Beineke
          </td>
          <td>2025-11-10</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="Abstract Multiple sclerosis is a chronic inflammatory disease affecting the central nervous system. While treatment made huge advances, progression remains a challenge. Eomesodermin+ Th cells are associated with cytotoxicity, neuroinflammation and disease progression in secondary progressive multiple sclerosis. We performed a prospective longitudinal study over one year to investigate the role of Eomesodermin+ T cells in multiple sclerosis progression and neurodegeneration. Patients underwent detailed clinical assessment and immunophenotyping. In a subcohort of patients, cross-sectional magnetic resonance imaging using voxel-based morphometry was performed. Frequencies of Eomesodermin+ Th cells could differentiate between patients with secondary and primary progressive multiple sclerosis and correlated with B-cells in secondary progressive multiple sclerosis. Secondary progressive patients experiencing a subjective worsening of disease activity showed higher baseline frequencies of Eomesodermin+ Th cells. Higher baseline frequencies of Eomesodermin+ Th cells predicted prospective one-year disability progression in a small group of secondary progressive patients. Conclusively, voxel-based morphometry analysis revealed pronounced infratentorial brain atrophy in a sub-cohort of patients with higher Eomesodermin+ Th frequencies. In summary, Eomesodermin+ Th cells may shape a dysregulated and proinflammatory immune milieu, driving disease progression and neurodegeneration in secondary progressive multiple sclerosis with potential as both biomarker and therapeutic target.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/127026680a9fcf5139e47dd60fd0ae3cb528e008" target='_blank'>
              Eomesodermin-expressing CD4 Th cells and association with multiple sclerosis progression and brain atrophy
              </a>
            </td>
          <td>
            Marielena Bongert, Emelie Schönauer, Paul Trendelenburg, Ulaş Ceylan, Theodoros Ladopoulos, Katja Vohl, David Bratek, Annika Mattukat, L. Beyer, K. Gerwert, Takashi Yamamura, Carsten Lukas, Ingo Schmitz, Ruth Schneider, I. Ayzenberg, Ralf Gold, S. Faissner
          </td>
          <td>2025-10-27</td>
          <td>Brain Communications</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="


 Emerging evidence has suggested that primary infection and/or insult can “train” or “prime” long-term alterations in the transcriptional and epigenetic profiles of innate immune cells, particularly macrophages. Currently, it is unknown whether those “infection-experienced” macrophages can facilitate adaptive immune memory responses after infection resolution. Here, we show that influenza virus infection induces lasting transcriptional and epigenetic changes in lung alveolar macrophages (AMs) compartment following the resolution of primary infection. Further analysis showed that the IL-1b was persistently upregulated in the “infection-experienced” AMs at the memory phase compared to those of AMs from the naïve mice, and the “primed” AMs represent the major source of IL-1b in the infection-experienced lungs. Strikingly, blocking IL-1β or ablating it in myeloid cells during the memory phase led to decreased number of antigen-specific CD8 resident memory T cells (Trm) specifically in the airway but not the lung parenchyma. Consistently, IL-1b blockade caused diminished Trm-mediated protective immunity during heterologous influenza virus re-challenge. Our data suggest that infection-primed innate immune compartment facilitates protective local adaptive immune memory in the respiratory mucosa after the resolution of primary infection. Our findings may inform future vaccine design aiming to induce strong mucosal CD8 T cell immunity against respiratory viral infections.



 Immune Response Regulation: Cellular Mechanisms (IRC)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c545200b85997582aa0e6b4cd460d5da7beff03a" target='_blank'>
              Infection-experienced alveolar macrophages sustain airway T cell memory 3555
              </a>
            </td>
          <td>
            I. Cheon, Y. Son, J. Im, Jie Sun
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="

 SARS-CoV-2, the pathogen of COVID-19, disrupts the alveolar epithelial barrier and triggers exacerbation of airway inflammation. The envelope (E) protein plays a key role in promoting epithelial damage and sustaining inflammation. We previously identified a SARS-CoV-2 variant (F8) containing a 12-bp deletion in the E gene. Compared to the 8X strain, which possesses the wild-type E gene, F8 could induce a higher expression of inflammatory factors in Calu-3 cells.



 This study analyzed the miRNA expression profiles in Calu-3 cells infected with either the F8 variant or the 8X strain. Quantitative Reverse Transcription Polymerase Chain Reaction (RT-qPCR) was employed to validate the differential expression of candidate miRNAs. Subsequent functional verification assays like ELISA were performed to elucidate the regulatory roles of these miRNAs in host signaling pathways, such as inflammatory responses.



 We discovered that F8 infection significantly upregulated miR-361-3p and downregulated let-7b-5p. Furthermore, miR-361-3p regulated the PI3K-Akt pathway by directly targeting and inhibiting TSPAN1, ultimately promoting PTEN expression. The downregulation of let-7b-5p might release the suppression on inflammatory cytokines (IL-6, IL-8, PTX3), and partially disorder ZO-1 expression in maintaining the barrier function.



 This study is the first to demonstrate that the SARS-CoV-2 E protein mutant F8 remodeled the host miRNAs network to coordinate the immune responses and barrier function. All findings provided valuable insights into the pathogenesis of SARS-CoV-2 variants.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8e3e728bf0af1f00a31c1d2eadcc47ca6aa1e2d4" target='_blank'>
              MicroRNA-mediated regulation of the immune response in Calu-3 cells infected with a SARS-CoV-2 E gene variant
              </a>
            </td>
          <td>
            Chenfan Sun, Fang Xu, Zhongji Pu, , Yu-dong Li, Hangjing Lu, Bei-Bei Wu, Yi-Sheng Sun, Ping-Ping Yao, Jian-Ming Jiang
          </td>
          <td>2025-12-15</td>
          <td>Frontiers in Microbiology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Brucellosis is a severe zoonotic disease caused by Brucella infection, which remains prevalent in several regions worldwide and poses a significant public health challenge. The host deploys complex immune mechanisms to combat the pathogen, including the recognition of pathogenic signals, secretion of inflammatory factors, and activation of innate and adaptive immune responses. Brucella, as a facultative intracellular pathogen, replicates within host cells and establishes chronic infections through diverse immune evasion strategies. These include subversion of Toll-like receptor (TLR) signaling, disruption of antigen presentation, and interference with T cell responses. This review focuses on Brucella species with significant human infectivity, such as B. melitensis and B. abortus, summarizing their interactions with the host immune system. Recent studies have highlighted TLR pathway inhibition, antigen presentation impairment, and T cell dysregulation as key mechanisms of immune evasion. Understanding these processes is crucial for elucidating Brucella pathogenesis and developing novel therapeutic and vaccine strategies against brucellosis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/09f26f3db52f5a11fc17e40e1ba459f8ee3fd969" target='_blank'>
              Brucella Immune Escape: TLR Subversion, Antigen Presentation Destruction and T Cell Disorder
              </a>
            </td>
          <td>
            Hanwei Jiao, Gengxu Zhou, Shengping Wu, Chi Meng, Lingjie Wang, Cailiang Fan, Jixiang Li, Yuefeng Chu
          </td>
          <td>2025-11-01</td>
          <td>Cells</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Respiratory syncytial virus (RSV) is the most common cause of acute bronchiolitis and pneumonia in children under 5 years of age. RSV infection is characterized by lung inflammation, viral expansion, and airway barrier destruction. The crosstalk between neurons and immune and non-immune cells develops from early life onwards. The lungs and airways are densely innervated by sympathetic neurons where they secrete the neurotransmitter noradrenaline (NA) at homeostasis and following injury in adult mice. NA, once secreted into the lungs, can act on immune and non-immune cells through β-adrenergic receptors (β-ARs). However, it is unknown whether NA-β-AR signaling axis regulates antiviral immunity during early-life infections. In a mouse model of neonatal RSV infection, we find that stimulation of adrenergic signaling via β2-AR agonist increases viral clearance, anti-inflammatory responses, and disease recovery. By contrast, loss of sympathetic neurons and β2-AR increases the RSV viral load and immunopathology in neonates. Stimulating β2-AR signaling has several downstream effects, including reduced airway mucus secretion and protection from endothelial barrier disruption, which together prevent airway blockade, respiratory failure, and facilitate control of RSV infection. Collectively, our studies demonstrate that sympathetic neurons and β2-AR signaling protect neonates from viral expansion and lung barrier breakdown, promoting antiviral defense.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a1080e6779c79237f286db40fc699be83e24e36f" target='_blank'>
              β2-adrenergic signaling controls neonatal respiratory syncytial virus infection by promoting viral clearance and airway protection
              </a>
            </td>
          <td>
            Sandeep Adhikari, Camille Carrier, P. Joshi, Pankaj Baral
          </td>
          <td>2025-12-18</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1c8423d9fefb3d644864a26f8dbc02503abeb9ee" target='_blank'>
              Blood pro-thrombotic analytes and platelet activation are associated with post-acute sequelae of COVID-19.
              </a>
            </td>
          <td>
            Luke A Whitcomb, K. Berry, S. LaVergne, Nicole Natter, Bridget Baxter, Sangeeta Rao, M. Tipton, Marina A. Gritsenko, Karl K. Weitz, Vince Gerbasi, L. Bramer, P. Piehowski, Tracy L. Webb, Marcela Henao-Tamayo, Adam J. Chicco, J. Dunn, Taru S. Dutt, Elizabeth P. Ryan
          </td>
          <td>2025-12-10</td>
          <td>BMC infectious diseases</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Background Although an increase in neutrophil count has been observed in patients with coronavirus disease 2019 (COVID-19), the relationship between the systemic neutrophil transcriptome and clinical course of COVID-19 remains unclear. Hence, we examined the relationship between the clinical course and RNA sequencing analysis results in COVID-19 patients. Methods Peripheral blood samples were obtained from 28 patients with COVID-19-associated ARDS and 16 healthy controls. Bulk RNA sequencing was performed, and clustering analysis was used to explore relationships between gene expression and clinical characteristics. In a separate cohort, neutrophils were isolated from the peripheral blood of five COVID-19 patients with ARDS for single-cell RNA sequencing to further characterize the neutrophil subpopulations. Results In bulk RNA sequencing analysis, COVID-19 patients with ARDS had elevated gene expression associated with neutrophils compared with healthy controls.Clustering analysis revealed no differences in the clinical characteristics of COVID-19 patients with ARDS. In the single-cell RNA sequencing analysis, clustering analysis showed that the patients were divided into two groups: those who could be weaned from the ventilator within 28 days and those who could not be weaned. Conclusion These findings indicate that differences in neutrophil gene expression may have important clinical implications. This study may support the exploratory identification of genomic factors, such as neutrophil gene expression, that are relevant to clinical parameters.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/be169a2ec01392f5c6227748d161603c47c0cb32" target='_blank'>
              Neutrophil gene expression in COVID-19 patients with acute respiratory distress syndrome
              </a>
            </td>
          <td>
            Hiroshi Ito, Masakazu Ishikawa, J. Yoshimura, Yuchen Liu, Shuhei Sakakibara, Fuminori Sugihara, Hisatake Matsumoto, H. Hirata, Hiroshi Ogura, Jun Oda, Daisuke Okuzaki
          </td>
          <td>2025-11-06</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Acute myocardial infarction (MI) is a major cardiovascular event and a leading cause of mortality worldwide. Beyond the initial ischemic injury, the inflammatory and immune responses play pivotal roles in both tissue damage and subsequent healing. While the anti-inflammatory strategies targeting neutrophil-driven injury have demonstrated potential in limiting early cardiac damage, growing evidence highlights the critical role of innate immune cells beyond the acute phase. Neutrophils, traditionally associated with tissue injury, also contribute to the resolution of inflammation and initiate key repair processes. Monocytes and macrophages follow a dynamic trajectory, transitioning from pro-inflammatory to reparative states, and play essential roles in debris clearance, angiogenesis, and scar formation. In the early inflammatory phase of acute MI, immune cells such as neutrophils and monocytes are rapidly recruited and activated. While they initially amplify inflammation through the release of pro-inflammatory mediators, their subsequent transition toward anti-inflammatory and reparative phenotypes helps limit tissue damage by clearing necrotic debris from the infarcted area and contributes to the resolution of inflammation. Accumulating evidence reveals a complex crosstalk between neutrophils and macrophages post-MI, with resident macrophages being involved in neutrophil recruitment, and neutrophil-derived signals participating in monocyte recruitment and macrophage polarization, thereby coordinating the spatial and temporal phases of cardiac repair. Understanding how neutrophil-derived mediators influence macrophage responses and whether macrophage-secreted factors reciprocally modulate neutrophil behavior opens promising pathways for developing targeted therapies to limit adverse remodeling following MI. Therefore, this review aims to (i) provide an overview of the roles of neutrophils and monocytes/macrophages in the pathophysiology of myocardial infarction, (ii) explore the mechanisms of communication, particularly via neutrophil-derived secreted factors, that influence monocyte/macrophage function and impact post-MI inflammation, repair, and remodeling, and (iii) highlight the potential therapies interfering with inflammation and neutrophil/macrophage cross-talk.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fc3567944147d2424e0448f1fecdd6994e604f8a" target='_blank'>
              Cross-Talk Between Neutrophils and Macrophages Post-Myocardial Infarction: From Inflammatory Drivers to Therapeutic Targets
              </a>
            </td>
          <td>
            Letiția Ciortan, R. Macarie, Elena Barbu, M. L. Naie, A. Mihaila, Mihaela Serbanescu, E. Butoi
          </td>
          <td>2025-10-30</td>
          <td>International Journal of Molecular Sciences</td>
          <td>1</td>
          <td>18</td>
        </tr>

        <tr id="


 Chronic inflammatory stress is a key characteristic of bone marrow failure syndromes (BMFS) and myelodysplastic syndromes (MDS), but we do not fully understand how hematopoietic stem cells (HSCs) respond to and are affected by this ongoing stress. HSCs can show immunological memory after short-term exposure to inflammation. This leads to lasting changes in their transcription, metabolism, and function. However, the molecular basis of this memory and its role in MDS pathogenesis remain poorly defined. Here, we identify mitochondrial antiviral signaling protein (MAVS) as a critical mediator of dsRNA-induced HSC immune memory and inflammation-driven hematopoietic dysfunction.
 Using repeated polyinosinic-polycytidylic acid (polyIC) exposure as a dsRNA mimetic, we show that HSCs undergo persistent transcriptional and epigenetic remodeling marked by increased expression and accessibility of immune and mitochondrial genes. ATAC-seq of polyIC-treated LSK cells revealed long-lasting chromatin changes with open region for CTCF, IRF1, and PU.1 binding motifs, closed regions for RUNX1, ERG, ETS binding motifs. RNA-seq identified sustained upregulation of innate immune effectors (CD74, S100a8/9) and mitochondrial regulators. We performed single-cell RNA-seq analysis of the LSK-SLAM pool. We identified 6 clusters, comprised of 3 clusters expressing HSC markers, one expressing multipotent progenitor markers, and 2 expressing cell cycle genes with megakaryocyte priming, consistent with LSK-SLAM heterogeneity. Interestingly, polyIC challenges expanded one HSC cluster marked by expression of immune genes (CD81, CD24a, Nr4a1, Cebpb), AP1 complex genes (Fos, Jun, Junb), as well as metabolic genes (OXPHOS, TCA, mTOR), at the expanse of other HSC-enriched clusters. This inflammatory signature is similar to what is found following LPS or mycobacterial challenges and consistent with immune memory. Immune memory involves metabolic reprograming. Mitochondria serve as platform of innate immune signaling, activating the inflammasome and the dsRNA sensing adaptor mitochondrial antiviral signaling protein (MAVS) to trigger immune responses. Confocal microscopy demonstrated persistent MAVS aggregation on mitochondria and elevated mitochondrial content in polyIC-challenged murine HSCs, months after transient polyIC challenge. Remarkably, MAVS-deficiency prevented expansion of HSC clones with immune memory in response to polyIC challenges. MAVS–/– mice resisted polyIC-induced HSC functional decline, and retained superior HSC engraftment capacity in serial competitive repopulation assay. Finally, MAVS-deficiency prevented the sustained activation of caspase-1 in HSCs that persisted in WT HSC months after polyIC challenge, linking MAVS to the inflammasome in polyIC-induced HSC dysfunction. Hence, HSC immune memory is mediated by MAVS.
 To probe MAVS's pathogenic potential, we utilized an inducible model of active TGF-β1 overexpression (TgCre+) that phenocopies key features of high-risk MDS upon inflammatory stimulation. PolyIC-treated TgCre+;MAVS+/+ mice developed cytopenias, myeloid dysplasia, increased HSC frequencies, elevated mitochondrial membrane potential, and persistent MAVS aggregation with increased caspase-1 activity. MAVS deletion (TgCre+;MAVS–/–) reversed cytopenias, normalized stem/progenitor ratios, and prevented dysplastic features, establishing MAVS as a central node connecting inflammation, mitochondrial stress, and ineffective hematopoiesis. These observations were extended to human MDS. CD34+CD38- cells from high-risk MDS patients showed elevated phospho-SMAD2, mitochondrial aggregation, sustained MAVS clustering, and caspase-1 activation, similar to murine data.
 Together, these findings indicate that repeated exposure to dsRNA elicits MAVS-dependent immune memory in HSCs, and causes HSC functional decline with expansion of a subset of inflammatory HSCs. MAVS-deficiency not only preserves HSC integrity following inflammatory stress but also reverses MDS-like features in vivo. Our findings establish MAVS as a critical molecular link between inflammation and hematopoietic failure and suggest mitochondrial associated immune signaling may be a promising therapeutic target in inflammation-driven MDS and related disorders.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3c6b5f7f34187a78587b80d05002010f5646c168" target='_blank'>
              Mavs mediates inflammatory memory in hematopoietic stem cells and promotes ineffective hematopoiesis
              </a>
            </td>
          <td>
            Waseem Nasr, V. Pham, Juying Xu, Micheal Jordan, Amit K. Verma, Gang Huang, M. Filippi
          </td>
          <td>2025-11-03</td>
          <td>Blood</td>
          <td>0</td>
          <td>32</td>
        </tr>

        <tr id="


 The vulnerability of older adults to severe viral infections and cancers highlights the importance of understanding immunosenescence, a process of age-related immune dysfunction. Older individuals have lower percentages of type I interferon (IFN-I) producing plasmacytoid dendritic cells (pDC) compared to younger individuals (p = 0.008). These cells are critical for antiviral immunity and are the most potent producers of IFN-I in response to viral stimulation. To investigate this decline, we examined how mitochondrial health, particularly mitochondrial reactive oxygen species (mtROS) and mitochondrial membrane potential (MMP), differ in pDC between younger (20s) and older (60+) individuals. Our results show pDC from older individuals exhibit lower mtROS expression and MMP levels than younger donors, both at baseline and following influenza A (IAV) stimulation. While stimulation increased mtROS in younger donors, no increase occurred in older donors. MMP differences between age groups were also seen in mock and stimulated conditions, with MMP trending downward after stimulation. To examine the role of mtROS in IFN-I production, we used Antimycin A, a mitochondrial complex III inhibitor. Early mtROS induction inhibited IFN-I production, while later mtROS induction enhanced it. These findings suggest that age-related mitochondrial changes, marked by altered mtROS and MMP, impair pDC IFN-I responses and highlight the importance of mitochondrial dynamics in pDC senescence.



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0d5623a5627077205216fc59779c9b4b0d5597fc" target='_blank'>
              Mitochondrial function in aging plasmacytoid dendritic cells and its role in type I interferon responses 3813
              </a>
            </td>
          <td>
            Nica Mariz Aquino
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="


 Respiratory syncytial virus (RSV) is a major cause of severe respiratory illness. While most symptoms of RSV infection are linked to airway inflammation, emerging clinical data reveals that RSV can infiltrate the central nervous system (CNS), and lead to neurological manifestations such as seizures and central apnea, and in rare cases, encephalopathy, that can have long-term neurodevelopmental consequences. Despite detection of viral infection in the CNS, the pathophysiological mechanisms of RSV-mediated CNS disease are not well defined. Here, we have modeled RSV-infection of the CNS using human primary neuronal cultures and human brain organoid models of infection. Using confocal microscopy, biochemical and single-cell genomics approaches, we have identified that RSV could productively infect neurons, caused cell death and inflammatory responses, and altered the overall transcriptome of neurons and non-neuronal CNS cell populations after infection. Moreover, we have identified key cell-surface adhesion molecules that are critical for RSV infection in the CNS, and optimized soluble forms of these cell-surface glycoproteins to block viral infection. Our findings advance our understanding of RSV dissemination into the CNS and highlight a potential soluble receptor-based therapy to mitigate against lung and CNS inflammation. This work paves the way for new therapeutic strategies against RSV, and establishes an approach for characterizing viral infection in the human CNS.



 Supported by Children’s Mercy Research Partners, Children’s Mercy Research Institute and Paul Henson Endowment Clinical Scholar Award.



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a31e2366a9a7df016f4bc922e0f7dae7542f7a45" target='_blank'>
              Identification of the cellular mechanisms of neurological inflammation after RSV infection using a human brain organoid model 3139
              </a>
            </td>
          <td>
            Eric S. Geanes, Rebecca McLennan, J. Gage Greening, Santosh Khanal, Daniel A. Louiselle, Elin Grundberg, Marc Herman, Todd Bradley
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Background: Long COVID—defined as the persistence of symptoms or the development of new symptoms beyond four weeks after acute SARS-CoV-2 infection—affects an estimated 10–30% of individuals recovering from COVID-19, posing a significant public health burden. Emerging evidence suggests that type I interferons (IFNs) (a critical group of cytokines in the antiviral defense) and hematologic alterations, such as lymphopenia and elevated inflammatory markers, are linked to both the severity of acute COVID-19 and the likelihood of developing long-term symptoms. The aim of this study is to explore the association between type I IFN signatures and long COVID. A second aim is to examine the relationship between laboratory findings during acute infection and long COVID. Methods: The study included 61 patients investigated for the presence of long COVID symptoms 16.5 ±1.5 months after acute infection. Patients were divided into two groups of higher symptom burden of long COVID and those with milder symptoms based on demographic, laboratory, and clinical data as well as type I IFN-inducible gene expression (MX-1, IFIT-1, and IFI-44) measured in peripheral blood by real-time PCR. Data collected during acute infection were recorded. Peripheral blood samples were collected during the acute phase of infection, within the first 48 h of hospital admission. IFN-inducible gene expression was measured prospectively at that time, and RNA was extracted immediately for subsequent analysis. Results: History of intubation emerged as a significant associated factor of severe long COVID, with 75% of intubated patients reporting >8 persistent symptoms approximately 16 months post-infection. Higher white blood cell (WBC) and neutrophil counts but lower eosinophil and monocyte counts in acute infection were found to be associated with a high burden of long COVID symptoms. Interestingly, absolute monocyte count was found to independently correlate with higher long COVID symptom burden. Lactate dehydrogenase (LDH) and serum glutamic-oxaloacetic transaminase (SGOT) also differed significantly between groups, with higher levels correlating with a high burden of long COVID symptoms. Notably, MX-1 transcript levels in peripheral blood at the time of acute infection were reduced in patients with a high burden of long COVID symptoms, suggesting that dysregulated immune responses during the acute phase may contribute to persistent symptoms. Conclusions: These findings suggest the potential association of hematological and immune markers with long COVID severity, as well as the importance of monitoring these parameters to identify at-risk patients for early interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/55948e1961f89d1c723409be2502799de1b2eb5e" target='_blank'>
              Type I Interferon-Related Gene Expression and Laboratory Abnormalities in Acute Infection Are Associated with Long COVID Symptom Burden
              </a>
            </td>
          <td>
            M. Emmanouil, V. Georgakopoulou, Konstantinos Drougkas, Panagiotis Lembessis, Charalampos Skarlis, A. Gkoufa, N. Sipsas, C. Mavragani
          </td>
          <td>2025-11-01</td>
          <td>Journal of Clinical Medicine</td>
          <td>0</td>
          <td>44</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c98081e2d94c1f8f3d01731f5e992ad893a30f3e" target='_blank'>
              Acute systemic inflammation induces region-specific morphological remodeling of astrocytes and microglia concurrent with depression-like behavior
              </a>
            </td>
          <td>
            An-Qi Zhang, Meng-Meng Zhang, Ling-Jie Li, Mei-Xue Yuan, Rong-Yu Liu, Peng Chen, Chen-Wei Wang, Yu Wang, Jiang Zhou, Qing-Hong Shan, Xinya Qin
          </td>
          <td>2025-11-28</td>
          <td>Histochemistry and Cell Biology</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8b1f851971ca708410ff0c33c84532d4113e8c34" target='_blank'>
              The antiviral Interferon pathway drives astrocyte aging and motor decline
              </a>
            </td>
          <td>
            Lara Labarta-Bajo, Ayesha R. Thanawalla, Irene L Gutierrez, Su May Lei Soe, Brent Y. Chick, Ioanna Andritsogianni, Setareh Metanat, Diana C. Hargreaves, S. Kaech, Eiman Azim, Nicola J. Allen
          </td>
          <td>2025-11-13</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Survivors of COVID-19 can experience long-term lung complications (pulmonary sequelae), but the underlying mechanisms remain unclear. While most patients with COVID-19 lung injury eventually recover essentially completely, some experience significant residual damage. To investigate the underlying differences, we analyzed, using bronchoalveolar lavage fluid (BALF), the alveolar immune cell compartments of a group of patients with post-COVID-19 interstitial lung disease (ILD) six months after acute COVID-19. Patients were categorized into two groups, based on High-Resolution Computed Tomography (HRCT) evaluation a year later: those with persistent HRCT abnormalities compatible with fibrosis (persistent post-COVID-19 ILD, n=6) and those with resolved lung lesions (resolved post-COVID-19 ILD, n=13). Additionally, 6 patients with pre-existing ILD were included in the study, after recovery from COVID-19. Bulk RNA transcriptomics analyses of BALF cells revealed innate immunity and inflammation pathways of neutrophil and monocyte chemotaxis to be enriched in patients with persistent HRCT abnormalities post-COVID-19, consistent with an increase in monocyte-like cell recruitment in the lungs. Pro-fibrotic SPP1 gene expression was significantly upregulated similarly to other fibrotic lung diseases. Conversely, patients with resolved post-COVID-19 ILD showed enhanced BALF cell gene expression signatures indicative of adaptive immune response activation. BALF gene expression patterns of low T-cell activation, high pro-fibrotic macrophage activation and neutrophil chemotaxis were similarly observed in patients with pre-existing fibrotic ILD following COVID-19. These findings suggest that immune response imbalance leading to prolonged activation of innate immunity and subdued adaptive immune responses may be associated with persistent post-COVID-19 ILD and the development of pulmonary fibrosis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3f0faca69cfb328bb72907f38427c47bebf12818" target='_blank'>
              BALF gene expression profiling reveals a fibrosis associated innate immune activation bias in persistent post-COVID-19 ILD.
              </a>
            </td>
          <td>
            Katerina M Katerina Antoniou, E. Vasarmidi, A. Galaras, M. Lourou, Ioanna Argyriou, D. Zevla, N. Bizymi, C. Skiadas, I. Lambiri, P. Hatzis, V. Aidinis, Nikolaos Tzanakis, A. Wells, E. Tsitoura
          </td>
          <td>2025-11-14</td>
          <td>American journal of physiology. Lung cellular and molecular physiology</td>
          <td>0</td>
          <td>43</td>
        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

</body>

<script>

  function create_author_list(author_list) {
    let td_author_element = document.getElementById();
    for (let i = 0; i < author_list.length; i++) {
          // tdElements[i].innerHTML = greet(tdElements[i].innerHTML);
          alert (author_list[i]);
      }
  }

  var trace1 = {
    x: ['2024', '2025'],
    y: [2, 4],
    name: 'Num of citations',
    yaxis: 'y1',
    type: 'scatter'
  };

  var data = [trace1];

  var layout = {
    yaxis: {
      title: 'Num of citations',
      }
  };
  Plotly.newPlot('myDiv1', data, layout);
</script>
<script>
var dataTableOptions = {
        initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;

                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);

                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';

                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    scrollX: true,
    scrollCollapse: true,
    paging: true,
    fixedColumns: true,
    columnDefs: [
        {"className": "dt-center", "targets": "_all"},
        // set width for both columns 0 and 1 as 25%
        { width: '7%', targets: 0 },
        { width: '30%', targets: 1 },
        { width: '25%', targets: 2 },
        { width: '15%', targets: 4 }

      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  }
  new DataTable('#table1', dataTableOptions);
  new DataTable('#table2', dataTableOptions);

  var table1 = $('#table1').DataTable();
  $('#table1 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table1.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
    }
  });
  var table2 = $('#table2').DataTable();
  $('#table2 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table2.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
    }
  });
</script>
<style>
  .child-row-content {
    text-align: justify;
    text-justify: inter-word;
    word-wrap: break-word; /* Ensure long words are broken */
    white-space: normal; /* Ensure text wraps to the next line */
    max-width: 100%; /* Ensure content does not exceed the table width */
    padding: 10px; /* Optional: add some padding for better readability */
    /* font size */
    font-size: small;
  }
</style>
</html>







  
  




  



                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
          <button type="button" class="md-top md-icon" data-md-component="top" hidden>
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8v12Z"/></svg>
  Back to top
</button>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    <script id="__config" type="application/json">{"base": "..", "features": ["navigation.top", "navigation.tabs"], "search": "../assets/javascripts/workers/search.b8dbb3d2.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}}</script>
    
    

      <script src="../assets/javascripts/bundle.c8d2eff1.min.js"></script>
      
    
<script>
  // Execute intro.js when a button with id 'intro' is clicked
  function startIntro(){
      introJs().setOptions({
          tooltipClass: 'customTooltip'
      }).start();
  }
</script>
<script>
  

  // new DataTable('#table1', {
  //   order: [[5, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });

  // new DataTable('#table2', {
  //   order: [[3, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });
  new DataTable('#table3', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
  new DataTable('#table4', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
</script>


  </body>
</html>